Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2014 | Nov. 05, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'VALIDUS HOLDINGS LTD | ' |
Entity Central Index Key | '0001348259 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-14 | ' |
Amendment Flag | 'false | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Well-known Seasoned Issuer | 'Yes | ' |
Entity Voluntary Filers | 'No | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 87,376,871 |
Consolidated_Balance_Sheets_Un
Consolidated Balance Sheets (Unaudited) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Thousands, unless otherwise specified | ||||
Assets | ' | ' | ||
Fixed maturities, at fair value (amortized cost: 2014—$4,668,585; 2013—$5,522,853) | $4,670,173 | $5,542,258 | ||
Short-term investments, at fair value (amortized cost: 2014—$1,684,997; 2013—$751,734) | 1,684,982 | [1] | 751,778 | [2] |
Other investments, at fair value (cost: 2014—$714,508; 2013—$637,728) | 718,633 | 618,316 | ||
Cash and cash equivalents | 843,747 | 1,056,346 | ||
Total investments and cash | 7,917,535 | 7,968,698 | ||
Investments in affiliates | 217,612 | 141,243 | ||
Premiums receivable | 936,306 | 697,233 | ||
Deferred acquisition costs | 186,277 | 134,269 | ||
Prepaid reinsurance premiums | 129,809 | 103,251 | ||
Securities lending collateral | 9,056 | 3,392 | ||
Loss reserves recoverable | 298,502 | 370,154 | ||
Paid losses recoverable | 62,991 | 80,080 | ||
Intangible assets | 103,287 | 106,407 | ||
Goodwill | 20,393 | 20,393 | ||
Accrued investment income | 15,415 | 18,876 | ||
Other assets | 155,867 | 202,436 | ||
Total assets | 10,053,050 | 9,846,432 | ||
Liabilities | ' | ' | ||
Reserve for losses and loss expenses | 2,752,168 | 3,030,399 | ||
Unearned premiums | 1,158,429 | 824,496 | ||
Reinsurance balances payable | 141,482 | 154,874 | ||
Securities lending payable | 9,522 | 3,858 | ||
Deferred income taxes | 11,687 | 19,086 | ||
Net payable for investments purchased | 54,735 | 19,383 | ||
Accounts payable and accrued expenses | 186,649 | 278,187 | ||
Notes payable to operating affiliates | 655,976 | 439,272 | ||
Senior notes payable | 247,279 | 247,198 | ||
Debentures payable | 539,953 | 541,416 | ||
Total liabilities | 5,757,880 | 5,558,169 | ||
Commitments and contingent liabilities | ' | ' | ||
Redeemable noncontrolling interest | 70,473 | 86,512 | ||
Shareholders' equity | ' | ' | ||
Common shares, 571,428,571 authorized, par value $0.175 (Issued: 2014—155,253,556; 2013—154,488,497; Outstanding: 2014—89,112,271; 2013—96,044,312) | 27,169 | 27,036 | ||
Treasury shares (2014—66,141,285; 2013—58,444,185) | -11,575 | -10,228 | ||
Additional paid-in-capital | 1,413,145 | 1,677,894 | ||
Accumulated other comprehensive loss | -2,738 | -617 | ||
Retained earnings | 2,276,409 | 2,010,009 | ||
Total shareholders' equity available to Validus | 3,702,410 | 3,704,094 | ||
Noncontrolling interest | 522,287 | 497,657 | ||
Total shareholders' equity | 4,224,697 | 4,201,751 | ||
Total liabilities, noncontrolling interests and shareholders’ equity | $10,053,050 | $9,846,432 | ||
[1] | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||
[2] | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Thousands, except Share data, unless otherwise specified | ||||
Assets | ' | ' | ||
Fixed maturities, at amortized cost or cost | $4,668,585 | $5,522,853 | ||
Short-term investments, at amortized cost or cost | 1,684,997 | [1] | 751,734 | [2] |
Other investments, at amortized cost or cost | $714,508 | $637,728 | ||
Shareholders' equity | ' | ' | ||
Common shares, shares authorized | 571,428,571 | 571,428,571 | ||
Common shares, par value | $0.18 | $0.18 | ||
Common shares, shares issued | 155,253,556 | 154,488,497 | ||
Common shares, shares outstanding | 89,112,271 | 96,044,312 | ||
Treasury stock, common shares | 66,141,285 | 58,444,185 | ||
[1] | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||
[2] | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Revenues | ' | ' | ' | ' | ||||
Gross premiums written | $358,974 | $356,760 | $2,026,639 | $2,163,833 | ||||
Reinsurance premiums ceded | -30,137 | -39,415 | -275,610 | -348,027 | ||||
Net premiums written | 328,837 | 317,345 | 1,751,029 | 1,815,806 | ||||
Change in unearned premiums | 165,859 | 213,943 | -307,373 | -205,999 | ||||
Net premiums earned | 494,696 | 531,288 | 1,443,656 | 1,609,807 | ||||
Net investment income | 25,261 | 20,009 | 69,909 | 71,868 | ||||
Net realized gains (losses) on investments | 4,595 | -6,320 | 16,193 | -1,190 | ||||
Change in net unrealized (losses) gains on investments | -84,974 | [1] | 69,967 | [1] | 16,146 | [1] | -78,618 | [1] |
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 | ||||
Other (loss) income | -4,080 | -2,806 | 14,985 | 4,297 | ||||
Foreign exchange (losses) gains | -11,441 | 6,036 | -14,761 | 4,735 | ||||
Total revenues | 425,811 | 619,218 | 1,554,009 | 1,615,173 | ||||
Expenses | ' | ' | ' | ' | ||||
Losses and loss expenses | 224,125 | 177,965 | 545,541 | 587,780 | ||||
Policy acquisition costs | 86,404 | 94,900 | 251,006 | 275,663 | ||||
General and administrative expenses | 83,319 | 81,089 | 231,606 | 232,335 | ||||
Share compensation expenses | 8,764 | 10,527 | 24,252 | 19,483 | ||||
Finance expenses | 15,354 | 15,317 | 47,380 | 47,252 | ||||
Transaction expenses | 149 | [2] | 0 | 3,401 | [2] | 0 | ||
Total expenses | 418,115 | 379,798 | 1,103,186 | 1,162,513 | ||||
Income before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 7,696 | 239,420 | 450,823 | 452,660 | ||||
Tax benefit (expense) | 953 | -5 | -398 | 220 | ||||
Income from operating affiliates | 3,761 | 1,463 | 13,580 | 8,779 | ||||
(Income) attributable to operating affiliate investors | -25,807 | -11,815 | -82,833 | -42,156 | ||||
Net (loss) income | -13,397 | 229,063 | 381,172 | 419,503 | ||||
Net loss (income) attributable to noncontrolling interest | 53,069 | -45,694 | -25,745 | 17,831 | ||||
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ||||
Other comprehensive (loss) income | ' | ' | ' | ' | ||||
Foreign currency translation adjustments | -5,198 | 4,390 | -2,121 | -5,209 | ||||
Other comprehensive (loss) income | -5,198 | 4,390 | -2,121 | -5,209 | ||||
Comprehensive income available to Validus | $34,474 | $187,759 | $353,306 | $432,125 | ||||
Weighted average number of common shares and common share equivalents outstanding | ' | ' | ' | ' | ||||
Basic | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 | ||||
Diluted | 91,939,610 | 103,613,766 | 95,937,641 | 105,264,913 | ||||
Basic earnings per share available to common shareholders | $0.42 | $1.82 | $3.83 | $4.06 | ||||
Earnings per diluted share available to common shareholders | $0.41 | $1.77 | $3.70 | $3.99 | ||||
Cash dividends declared per share | $0.30 | $0.30 | $0.90 | $2.90 | ||||
[1] | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. | |||||||
[2] | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the three months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. |
Consolidated_Statements_of_Sha
Consolidated Statements of Shareholders' Equity (Unaudited) (USD $) | Total | Common shares | Treasury shares | Additional paid-in capital | Accumulated other comprehensive loss | Retained earnings |
In Thousands | ||||||
Balance - Beginning of period at Dec. 31, 2012 | ' | $26,722 | ($7,836) | $2,160,478 | ($2,953) | $1,844,416 |
Common shares issued (redeemed), net | ' | 296 | ' | -134 | ' | ' |
Repurchase of common shares | ' | ' | -1,699 | -355,485 | ' | ' |
Share compensation expenses | ' | ' | ' | 19,483 | ' | ' |
Other comprehensive loss | -5,209 | ' | ' | ' | -5,209 | ' |
Dividends | ' | ' | ' | ' | ' | -331,251 |
Net income | 419,503 | ' | ' | ' | ' | 419,503 |
Net loss (income) attributable to noncontrolling interest | 17,831 | ' | ' | ' | ' | 17,831 |
Amounts reclassified to retained earnings | ' | ' | ' | ' | 4,290 | -4,290 |
Total shareholders' equity at Sep. 30, 2013 | 4,256,095 | ' | ' | ' | ' | ' |
Noncontrolling interest at Sep. 30, 2013 | 471,933 | ' | ' | ' | ' | ' |
Balance - End of period at Sep. 30, 2013 | 3,784,162 | 27,018 | -9,535 | 1,824,342 | -3,872 | 1,946,209 |
Balance - Beginning of period at Dec. 31, 2013 | 3,704,094 | 27,036 | -10,228 | 1,677,894 | -617 | 2,010,009 |
Common shares issued (redeemed), net | ' | 133 | ' | -3,822 | ' | ' |
Repurchase of common shares | ' | ' | -1,347 | -285,179 | ' | ' |
Share compensation expenses | ' | ' | ' | 24,252 | ' | ' |
Other comprehensive loss | -2,121 | ' | ' | ' | -2,121 | ' |
Dividends | ' | ' | ' | ' | ' | -89,027 |
Net income | 381,172 | ' | ' | ' | ' | 381,172 |
Net loss (income) attributable to noncontrolling interest | -25,745 | ' | ' | ' | ' | -25,745 |
Amounts reclassified to retained earnings | ' | ' | ' | ' | 0 | 0 |
Total shareholders' equity at Sep. 30, 2014 | 4,224,697 | ' | ' | ' | ' | ' |
Noncontrolling interest at Sep. 30, 2014 | 522,287 | ' | ' | ' | ' | ' |
Balance - End of period at Sep. 30, 2014 | $3,702,410 | $27,169 | ($11,575) | $1,413,145 | ($2,738) | $2,276,409 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | ||
Cash flows provided by (used in) operating activities | ' | ' | ||
Net income | $381,172 | $419,503 | ||
Adjustments to reconcile net income to cash provided by (used in) operating activities: | ' | ' | ||
Share compensation expenses | 24,252 | 19,483 | ||
Gain on sale of subsidiary | -709 | 0 | ||
Gain on deconsolidation of subsidiary | -1,372 | 0 | ||
Amortization of discount on senior notes | 81 | 81 | ||
Income from investment affiliate | -7,881 | -4,274 | ||
Net realized (gains) losses on investments | -16,193 | 1,190 | ||
Change in net unrealized (gains) losses on investments | -16,146 | [1] | 78,618 | [1] |
Amortization of intangible assets | 3,120 | 3,120 | ||
Income from operating affiliates | -13,580 | -8,779 | ||
Foreign exchange losses included in net income | 10,841 | 4,927 | ||
Amortization of premium on fixed maturities | 11,922 | 14,870 | ||
Change in: | ' | ' | ||
Premiums receivable | -241,175 | -226,154 | ||
Deferred acquisition costs | -52,008 | -19,951 | ||
Prepaid reinsurance premiums | -26,558 | -69,469 | ||
Loss reserves recoverable | 70,444 | 20,411 | ||
Paid losses recoverable | 17,245 | 16,218 | ||
Income taxes recoverable | 0 | -3,099 | ||
Accrued investment income | 3,431 | 3,466 | ||
Other assets | 30,125 | -11,214 | ||
Reserve for losses and loss expenses | -271,063 | -293,673 | ||
Unearned premiums | 333,933 | 275,468 | ||
Reinsurance balances payable | -12,836 | -634 | ||
Deferred income taxes | -7,385 | 2,565 | ||
Accounts payable and accrued expenses | -70,809 | -17,783 | ||
Net cash provided by operating activities | 148,851 | 204,890 | ||
Cash flows provided by (used in) investing activities | ' | ' | ||
Proceeds on sales of investments | 3,587,124 | 3,598,080 | ||
Proceeds on maturities of investments | 466,872 | 406,079 | ||
Purchases of fixed maturities | -3,161,908 | -4,414,320 | ||
(Purchases) sales of short-term investments, net | -961,264 | 348,554 | ||
Purchases of other investments, net | -69,932 | -21,793 | ||
Increase in securities lending collateral | -5,664 | -796 | ||
Redemption of investment in operating affiliates | 58,547 | 86,657 | ||
Purchase of investment in investment affiliate | 0 | -13,089 | ||
Proceeds sale of subsidiary | 16,459 | 0 | ||
Net cash used in investing activities | -69,766 | -10,628 | ||
Cash flows provided by (used in) financing activities | ' | ' | ||
Net proceeds on issuance of notes payable to operating affiliates | 43,175 | 418,299 | ||
(Redemption) issuance of common shares, net | -3,689 | 162 | ||
Purchases of common shares under share repurchase program | -286,526 | -357,184 | ||
Dividends paid | -89,719 | -329,201 | ||
Increase in securities lending payable | 5,664 | 796 | ||
Investment in third party redeemable noncontrolling interest | 50,704 | 62,790 | ||
Investment in third party noncontrolling interest | 0 | 58,500 | ||
Net cash used in financing activities | -280,391 | -145,838 | ||
Effect of foreign currency rate changes on cash and cash equivalents | -11,293 | -13,185 | ||
Net (decrease) increase in cash | -212,599 | 35,239 | ||
Cash and cash equivalents - beginning of period | 1,056,346 | 1,219,379 | ||
Cash and cash equivalents - end of period | 843,747 | 1,254,618 | ||
Taxes paid during the period | 7,286 | 5,325 | ||
Interest paid during the period | $46,421 | $44,112 | ||
[1] | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. |
Basis_of_preparation_and_conso
Basis of preparation and consolidation | 9 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of presentation and consolidation | ' |
Basis of preparation and consolidation | |
These unaudited Consolidated Financial Statements (the "Consolidated Financial Statements") include Validus Holdings, Ltd. and its wholly and majority owned subsidiaries (together the "Company") and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the U.S. Securities and Exchange Commission (the "SEC"). | |
In the opinion of management, these Consolidated Financial Statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair presentation of the Company's financial position and results of operations as at the end of and for the periods presented. To facilitate comparison of information, certain amounts in prior periods have been reclassified to conform to current period presentation. The consolidated statement of cash flows for the nine months ended September 30, 2013 includes a reclassification of $19,400 that increased net cash flows used in financing activities and net cash flows provided by operating activities to revise the presentation of subscriptions received in advance from third party investors. For the three and nine months ended September 30, 2013, $11,815 and $42,156 respectively, have been reclassified into income attributable to operating affiliate investors from finance expenses to conform to current period presentation. All significant intercompany accounts and transactions have been eliminated. The results of operations for any interim period are not necessarily indicative of the results for a full year. | |
The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ materially from those estimates. The Company’s principal estimates include: | |
•reserve for losses and loss expenses; | |
•premium estimates for business written on a line slip or proportional basis; | |
•the valuation of goodwill and intangible assets; | |
•reinsurance recoverable balances including the provision for uncollectible amounts; and | |
•investment valuation of financial assets. | |
The term “ASC” used in these notes refers to Accounting Standard Codification issued by the U.S. Financial Accounting Standards Board (“FASB”). |
Recent_accounting_pronouncemen
Recent accounting pronouncements | 9 Months Ended |
Sep. 30, 2014 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Recent accounting pronouncements | ' |
Recent accounting pronouncements | |
Adoption of New Accounting Standards | |
Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity | |
In March 2013, the FASB issued Accounting Standard Update No. 2013-05, “Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (ASU 2013-05). The objective of this Update is to resolve the diversity in practice about whether Subtopic 810-10, Consolidation-Overall, or Subtopic 830-30, Foreign Currency Matters-Translation of Financial Statements, applies to the release of the cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary within a foreign entity. The amendments became effective for the Company on January 1, 2014. Adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements. | |
Financial Services - Investment Companies - Amendments to the Scope, Measurement, and Disclosure Requirements | |
In June 2013, the FASB issued Accounting Standard Update No. 2013-08, “Financial Services - Investment Companies - Amendments to the Scope, Measurement, and Disclosure Requirements” (ASU 2013-08). The amendments in this Update change the assessment of whether an entity is an investment company by developing a new two-tiered approach for that assessment, which requires an entity to possess certain fundamental characteristics while allowing judgment in assessing other typical characteristics. The new approach requires an entity to assess all of the characteristics of an investment company and consider its purpose and determine whether it is an investment company. The amendments became effective for the Company on January 1, 2014. The Company performed an assessment and has concluded that the AlphaCat ILS funds meet the characteristics outlined in this Update and therefore will continue to be treated as investment companies. | |
Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists | |
In July 2013, the FASB issued Accounting Standard Update No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (ASU 2013-11). This Update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. An unrecognized tax benefit should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. To the extent a net operating loss carryforward is not available to settle any additional income taxes that would result from the disallowance of a tax position at the reporting date, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments became effective for the Company on January 1, 2014. Adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements. | |
Recently Issued Accounting Standards Not Yet Adopted | |
In May 2014, the FASB issued Accounting Standard Update No. 2014-09, “Revenue from Contracts with Customers” (ASU 2014-09). The guidance in this Update affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards (for example, insurance contracts or lease contracts). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Earlier adoption is not permitted. The Company is currently evaluating the impact of this guidance on the Company’s Consolidated Financial Statements. | |
In June 2014, the FASB issued Accounting Standard Update No. 2014-12, “Compensation - Stock Compensation (Topic 718) - Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period” (ASU 2014-12). The amendments in this Update apply to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. That is the case when an employee is eligible to retire or otherwise terminate employment before the end of the period in which a performance target (for example, an initial public offering or a profitability target) could be achieved and still be eligible to vest in the award if and when the performance target is achieved. The amendments in this Update are effective for annual reporting periods beginning after December 15, 2015, including interim periods within that reporting period. Earlier adoption is permitted. The Company is currently evaluating the impact of this guidance; however, it is not expected to have a material impact on the Company's Consolidated Financial Statements. | |
In August 2014, the FASB issued Accounting Standard Update 2014-13, “Consolidation (Topic 810) - Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity” (ASU 2014-13). The fair value of the financial assets of a collateralized financing entity, as determined under GAAP, may differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. The amendments in this Update provide an alternative to Topic 820 for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate that difference. The amendments in this Update are effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted as of the beginning of an annual period. The Company is currently evaluating the impact of this guidance on the Company’s Consolidated Financial Statements. | |
In August 2014, the FASB issued Accounting Standard Update 2014-15, “Presentation of Financial Statements - Going Concern - Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). The amendments in this Update require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the impact of this guidance; however, it will not have a material impact on the Company's Consolidated Financial Statements. |
Investments
Investments | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||
Investments | ' | |||||||||||||||
Investments | ||||||||||||||||
(a) | Fixed maturity, short-term and other investments | |||||||||||||||
The Company's investments in fixed maturities, short-term investments and other investments are classified as trading and carried at fair value, with related changes in net unrealized gains or losses included in earnings. | ||||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at September 30, 2014 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 786,318 | $ | 1,735 | $ | (1,798 | ) | $ | 786,255 | |||||||
Non-U.S. government and government agency | 383,378 | 1,775 | (3,956 | ) | 381,197 | |||||||||||
U.S. states, municipalities and political subdivisions | 73,996 | 557 | (188 | ) | 74,365 | |||||||||||
Agency residential mortgage-backed securities | 368,646 | 7,877 | (1,296 | ) | 375,227 | |||||||||||
Non-agency residential mortgage-backed securities | 17,370 | 238 | (409 | ) | 17,199 | |||||||||||
U.S. corporate | 1,168,304 | 5,601 | (4,987 | ) | 1,168,918 | |||||||||||
Non-U.S. corporate | 593,619 | 4,071 | (3,055 | ) | 594,635 | |||||||||||
Bank loans | 488,904 | 616 | (5,732 | ) | 483,788 | |||||||||||
Catastrophe bonds | 47,574 | 1,305 | (541 | ) | 48,338 | |||||||||||
Asset-backed securities | 566,135 | 981 | (664 | ) | 566,452 | |||||||||||
Commercial mortgage-backed securities | 174,341 | 48 | (590 | ) | 173,799 | |||||||||||
Total fixed maturities | 4,668,585 | 24,804 | (23,216 | ) | 4,670,173 | |||||||||||
Total short-term investments (b) | 1,684,997 | 4 | (19 | ) | 1,684,982 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 2,802 | 162 | (921 | ) | 2,043 | |||||||||||
Hedge funds (a) | 570,372 | 101,610 | (104,142 | ) | 567,840 | |||||||||||
Private equity investments | 11,295 | 3,832 | (108 | ) | 15,019 | |||||||||||
Investment funds | 123,840 | 350 | — | 124,190 | ||||||||||||
Mutual funds | 6,199 | 3,342 | — | 9,541 | ||||||||||||
Total other investments | 714,508 | 109,296 | (105,171 | ) | 718,633 | |||||||||||
Total investments including noncontrolling interests | $ | 7,068,090 | $ | 134,104 | $ | (128,406 | ) | $ | 7,073,788 | |||||||
Noncontrolling interest (a) | $ | (502,830 | ) | $ | (86,263 | ) | $ | 93,728 | $ | (495,365 | ) | |||||
Redeemable noncontrolling interest (b) | $ | (11,637 | ) | $ | — | $ | — | $ | (11,637 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 6,553,623 | $ | 47,841 | $ | (34,678 | ) | $ | 6,566,786 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at December 31, 2013 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,368,826 | $ | 2,589 | $ | (6,736 | ) | $ | 1,364,679 | |||||||
Non-U.S. government and government agency | 454,578 | 6,511 | (2,021 | ) | 459,068 | |||||||||||
U.S. states, municipalities and political subdivisions | 42,978 | 459 | (317 | ) | 43,120 | |||||||||||
Agency residential mortgage-backed securities | 305,450 | 8,310 | (2,261 | ) | 311,499 | |||||||||||
Non-agency residential mortgage-backed securities | 16,530 | 143 | (914 | ) | 15,759 | |||||||||||
U.S. corporate | 1,328,960 | 9,208 | (5,684 | ) | 1,332,484 | |||||||||||
Non-U.S. corporate | 711,581 | 5,917 | (3,173 | ) | 714,325 | |||||||||||
Bank loans | 712,859 | 5,659 | (1,402 | ) | 717,116 | |||||||||||
Catastrophe bonds | 72,000 | 2,551 | — | 74,551 | ||||||||||||
Asset-backed securities | 509,091 | 1,409 | (843 | ) | 509,657 | |||||||||||
Total fixed maturities | 5,522,853 | 42,756 | (23,351 | ) | 5,542,258 | |||||||||||
Total short-term investments (b) | 751,734 | 45 | (1 | ) | 751,778 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 3,141 | 83 | (921 | ) | 2,303 | |||||||||||
Hedge funds (a) | 584,518 | 71,641 | (95,076 | ) | 561,083 | |||||||||||
Private equity investments | 12,333 | 1,410 | (258 | ) | 13,485 | |||||||||||
Investment funds | 31,537 | 92 | — | 31,629 | ||||||||||||
Mutual funds | 6,199 | 3,617 | — | 9,816 | ||||||||||||
Total other investments | 637,728 | 76,843 | (96,255 | ) | 618,316 | |||||||||||
Total investments including noncontrolling interests | $ | 6,912,315 | $ | 119,644 | $ | (119,607 | ) | $ | 6,912,352 | |||||||
Noncontrolling interest (a) | (512,121 | ) | (62,850 | ) | 85,569 | (489,402 | ) | |||||||||
Redeemable noncontrolling interest (b) | $ | (18,365 | ) | $ | — | $ | — | $ | (18,365 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 6,381,829 | $ | 56,794 | $ | (34,038 | ) | $ | 6,404,585 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
As of June 30, 2014, the Company changed the methodology of assigning investment ratings to its fixed maturities portfolio. In prior periods, investment ratings were the lower of Moody’s or Standard & Poor’s rating for each investment security, presented in Standard & Poor’s equivalent rating. As of June 30, 2014, investment ratings are the median of Moody’s, Standard & Poor’s and Fitch, presented in Standard & Poor’s equivalent rating. For investments where only two ratings are available, the lower of the two ratings shall apply, presented in Standard & Poor’s equivalent rating. For investments where Moody’s and Standard & Poor’s ratings are not available, Fitch ratings are used and presented in Standard & Poor’s equivalent rating. The December 31, 2013 comparative data was restated as a result, to conform to current period presentation. | ||||||||||||||||
The following table sets forth certain information regarding the investment ratings of the Company’s fixed maturities portfolio as at September 30, 2014 and December 31, 2013. | ||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||
Estimated Fair Value | % of Total | Estimated Fair Value | % of Total | |||||||||||||
AAA | $ | 2,174,861 | 46.6 | % | $ | 2,510,781 | 45.3 | % | ||||||||
AA | 594,858 | 12.7 | % | 696,998 | 12.6 | % | ||||||||||
A | 960,153 | 20.6 | % | 1,233,716 | 22.3 | % | ||||||||||
BBB | 363,626 | 7.8 | % | 323,085 | 5.8 | % | ||||||||||
Total investment-grade fixed maturities | 4,093,498 | 87.7 | % | 4,764,580 | 86 | % | ||||||||||
BB | 283,954 | 6.1 | % | 354,992 | 6.4 | % | ||||||||||
B | 269,380 | 5.8 | % | 383,639 | 6.9 | % | ||||||||||
CCC | 1,341 | — | % | 2,453 | — | % | ||||||||||
CC | 2,330 | — | % | 2,496 | 0.1 | % | ||||||||||
C | 146 | — | % | 235 | — | % | ||||||||||
D/NR | 19,524 | 0.4 | % | 33,863 | 0.6 | % | ||||||||||
Total non-investment grade fixed maturities | 576,675 | 12.3 | % | 777,678 | 14 | % | ||||||||||
Total fixed maturities | $ | 4,670,173 | 100 | % | $ | 5,542,258 | 100 | % | ||||||||
The amortized cost and estimated fair value amounts for fixed maturities held at September 30, 2014 and December 31, 2013 are shown below by contractual maturity. Actual maturity may differ from contractual maturity because certain borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties. | ||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||
Amortized Cost | Estimated Fair Value | Amortized Cost | Estimated Fair Value | |||||||||||||
Due in one year or less | $ | 277,213 | $ | 278,507 | $ | 688,855 | $ | 692,768 | ||||||||
Due after one year through five years | 2,678,792 | 2,679,938 | 3,603,459 | 3,613,847 | ||||||||||||
Due after five years through ten years | 496,922 | 491,364 | 396,389 | 395,633 | ||||||||||||
Due after ten years | 89,166 | 87,687 | 3,079 | 3,095 | ||||||||||||
3,542,093 | 3,537,496 | 4,691,782 | 4,705,343 | |||||||||||||
Asset-backed and mortgage-backed securities | 1,126,492 | 1,132,677 | 831,071 | 836,915 | ||||||||||||
Total fixed maturities | $ | 4,668,585 | $ | 4,670,173 | $ | 5,522,853 | $ | 5,542,258 | ||||||||
(b) | Net investment income | |||||||||||||||
Net investment income was derived from the following sources: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||
Fixed maturities and short-term investments | $ | 22,544 | $ | 20,936 | $ | 68,048 | $ | 74,618 | ||||||||
Other investments | 2,879 | — | 2,879 | — | ||||||||||||
Cash and cash equivalents | 1,581 | 1,079 | 4,534 | 3,241 | ||||||||||||
Securities lending income | 1 | 3 | 5 | 3 | ||||||||||||
Total gross investment income | 27,005 | 22,018 | 75,466 | 77,862 | ||||||||||||
Investment expenses | (1,744 | ) | (2,009 | ) | (5,557 | ) | (5,994 | ) | ||||||||
Total net investment income | $ | 25,261 | $ | 20,009 | $ | 69,909 | $ | 71,868 | ||||||||
Net investment income from other investments includes distributed and undistributed net income from certain investment funds. | ||||||||||||||||
(c) | Net realized gains (losses) and change in net unrealized (losses) gains on investments | |||||||||||||||
The following represents an analysis of net realized gains (losses) and the change in net unrealized (losses) gains on investments: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||
Fixed maturities, short-term and other investments | ||||||||||||||||
Gross realized gains (a) | $ | 8,075 | $ | 7,706 | $ | 23,184 | $ | 25,578 | ||||||||
Gross realized (losses) | (3,480 | ) | (14,026 | ) | (6,991 | ) | (26,768 | ) | ||||||||
Net realized gains (losses) on investments | 4,595 | (6,320 | ) | 16,193 | (1,190 | ) | ||||||||||
Change in net unrealized (losses) gains on investments (a) | (84,974 | ) | 69,967 | 16,146 | (78,618 | ) | ||||||||||
Total net realized gains (losses) and change in net unrealized (losses) gains on investments including noncontrolling interest | (80,379 | ) | 63,647 | 32,339 | (79,808 | ) | ||||||||||
Noncontrolling interest (a) | 52,595 | (42,579 | ) | (22,613 | ) | 25,766 | ||||||||||
Total net realized gains (losses) and change in net unrealized (losses) gains on investments excluding noncontrolling interest | $ | (27,784 | ) | $ | 21,068 | $ | 9,726 | $ | (54,042 | ) | ||||||
(a) | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. | |||||||||||||||
(d) | Pledged investments | |||||||||||||||
The following tables outline investments pledged as collateral under the Company's credit facilities. For further details on the credit facilities, please refer to Note 12: “Debt and financing arrangements.” | ||||||||||||||||
September 30, 2014 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments and cash pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 301,340 | 393,720 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 19,743 | 35,414 | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | 31,054 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 30,000 | 30,000 | 30,059 | |||||||||||||
IPC bi-lateral facility | 40,000 | 16,975 | 96,633 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 288,739 | 456,458 | |||||||||||||
Total | $ | 1,605,000 | $ | 682,091 | $ | 1,043,338 | ||||||||||
December 31, 2013 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments and cash pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 358,567 | 507,620 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 16,726 | 130,256 | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | 30,801 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 24,800 | 24,800 | 24,806 | |||||||||||||
IPC bi-lateral facility | 40,000 | 20,177 | 98,465 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 305,686 | 454,458 | |||||||||||||
Total | $ | 1,599,800 | $ | 751,250 | $ | 1,246,406 | ||||||||||
In addition, $3,035,784 of cash and cash equivalents, short-term investments and fixed maturities were pledged during the normal course of business as at September 30, 2014 (December 31, 2013: $2,947,475). Of those, $3,030,932 were held in trust (December 31, 2013: $2,942,508). Pledged assets are generally for the benefit of the Company's cedants and policyholders, to support AlphaCat's fully collateralized reinsurance transactions and to facilitate the accreditation of Talbot as an alien insurer/reinsurer by certain regulators. |
Fair_value_measurements
Fair value measurements | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair value measurements | ' | |||||||||||||||
Fair value measurements | ||||||||||||||||
(a) | Classification within the fair value hierarchy | |||||||||||||||
Fair value is defined as the price to sell an asset or transfer a liability in an orderly transaction between market participants. Under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The fair value hierarchy prioritizes the inputs, which refer broadly to assumptions market participants would use in pricing an asset or liability, into three levels. It gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. | ||||||||||||||||
The three levels of the fair value hierarchy are described below: | ||||||||||||||||
Level 1 - Fair values are measured based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. | ||||||||||||||||
Level 2 - Fair values are measured based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g., interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data. | ||||||||||||||||
Level 3 - Fair values are measured based on inputs that are unobservable and significant to the overall fair value measurement. The unobservable inputs reflect the Company's own judgments about assumptions where there is little, if any, market activity for that asset or liability that market participants might use. | ||||||||||||||||
The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the instrument. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. | ||||||||||||||||
Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This may lead the Company to change the selection of our valuation technique (for example, from market to cash flow approach) or to use multiple valuation techniques to estimate the fair value of a financial instrument. These circumstances could cause an instrument to be reclassified between levels within the fair value hierarchy. | ||||||||||||||||
There have been no material changes in the Company's valuation techniques during the period, or periods, represented by these Consolidated Financial Statements. The following methods and assumptions were used in estimating the fair value of each class of financial instrument recorded in the Consolidated Balance Sheets. | ||||||||||||||||
At September 30, 2014, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 786,255 | $ | — | $ | 786,255 | ||||||||
Non-U.S. government and government agency | — | 381,197 | — | 381,197 | ||||||||||||
U.S. states, municipalities and political subdivisions | — | 74,365 | — | 74,365 | ||||||||||||
Agency residential mortgage-backed securities | — | 375,227 | — | 375,227 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 17,199 | — | 17,199 | ||||||||||||
U.S. corporate | — | 1,168,918 | — | 1,168,918 | ||||||||||||
Non-U.S. corporate | — | 594,635 | — | 594,635 | ||||||||||||
Bank loans | — | 483,788 | — | 483,788 | ||||||||||||
Catastrophe bonds | — | 43,337 | 5,001 | 48,338 | ||||||||||||
Asset-backed securities | — | 566,452 | — | 566,452 | ||||||||||||
Commercial mortgage-backed securities | — | 173,799 | — | 173,799 | ||||||||||||
Total fixed maturities | — | 4,665,172 | 5,001 | 4,670,173 | ||||||||||||
Total short-term investments (b) | 1,671,911 | 13,071 | — | 1,684,982 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,043 | 2,043 | ||||||||||||
Hedge funds (a) | — | — | 567,840 | 567,840 | ||||||||||||
Private equity investments | — | — | 15,019 | 15,019 | ||||||||||||
Investment funds | — | 21,310 | 102,880 | 124,190 | ||||||||||||
Mutual funds | — | 9,541 | — | 9,541 | ||||||||||||
Total other investments | — | 30,851 | 687,782 | 718,633 | ||||||||||||
Total investments including noncontrolling interests | $ | 1,671,911 | $ | 4,709,094 | $ | 692,783 | $ | 7,073,788 | ||||||||
Noncontrolling interest (a) | $ | — | $ | — | $ | (495,365 | ) | $ | (495,365 | ) | ||||||
Redeemable noncontrolling interest (b) | $ | (11,637 | ) | $ | — | $ | — | $ | (11,637 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 1,660,274 | $ | 4,709,094 | $ | 197,418 | $ | 6,566,786 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
At December 31, 2013, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,364,679 | $ | — | $ | 1,364,679 | ||||||||
Non-U.S. government and government agency | — | 459,068 | — | 459,068 | ||||||||||||
U.S. states, municipalities and political subdivisions | — | 43,120 | — | 43,120 | ||||||||||||
Agency residential mortgage-backed securities | — | 311,499 | — | 311,499 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 15,759 | — | 15,759 | ||||||||||||
U.S. corporate | — | 1,332,484 | — | 1,332,484 | ||||||||||||
Non-U.S. corporate | — | 714,325 | — | 714,325 | ||||||||||||
Bank loans | — | 717,116 | — | 717,116 | ||||||||||||
Catastrophe bonds | — | 74,551 | — | 74,551 | ||||||||||||
Asset-backed securities | — | 509,657 | — | 509,657 | ||||||||||||
Total fixed maturities | — | 5,542,258 | — | 5,542,258 | ||||||||||||
Total short-term investments (b) | 747,215 | 4,563 | — | 751,778 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,303 | 2,303 | ||||||||||||
Hedge funds (a) | — | — | 561,083 | 561,083 | ||||||||||||
Private equity investments | — | — | 13,485 | 13,485 | ||||||||||||
Investment fund | — | 31,629 | — | 31,629 | ||||||||||||
Mutual funds | — | 9,816 | — | 9,816 | ||||||||||||
Total other investments | — | 41,445 | 576,871 | 618,316 | ||||||||||||
Total investments including noncontrolling interests | $ | 747,215 | $ | 5,588,266 | $ | 576,871 | $ | 6,912,352 | ||||||||
Noncontrolling interest (a) | $ | — | $ | — | $ | (489,402 | ) | $ | (489,402 | ) | ||||||
Redeemable noncontrolling interest (b) | $ | (18,365 | ) | $ | — | $ | — | $ | (18,365 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 728,850 | $ | 5,588,266 | $ | 87,469 | $ | 6,404,585 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
At September 30, 2014, Level 3 investments excluding the noncontrolling interests totaled $197,418 (December 31, 2013: $87,469), representing 3.0% (December 31, 2013: 1.4%) of total investments, excluding noncontrolling interests, measured at fair value on a recurring basis. | ||||||||||||||||
(b) | Level 1 assets measured at fair value | |||||||||||||||
Short term investments | ||||||||||||||||
Short term investments categorized as Level 1 consist primarily of highly liquid securities, all with maturities less than one year from the date of purchase. The fair value of the Company's portfolio of short term investments are generally determined using amortized cost which approximates fair value. The Company has determined that certain of its short-term investments, held in highly liquid money market-type funds, should be included in Level 1 as their fair values are based on quoted market prices in active markets. | ||||||||||||||||
(c) | Level 2 assets measured at fair value | |||||||||||||||
Fixed maturity investments | ||||||||||||||||
Fixed maturity investments included in Level 2 include U.S. government and government agency, non-U.S. government and government agency, U.S. states, municipalities and political subdivisions, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, U.S. corporate, non-U.S. corporate, bank loans, catastrophe bonds, asset-backed securities and commercial mortgage-backed securities. | ||||||||||||||||
In general, valuation of the Company's fixed maturity investment portfolios is provided by pricing services, such as index providers and pricing vendors, as well as broker quotations. The pricing vendors provide valuations for a high volume of liquid securities that are actively traded. For securities that do not trade on an exchange, the pricing services generally utilize market data and other observable inputs in matrix pricing models to determine month end prices. Prices are generally verified using third party data. Securities which are priced by an index provider are generally included in the index. | ||||||||||||||||
In general, broker-dealers value securities through their trading desks based on observable inputs. The methodologies include mapping securities based on trade data, bids or offers, observed spreads, and performance on newly issued securities. Broker-dealers also determine valuations by observing secondary trading of similar securities. Prices obtained from broker quotations are considered non-binding, however they are based on observable inputs and by observing secondary trading of similar securities obtained from active, non-distressed markets. | ||||||||||||||||
The Company considers these Level 2 inputs as they are corroborated with other market observable inputs. The techniques generally used to determine the fair value of the Company's fixed maturity investments are detailed below by asset class. | ||||||||||||||||
U.S. government and government agency | ||||||||||||||||
U.S. government and government agency securities consist primarily of debt securities issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. Fixed maturity investments included in U.S. government and government agency securities are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources and integrate other observations from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The fair value of each security is individually computed using analytical models which incorporate option adjusted spreads and other daily interest rate data. | ||||||||||||||||
Non-U.S. government and government agency | ||||||||||||||||
Non-U.S. government and government agency securities consist of debt securities issued by non-U.S. governments and their agencies along with supranational organizations (also known as sovereign debt securities). Securities held in these sectors are primarily priced by pricing services who employ proprietary discounted cash flow models to value the securities. Key quantitative inputs for these models are daily observed benchmark curves for treasury, swap and high issuance credits. The pricing services then apply a credit spread for each security which is developed by in-depth and real time market analysis. For securities in which trade volume is low, the pricing services utilize data from more frequently traded securities with similar attributes. These models may also be supplemented by daily market and credit research for international markets. | ||||||||||||||||
U.S. states, municipalities and political subdivisions | ||||||||||||||||
The Company's U.S. states, municipalities and political subdivisions portfolio contains debt securities issued by U.S. domiciled state and municipal entities. These securities are generally priced by independent pricing services using the techniques described for U.S. government and government agency securities described above. | ||||||||||||||||
Agency residential mortgage-backed securities | ||||||||||||||||
The Company's agency residential mortgage-backed investments are primarily priced by pricing services using a mortgage pool specific model which utilizes daily inputs from the active to be announced ("TBA") market which is very liquid, as well as the U.S. treasury market. The model also utilizes additional information, such as the weighted average maturity, weighted average coupon and other available pool level data which is provided by the sponsoring agency. Valuations are also corroborated with daily active market quotes. | ||||||||||||||||
Non-agency residential mortgage-backed securities | ||||||||||||||||
The Company's non-agency mortgage-backed investments include non-agency prime residential mortgage-backed fixed maturity investments. The Company has no fixed maturity investments classified as sub-prime held in its fixed maturity investments portfolio. Securities held in these sectors are primarily priced by pricing services using an option adjusted spread model or other relevant models, which principally utilize inputs including benchmark yields, available trade information or broker quotes, and issuer spreads. The pricing services also review collateral prepayment speeds, loss severity and delinquencies among other collateral performance indicators for the securities valuation, when applicable. | ||||||||||||||||
U.S. corporate | ||||||||||||||||
Corporate debt securities consist primarily of investment-grade debt of a wide variety of U.S. corporate issuers and industries. The Company's corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. In certain instances, securities are individually evaluated using a spread which is added to the U.S. treasury curve or a security specific swap curve as appropriate. | ||||||||||||||||
Non-U.S. corporate | ||||||||||||||||
Non-U.S. corporate debt securities consist primarily of investment-grade debt of a wide variety of non-U.S. corporate issuers and industries. The Company's non-U.S. corporate fixed maturity investments are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. | ||||||||||||||||
Bank loans | ||||||||||||||||
The Company's bank loan investments consist primarily of below-investment-grade debt of a wide variety of corporate issuers and industries. The Company's bank loans are primarily priced by pricing services. When evaluating these securities, the pricing services gather information from market sources regarding the issuer of the security and obtain credit data, as well as other observations, from markets and sector news. Evaluations are updated by obtaining broker dealer quotes and other market information including actual trade volumes, when available. The pricing services also consider the specific terms and conditions of the securities, including any specific features which may influence risk. | ||||||||||||||||
Catastrophe bonds | ||||||||||||||||
Catastrophe bonds are based on broker or underwriter bid indications. To the extent that these indications are based on significant unobservable inputs, the relevant bonds will be classified as a Level 3 asset. | ||||||||||||||||
Asset-backed securities | ||||||||||||||||
Asset backed securities include mostly investment-grade debt securities backed by pools of loans with a variety of underlying collateral, including automobile loan receivables, student loans, credit card receivables, and collateralized loan obligations originated by a variety of financial institutions. Securities held in these sectors are primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector. | ||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||
Commercial mortgage backed securities are investment-grade debt primarily priced by pricing services. The pricing services apply dealer quotes and other available trade information such as bids and offers, prepayment speeds which may be adjusted for the underlying collateral or current price data, the U.S. treasury curve and swap curve as well as cash settlement. The pricing services determine the expected cash flows for each security held in this sector using historical prepayment and default projections for the underlying collateral and current market data. In addition, a spread is applied to the relevant benchmark and used to discount the cash flows noted above to determine the fair value of the securities held in this sector. | ||||||||||||||||
Short term investments | ||||||||||||||||
Short term investments consist primarily of highly liquid securities, all with maturities less than one year from the date of purchase. The fair value of the Company's portfolio of short term investments is generally determined using amortized cost which approximates fair value. The Company has determined that, other than highly liquid money market-type funds, the remaining securities are classified within Level 2 because these securities are typically not actively traded due to their approaching maturity and, as such, their amortized cost approximates fair value. | ||||||||||||||||
Investment funds | ||||||||||||||||
Investment funds classified as Level 2 assets consists of one pooled investment which is invested in fixed income securities with high credit ratings. The investment fund is only open to Lloyd’ Trust Fund participants. The fair value of units in the investment fund is based on the net asset value of the fund as reported by Lloyd’s Treasury & Investment Management. | ||||||||||||||||
Mutual funds | ||||||||||||||||
Mutual funds consist of two investment funds which are invested in various quoted investments. The fair value of units in the mutual funds is based on the net asset value of the fund as reported by the fund manager. | ||||||||||||||||
(d) | Level 3 assets measured at fair value | |||||||||||||||
Level 3 includes financial instruments that are valued using market approach and income approach valuation techniques. These models incorporate both observable and unobservable inputs. The Company's hedge funds, a fund of hedge funds, private equity investments, an investment fund and certain catastrophe bonds are the only financial instruments in this category as at September 30, 2014. For each respective hedge fund investment, the Company obtains and reviews the valuation methodology used by the fund administrators and investment managers to ensure that the hedge fund investments are following fair value principles consistent with U.S. GAAP in determining the net asset value (“NAV”). | ||||||||||||||||
Within the hedge fund industry, there is a general lack of transparency necessary to facilitate a detailed independent assessment of the values placed on the securities underlying the NAV provided by the fund manager or fund administrator. To address this, on a quarterly basis, we perform a number of monitoring procedures designed to assist in the assessment of the quality of the information provided by managers and administrators. These procedures include, but are not limited to, regular review and discussion of each fund's performance with its manager and regular evaluation of fund performance against applicable benchmarks. | ||||||||||||||||
Fund of hedge funds | ||||||||||||||||
The fund of hedge funds includes a side pocket. While a redemption request has been submitted, the timing of receipt of proceeds on the side pocket is unknown. The fund's administrator provides a monthly reported NAV with a one-month delay in its valuation. As a result, the fund administrator's August 31, 2014 NAV was used as a basis for fair value measurement in the Company's September 30, 2014 Consolidated Balance Sheet. The fund manager has provided an estimate of the fund NAV at September 30, 2014 based on the estimated performance provided from the underlying funds. To determine the reasonableness of the estimated NAV, the Company compares the one-month delayed fund administrator's NAV to the fund manager's estimated NAV that incorporates relevant valuation sources on a timely basis. Material variances are recorded in the current reporting period while immaterial variances are recorded in the following reporting period. As this valuation technique incorporates both observable and significant unobservable inputs, the fund of hedge funds is classified as a Level 3 asset. | ||||||||||||||||
Hedge funds | ||||||||||||||||
The hedge funds were valued at $567,840 at September 30, 2014 (December 31, 2013: $561,083). The hedge funds consist of investments in five Paulson & Co. managed funds (the "Paulson hedge funds") and one hedge fund assumed in the acquisition of Flagstone Reinsurance Holdings, S.A. (the "Flagstone Acquisition") (the "Flagstone hedge fund"). | ||||||||||||||||
The Paulson hedge funds' administrator provides monthly reported NAVs with a one-month delay in its valuation. As a result, the funds' administrator's August 31, 2014 NAV was used as a partial basis for fair value measurement in the Company's September 30, 2014 Consolidated Balance Sheet. The fund manager provides an estimate of the NAV at September 30, 2014 based on estimated performance. The Company adjusts fair value to the fund manager's estimated NAV that incorporates relevant valuation sources on a timely basis. To determine the reasonableness of the estimated NAV, the Company assesses the variance between the fund manager's estimated NAV and the fund administrator's NAV. Material variances are recorded in the current reporting period while immaterial variances are recorded in the following reporting period. Historically, the Company's valuation estimates have not materially differed from the subsequent NAVs. | ||||||||||||||||
The Flagstone hedge fund's administrator provides quarterly NAVs with a three-month delay in valuation. As a result, the June 30, 2014 NAV was used as a basis for fair value measurement in the Company's September 30, 2014 Consolidated Balance Sheet. | ||||||||||||||||
As these valuation techniques incorporate both observable and significant unobservable inputs, both the Paulson hedge funds and the Flagstone hedge fund are classified as Level 3 assets. The Paulson hedge funds are subject to quarterly liquidity. | ||||||||||||||||
Private equity investments | ||||||||||||||||
Private equity investments consist of investments in five private equity funds. The private equity funds' respective fund administrators provide quarterly or semi-annual NAVs with a three-month or six-month delay in valuation as well as audited NAVs as at December 31. As a result, the June 30, 2014 or March 31, 2014 NAV was used as a basis for fair value measurement in the Company's September 30, 2014 Consolidated Balance Sheet. As this valuation technique incorporates both observable and significant unobservable inputs, the private equity investments are classified as Level 3 assets. | ||||||||||||||||
Investment funds | ||||||||||||||||
Investment funds classified as Level 3 assets consists of one structured securities fund that invests across asset backed securities, residential mortgage backed securities and commercial mortgage backed securities. The fair value of units in the investment fund is based on the NAV of the fund as reported by the independent fund administrator. The fund's administrator provides a monthly reported NAV with a one-month delay in its valuation. As a result, the fund administrator's August 31, 2014 NAV was used as a basis for fair value measurement in the Company's September 30, 2014 Consolidated Balance Sheet. As this valuation technique incorporates both observable and significant unobservable inputs, the investment fund investment is classified as a Level 3 asset. | ||||||||||||||||
The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
30-Sep-14 | 30-Sep-13 | 30-Sep-14 | 30-Sep-13 | |||||||||||||
Level 3 investments - Beginning of period | $ | 746,396 | $ | 505,158 | $ | 576,871 | $ | 556,234 | ||||||||
Purchases | 25,784 | 33,154 | 125,784 | 98,669 | ||||||||||||
Sales | (24,175 | ) | (35,264 | ) | (49,508 | ) | (80,095 | ) | ||||||||
Settlements | — | — | (1,500 | ) | — | |||||||||||
Net realized gains | 2,554 | 4,503 | 8,198 | 4,843 | ||||||||||||
Change in net unrealized gains (losses) | (57,776 | ) | 42,917 | 26,235 | (29,183 | ) | ||||||||||
Transfers into Level 3 | — | — | 6,703 | — | ||||||||||||
Level 3 investments - End of period | $ | 692,783 | $ | 550,468 | $ | 692,783 | $ | 550,468 | ||||||||
Noncontrolling interest (a) | (495,365 | ) | (465,472 | ) | (495,365 | ) | (465,472 | ) | ||||||||
Level 3 investments excluding noncontrolling interest | $ | 197,418 | $ | 84,996 | $ | 197,418 | $ | 84,996 | ||||||||
(a) | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
There have not been any transfers into or out of Levels 1, 2 and 3 during the three months ended September 30, 2014 or 2013. During the nine months ended September 30, 2014 there was a transfer of investments from Level 2 into Level 3 of the fair value hierarchy. This transfer was due to a reassessment of the extent of unobservable inputs used in establishing the fair value of certain catastrophe bonds. There were no transfers into or out of Level 3 during the nine months ended September 30, 2013. |
Investments_in_affiliates
Investments in affiliates | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ' | |||||||||||||||||||||||
Investments in affiliates | ' | |||||||||||||||||||||||
Investments in affiliates | ||||||||||||||||||||||||
The following table presents the Company's investments in affiliates as at September 30, 2014 and December 31, 2013: | ||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | |||||||||||||||||||||||
Investment affiliate | $ | 42,381 | $ | 34,500 | ||||||||||||||||||||
Operating affiliates | 175,231 | 106,743 | ||||||||||||||||||||||
Investments in affiliates | $ | 217,612 | $ | 141,243 | ||||||||||||||||||||
(a) | Investment affiliate | |||||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | ||||||||||||||||||||||||
On December 20, 2011, the Company entered into an Assignment and Assumption Agreement (the "Agreement") with Aquiline Capital Partners LLC, a Delaware limited liability company (the "Assignor") and Aquiline Capital Partners II GP (Offshore) Ltd., a Cayman Islands company limited by shares (the "General Partner") pursuant to which the Company has assumed 100% of the Assignor's interest in Aquiline Financial Services Fund II L.P. (the "Partnership") representing a total capital commitment of $50,000 (the "Commitment"), as a limited partner in the Partnership (the "Transferred Interest"). The Transferred Interest is governed by the terms of an Amended and Restated Exempted Limited Partnership Agreement dated as of July 2, 2010 (the "Limited Partnership Agreement"). Pursuant to the terms of the Limited Partnership Agreement, the Commitment will expire on July 2, 2015. | ||||||||||||||||||||||||
The Partnership provides quarterly capital account statements with a three-month delay in its valuation. As a result, the Partnership's June 30, 2014 capital account statement was used as the basis for calculating the Company's share of Partnership income for the period. | ||||||||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in the Company's investment affiliate balance for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Investment affiliate, beginning of period | $ | 40,627 | $ | 25,352 | $ | 34,500 | $ | 15,218 | ||||||||||||||||
Capital contributions | — | 6,185 | — | 13,089 | ||||||||||||||||||||
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 | ||||||||||||||||||||
Investment affiliate, end of period | $ | 42,381 | $ | 32,581 | $ | 42,381 | $ | 32,581 | ||||||||||||||||
The following table presents the Company's investment in the Partnership as at September 30, 2014: | ||||||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | $ | 32,110 | — | % | 6.7 | % | $ | 42,381 | ||||||||||||||||
The following table presents the Company's investment in the Partnership as at December 31, 2013: | ||||||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | $ | 32,110 | — | % | 6.7 | % | $ | 34,500 | ||||||||||||||||
(b) | Operating affiliates | |||||||||||||||||||||||
AlphaCat Re 2011 Ltd. | ||||||||||||||||||||||||
On May 25, 2011, the Company joined with other investors in capitalizing AlphaCat Re 2011 Ltd. ("AlphaCat Re 2011"), a special purpose reinsurer formed for the purpose of writing collateralized reinsurance and retrocessional reinsurance. AlphaCat Re 2011 was a market facing entity and the Company's investment in AlphaCat Re 2011 has been treated as an equity method investment. | ||||||||||||||||||||||||
AlphaCat Re 2011 is now considered "off-risk" as the risk periods for all reinsurance contracts written have expired. As a result, partial returns of investment have been made to the investors of AlphaCat Re 2011.The Company's portion of the returns made during the three and nine months ended September 30, 2014 and 2013 are included in the tables below. | ||||||||||||||||||||||||
AlphaCat Re 2012 Ltd. | ||||||||||||||||||||||||
On May 29, 2012, the Company joined with other investors in capitalizing AlphaCat Re 2012 Ltd. ("AlphaCat Re 2012"), a special purpose reinsurer formed for the purpose of writing collateralized reinsurance with a particular focus on windstorm risks for Florida domiciled insurance companies. AlphaCat Re 2012 was a market facing entity and the Company's investment in AlphaCat Re 2012 has been treated as an equity method investment. | ||||||||||||||||||||||||
AlphaCat Re 2012 is now considered "off-risk" as the risk periods for all reinsurance contracts written have expired. As a result, partial returns of investment have been made to the investors of AlphaCat Re 2012.The Company's portion of the returns made during the three and nine months ended September 30, 2014 and 2013 are included in the tables below. | ||||||||||||||||||||||||
AlphaCat 2013, Ltd. | ||||||||||||||||||||||||
On December 17, 2012, the Company joined with other investors in capitalizing AlphaCat 2013, Ltd. ("AlphaCat 2013"), an entity formed for the purpose of investing in collateralized reinsurance and retrocession on a worldwide basis. AlphaCat 2013 deployed its capital through transactions entered into by AlphaCat Reinsurance Ltd. (“AlphaCat Re”) and the Company's investment in AlphaCat 2013 has been treated as an equity method investment. | ||||||||||||||||||||||||
AlphaCat 2013 is now considered "off-risk" as the risk periods for all risk-linked instruments have expired. As a result, partial returns of investment have been made to the investors of AlphaCat 2013. The Company's portion of the returns made during the three and nine months ended September 30, 2014 and 2013 are included in the tables below. | ||||||||||||||||||||||||
AlphaCat 2014, Ltd. | ||||||||||||||||||||||||
On December 20, 2013, the Company joined with other investors in capitalizing AlphaCat 2014, Ltd. (“AlphaCat 2014”), an entity formed for the purpose of investing in collateralized reinsurance and retrocessional contracts for the January 1, 2014 renewal season. AlphaCat 2014 deploys its capital through transactions entered into by AlphaCat Re and the Company's investment in AlphaCat 2014 has been treated as an equity method investment. | ||||||||||||||||||||||||
AlphaCat ILS funds | ||||||||||||||||||||||||
The AlphaCat ILS funds invest in instruments with returns linked to property catastrophe reinsurance, retrocession and insurance linked securities ("ILS") contracts. AlphaCat ILS funds all deploy their capital through the AlphaCat Master Fund Ltd. (the “Master Fund”) and AlphaCat Re. All three funds are variable interest entities, with one being consolidated by the Company as the primary beneficiary and one being accounted for as an equity method investment because the Company holds an equity interest of 7.9% and has significant influence. The third fund had been consolidated by the Company as the primary beneficiary from its formation through to December 31, 2013. However, on January 1, 2014 the fund received $35,000 in additional third party subscriptions, resulting in a reduction of the Company’s equity interest below 50%. Since the Company retains significant influence, this fund has been deconsolidated and accounted for as an equity method investment from January 1, 2014. The fair value of the retained interest, based on the fair value of the underlying instruments in Master Fund and AlphaCat Re, amounted to $113,455 at January 1, 2014. The deconsolidation resulted in a gain of $1,372 which is included in the Consolidated Statements of Comprehensive Income as other income for the nine months ended September 30, 2014. The Company's maximum exposure to any of the funds is the amount of capital invested at any given time. | ||||||||||||||||||||||||
AlphaCat Master Fund Ltd. and AlphaCat Reinsurance Ltd. | ||||||||||||||||||||||||
The Company utilizes Master Fund and AlphaCat Re for the purpose of investing in capital market products and writing collateralized reinsurance, respectively, on behalf of certain entities within the AlphaCat operating segment. Master Fund and AlphaCat Re are market facing entities which enter into transactions on behalf of AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS funds. The Company owns all of the voting equity interest in Master Fund and AlphaCat Re and, as a result, their financial statements are included in the Consolidated Financial Statements of the Company. | ||||||||||||||||||||||||
The following tables present a reconciliation of the beginning and ending investment in operating affiliates for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||
As at June 30, 2014 | $ | 4,172 | $ | 2,204 | $ | 2,580 | $ | 25,014 | $ | 139,022 | $ | 172,992 | ||||||||||||
Return of investment | — | (1,516 | ) | (6 | ) | — | — | (1,522 | ) | |||||||||||||||
(Loss) income from operating affiliates | (5 | ) | (9 | ) | 7 | 1,367 | 2,401 | 3,761 | ||||||||||||||||
As at September 30, 2014 | $ | 4,167 | $ | 679 | $ | 2,581 | $ | 26,381 | $ | 141,423 | $ | 175,231 | ||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS fund | Total | ||||||||||||||||||||
As at June 30, 2013 | $ | 11,054 | $ | 5,204 | $ | 48,536 | $ | 20,326 | $ | 85,120 | ||||||||||||||
Return of investment | (2,800 | ) | (4,550 | ) | — | — | (7,350 | ) | ||||||||||||||||
(Loss) income from operating affiliates | (270 | ) | (7 | ) | 585 | 1,155 | 1,463 | |||||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||||||
Nine Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||
As at December 31, 2013 | $ | 9,809 | $ | 1,313 | $ | 51,744 | $ | 21,982 | $ | 21,895 | $ | 106,743 | ||||||||||||
Return of investment | (5,825 | ) | (1,516 | ) | (51,206 | ) | — | — | (58,547 | ) | ||||||||||||||
Fair value of retained interest on deconsolidation of AlphaCat ILS fund | — | — | — | — | 113,455 | 113,455 | ||||||||||||||||||
Income from operating affiliates | 183 | 882 | 2,043 | 4,399 | 6,073 | 13,580 | ||||||||||||||||||
As at September 30, 2014 | $ | 4,167 | $ | 679 | $ | 2,581 | $ | 26,381 | $ | 141,423 | $ | 175,231 | ||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS fund | Total | ||||||||||||||||||||
As at December 31, 2012 | $ | 62,792 | $ | 29,319 | $ | 45,000 | $ | 20,000 | $ | 157,111 | ||||||||||||||
Return of investment | (54,914 | ) | (31,743 | ) | — | — | (86,657 | ) | ||||||||||||||||
Income from operating affiliates | 106 | 3,071 | 4,121 | 1,481 | 8,779 | |||||||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||||||
The following table presents the Company's investments in AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS funds in the Consolidated Financial Statements as at September 30, 2014: | ||||||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||||||
Cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||||||
AlphaCat Re 2011 | $ | 4,167 | 43.7 | % | 22.3 | % | $ | 4,167 | ||||||||||||||||
AlphaCat Re 2012 | 679 | 49 | % | 37.9 | % | 679 | ||||||||||||||||||
AlphaCat 2013 | 2,581 | 40.9 | % | 19.7 | % | 2,581 | ||||||||||||||||||
AlphaCat 2014 | 22,000 | 42.3 | % | 19.6 | % | 26,381 | ||||||||||||||||||
AlphaCat ILS funds | 133,455 | n/a | (a) | 141,423 | ||||||||||||||||||||
Total | $ | 162,882 | $ | 175,231 | ||||||||||||||||||||
(a) | Equity ownership in the two funds were 7.9% and 49.0% respectively as at September 30, 2014. | |||||||||||||||||||||||
The following table presents the Company's investments in AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS fund in the Consolidated Financial Statements as at December 31, 2013: | ||||||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||||||
Cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||||||
AlphaCat Re 2011 | $ | 9,882 | 43.7 | % | 22.3 | % | $ | 9,809 | ||||||||||||||||
AlphaCat Re 2012 | 654 | 49 | % | 37.9 | % | 1,313 | ||||||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 51,744 | ||||||||||||||||||
AlphaCat 2014 | 22,000 | 42.3 | % | 19.6 | % | 21,982 | ||||||||||||||||||
AlphaCat ILS fund | 20,000 | n/a | 9.1 | % | 21,895 | |||||||||||||||||||
Total | $ | 97,536 | $ | 106,743 | ||||||||||||||||||||
(c) | Notes payable and (income) attributable to operating affiliates | |||||||||||||||||||||||
Notes are issued during the course of a year by Master Fund and AlphaCat Re to AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS funds (collectively the “feeder funds”) in order to fund the purchase of capital market products and to write collateralized reinsurance on their behalf. The underlying capital market products and collateralized reinsurance typically have at least a twelve month duration; however, they do not have a stated maturity date. Since repayment is dependent on the settlement of the underlying transactions, the notes are subsequently redeemed as the underlying transactions are settled. The Company’s investments in the feeder funds, together with investments made by third parties, are provided as consideration for these notes to Master Fund and AlphaCat Re, which are consolidated in the Company’s Consolidated Financial Statements. The effective economic interest in Master Fund and AlphaCat Re that results from these transactions is represented on the Consolidated Balance Sheet as notes payable to operating affiliates. The subsequent income or loss generated by the relevant capital market products or collateralized reinsurance is transferred to the operating affiliates as (income) loss attributable to operating affiliate investors in the Company’s Consolidated Statements of Comprehensive Income. The notes do not have any principal amount, since the final amount payable is dependent on the income or loss. To the extent that the (income) loss attributable to operating affiliate investors has not been returned to investors, it is included in accounts payable and accrued expenses in the Consolidated Balance Sheets. | ||||||||||||||||||||||||
The following tables present a reconciliation of the beginning and ending notes payable to operating affiliates for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||||
As at June 30, 2014 | $ | — | $ | 157,992 | $ | 464,958 | $ | 622,950 | ||||||||||||||||
Issuance of notes payable to operating affiliates | — | — | 53,498 | 53,498 | ||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | — | (13,990 | ) | (13,990 | ) | ||||||||||||||||||
Foreign exchange gain | — | (410 | ) | (6,072 | ) | (6,482 | ) | |||||||||||||||||
As at September 30, 2014 | $ | — | $ | 157,582 | $ | 498,394 | $ | 655,976 | ||||||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||||||||
As at June 30, 2013 | $ | 222,135 | $ | 208,958 | $ | 431,093 | ||||||||||||||||||
Issuance of notes payable to operating affiliates | — | 6,733 | 6,733 | |||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | (3,553 | ) | (3,553 | ) | |||||||||||||||||||
Foreign exchange loss | 1,196 | 2,501 | 3,697 | |||||||||||||||||||||
As at September 30, 2013 | $ | 223,331 | $ | 214,639 | $ | 437,970 | ||||||||||||||||||
Nine Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||||
As at December 31, 2013 | $ | 223,809 | $ | — | $ | 215,463 | $ | 439,272 | ||||||||||||||||
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | — | — | 178,837 | 178,837 | ||||||||||||||||||||
Issuance of notes payable to operating affiliates | — | 157,914 | 487,329 | 645,243 | ||||||||||||||||||||
Redemption of notes payable to operating affiliates | (223,512 | ) | — | (378,556 | ) | (602,068 | ) | |||||||||||||||||
Foreign exchange gain | (297 | ) | (332 | ) | (4,679 | ) | (5,308 | ) | ||||||||||||||||
As at September 30, 2014 | $ | — | $ | 157,582 | $ | 498,394 | $ | 655,976 | ||||||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||||||||
As at December 31, 2012 | $ | — | $ | — | $ | — | ||||||||||||||||||
Issuance of notes payable to operating affiliates | 223,082 | 218,044 | 441,126 | |||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | (3,553 | ) | (3,553 | ) | |||||||||||||||||||
Foreign exchange loss | 249 | 148 | 397 | |||||||||||||||||||||
As at September 30, 2013 | $ | 223,331 | $ | 214,639 | $ | 437,970 | ||||||||||||||||||
The portion of notes payable to operating affiliates that were due to the Company, as an investor in the affiliates, and third party investors as at September 30, 2014 amounted to $164,169 and $491,807, respectively (December 31, 2013: $63,654 and $375,618). | ||||||||||||||||||||||||
The following table presents the (income) attributable to operating affiliate investors for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
AlphaCat 2013 | $ | (98 | ) | $ | (4,074 | ) | $ | (14,218 | ) | $ | (29,357 | ) | ||||||||||||
AlphaCat 2014 | (11,309 | ) | — | (32,990 | ) | — | ||||||||||||||||||
AlphaCat ILS funds | (14,400 | ) | (7,741 | ) | (35,625 | ) | (12,799 | ) | ||||||||||||||||
(Income) attributable to operating affiliate investors | $ | (25,807 | ) | $ | (11,815 | ) | $ | (82,833 | ) | $ | (42,156 | ) | ||||||||||||
The portion of income attributable to operating affiliate investors that was due to the Company, as an investor in the affiliates, and third party investors for the three months ended September 30, 2014 amounted to $4,993 and $20,814, respectively (2013: $1,505 and $10,310). The portion of income attributable to operating affiliate investors that was due to the Company, as an investor in the affiliates, and third party investors for the nine months ended September 30, 2014 amounted to $16,552 and $66,281, respectively (2013: $7,114 and $35,042). |
Noncontrolling_interest
Noncontrolling interest | 9 Months Ended | |||||||||||
Sep. 30, 2014 | ||||||||||||
Noncontrolling Interest [Abstract] | ' | |||||||||||
Noncontrolling interest | ' | |||||||||||
Noncontrolling interest | ||||||||||||
On April 2, 2012, the Company joined with other investors in capitalizing PaCRe Ltd. ("PaCRe"), a Class 4 Bermuda reinsurer formed for the purpose of writing high excess property catastrophe reinsurance. The Company has an equity interest of 10% and the remaining 90% interest is held by third party investors. The Company has a majority voting equity interest in PaCRe and as a result, the financial statements of PaCRe are included in the Consolidated Financial Statements of the Company. The portion of PaCRe’s earnings attributable to third party investors is recorded in the Consolidated Statements of Comprehensive Income as net (income) loss attributable to noncontrolling interest. PaCRe's shareholder rights do not include redemption features within the control of the third party shareholders. The third party equity is recorded in the Company’s Consolidated Balance Sheets as noncontrolling interest. | ||||||||||||
The portion of earnings from the one consolidated AlphaCat ILS fund attributable to third party investors is recorded in the Consolidated Statements of Comprehensive Income as net (income) loss attributable to noncontrolling interest. The AlphaCat ILS funds have rights that enable shareholders, subject to certain limitations, to redeem their shares. The third party equity is therefore recorded in the Company’s Consolidated Balance Sheets as redeemable noncontrolling interest. When and if a redemption notice is received, the fair value of the redemption is reclassified to a liability. | ||||||||||||
The following tables present a reconciliation of the beginning and ending balances of redeemable noncontrolling interest and noncontrolling interest for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at June 30, 2014 | $ | 66,282 | $ | 575,347 | $ | 641,629 | ||||||
Issuance of shares | 4,200 | — | 4,200 | |||||||||
Loss attributable to noncontrolling interest | (9 | ) | (53,060 | ) | (53,069 | ) | ||||||
As at September 30, 2014 | $ | 70,473 | $ | 522,287 | $ | 592,760 | ||||||
Three Months Ended September 30, 2013 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at June 30, 2013 | $ | 70,690 | $ | 427,755 | $ | 498,445 | ||||||
Issuance of shares | 13,000 | — | 13,000 | |||||||||
Income attributable to noncontrolling interest | 1,516 | 44,178 | 45,694 | |||||||||
Redemption of shares | (10,207 | ) | — | (10,207 | ) | |||||||
As at September 30, 2013 | $ | 74,999 | $ | 471,933 | $ | 546,932 | ||||||
Nine Months Ended September 30, 2014 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at December 31, 2013 | $ | 86,512 | $ | 497,657 | $ | 584,169 | ||||||
Issuance of shares | 61,200 | — | 61,200 | |||||||||
Income attributable to noncontrolling interest | 1,115 | 24,630 | 25,745 | |||||||||
Adjustment to noncontrolling interest as a result of deconsolidation | (78,354 | ) | — | (78,354 | ) | |||||||
As at September 30, 2014 | $ | 70,473 | $ | 522,287 | $ | 592,760 | ||||||
Nine Months Ended September 30, 2013 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at December 31, 2012 | $ | — | $ | 434,280 | $ | 434,280 | ||||||
Issuance of shares | 82,190 | 58,500 | 140,690 | |||||||||
Income (loss) attributable to noncontrolling interest | 3,016 | (20,847 | ) | (17,831 | ) | |||||||
Redemption of shares | (10,207 | ) | — | (10,207 | ) | |||||||
As at September 30, 2013 | $ | 74,999 | $ | 471,933 | $ | 546,932 | ||||||
Derivative_instruments
Derivative instruments | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||||||
Derivative instruments | ' | ||||||||||||||||||||||||
Derivative instruments | |||||||||||||||||||||||||
The Company enters into derivative instruments for risk management purposes, specifically to hedge unmatched foreign currency exposures and interest rate exposures. As at September 30, 2014, the Company held foreign currency forward contracts to mitigate the risk of fluctuations in the U.S. dollar against a number of foreign currencies. As at September 30, 2014, the Company held two interest rate swaps to fix the payment of interest on the Company's 2006 and 2007 Junior Subordinated Deferrable Debentures, as well as three interest rate swaps and one cross-currency interest rate swap to fix the payment of interest and mitigate the foreign exchange rate impact on Flagstone's 2006 and 2007 Junior Subordinated Deferrable Debentures. | |||||||||||||||||||||||||
The following table summarizes information on the classification and amount of the fair value of derivatives designated as hedging instruments on the Consolidated Balance Sheets at September 30, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As at September 30, 2014 | As at December 31, 2013 | ||||||||||||||||||||||||
Derivatives designated as hedging instruments: | Net Notional Exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net Notional Exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Foreign currency forward contracts | $ | 246,638 | $ | 592 | $ | 16,672 | $ | 163,576 | $ | 1,167 | $ | 2,313 | |||||||||||||
Interest rate swap contracts | $ | 552,263 | $ | 25 | $ | 912 | $ | 552,263 | $ | 28 | $ | 911 | |||||||||||||
(a) | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. | ||||||||||||||||||||||||
(a) | Classification within the fair value hierarchy | ||||||||||||||||||||||||
As described in Note 4: "Fair value measurements" under U.S. GAAP, a company must determine the appropriate level in the fair value hierarchy for each fair value measurement. The assumptions used within the valuation of the Company's derivative instruments are observable in the marketplace, can be derived from observable data or are supported by observable levels at which other similar transactions are executed in the marketplace. Accordingly, these derivatives were classified within Level 2 of the fair value hierarchy. | |||||||||||||||||||||||||
(b) | Derivative instruments designated as a fair value hedge | ||||||||||||||||||||||||
The Company designates its foreign currency derivative instruments as fair value hedges and formally and contemporaneously documents all relationships between the derivative instruments and hedged items and links the derivative instruments to specific assets and liabilities. The Company assesses the effectiveness of the hedges, both at inception and on an on-going basis and determines whether the hedges are highly effective in offsetting changes in fair value of the linked hedged items. | |||||||||||||||||||||||||
The following table provides the total impact on earnings, recognized in income within foreign exchange gains (losses), relating to the derivative instruments formally designated as fair value hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
Foreign currency forward contracts | September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||||||||||
Amount of (loss) gain recognized in income on derivative | $ | (14,817 | ) | $ | 3,116 | $ | (9,979 | ) | $ | 2,670 | |||||||||||||||
Amount of gain (loss) on hedged item recognized in income attributable to risk being hedged | $ | 14,817 | $ | (3,116 | ) | $ | 9,979 | $ | (2,670 | ) | |||||||||||||||
Amount of gain (loss) recognized in income on derivative (ineffective portion) | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
(c) | Derivative instruments designated as a cash flow hedge | ||||||||||||||||||||||||
The Company designates its interest rate derivative instruments as cash flow hedges and formally and contemporaneously documents all relationships between the hedging instruments and hedged items and links the derivative instruments to specific assets and liabilities. The Company assesses the effectiveness of the hedges, both at inception and on an on-going basis and determines whether the hedges are highly effective in offsetting changes in fair value of the linked hedged items. The Company currently applies the long haul method when assessing the hedge's effectiveness. | |||||||||||||||||||||||||
The following table provides the total impact on other comprehensive income (loss) and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
Interest rate swap contracts | September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||||||||||
Amount of effective portion recognized in other comprehensive income | $ | 3,302 | $ | 3,268 | $ | 9,762 | $ | 7,838 | |||||||||||||||||
Amount of effective portion subsequently reclassified to earnings | $ | (3,302 | ) | $ | (3,268 | ) | $ | (9,762 | ) | $ | (7,838 | ) | |||||||||||||
Amount of ineffective portion excluded from effectiveness testing | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
The above balances relate to interest payments and have therefore been classified as finance expenses in the Consolidated Statements of Comprehensive Income. | |||||||||||||||||||||||||
(d) | Balance sheet offsetting | ||||||||||||||||||||||||
There was no balance sheet offsetting activity as at September 30, 2014 or December 31, 2013. | |||||||||||||||||||||||||
The Company currently provides cash collateral as security for interest rate swap contracts. The Company does not provide cash collateral or financial instruments as security for foreign currency forward contracts. Our derivative instruments are generally traded under International Swaps and Derivatives Association master netting agreements, which establish terms that apply to all transactions. On a periodic basis, the amounts receivable from or payable to the counterparties are settled in cash. | |||||||||||||||||||||||||
The Company has not elected to settle multiple transactions with an individual counterparty on a net basis. |
Reserve_for_losses_and_loss_ex
Reserve for losses and loss expenses | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | ' | |||||||||||||||
Reserve for losses and loss expenses | ' | |||||||||||||||
Reserve for losses and loss expenses | ||||||||||||||||
Reserves for losses and loss expenses are based in part upon the estimation of case reserves from broker, insured and ceding company reported data. The Company also uses statistical and actuarial methods to estimate ultimate expected losses and loss expenses, from which incurred but not reported losses can be calculated. The period of time from the occurrence of a loss to the reporting of a loss to the Company and to the settlement of the Company's liability may be several months or years. During this period, additional facts and trends may be revealed. As these factors become apparent, reserves will be adjusted, sometimes requiring an increase or decrease in the overall reserves of the Company, and at other times requiring a reallocation of incurred but not reported reserves to specific case reserves. These estimates are reviewed and adjusted regularly, and such adjustments, if any, are reflected in earnings in the period in which they become known. While management believes that it has made a reasonable estimate of ultimate losses, there can be no assurances that ultimate losses and loss expenses will not exceed this estimate. | ||||||||||||||||
The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Reserve for losses and loss expenses, beginning of period | $ | 2,867,307 | $ | 3,283,450 | $ | 3,030,399 | $ | 3,517,573 | ||||||||
Losses and loss expenses recoverable | (338,734 | ) | (418,693 | ) | (370,154 | ) | (439,967 | ) | ||||||||
Net reserves for losses and loss expenses, beginning of period | 2,528,573 | 2,864,757 | 2,660,245 | 3,077,606 | ||||||||||||
Net reserves disposed | — | — | — | (18,591 | ) | |||||||||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||||||||||||||
Current year | 279,690 | 243,015 | 713,177 | 759,617 | ||||||||||||
Prior years | (55,565 | ) | (65,050 | ) | (167,636 | ) | (171,837 | ) | ||||||||
Total incurred losses and loss expenses | 224,125 | 177,965 | 545,541 | 587,780 | ||||||||||||
Less net losses and loss expenses paid in respect of losses occurring in: | ||||||||||||||||
Current year | (74,618 | ) | (59,701 | ) | (99,326 | ) | (95,535 | ) | ||||||||
Prior years | (183,697 | ) | (215,167 | ) | (633,048 | ) | (732,118 | ) | ||||||||
Total net paid losses | (258,315 | ) | (274,868 | ) | (732,374 | ) | (827,653 | ) | ||||||||
Foreign exchange | (40,717 | ) | 34,363 | (19,746 | ) | (16,925 | ) | |||||||||
Net reserve for losses and loss expenses, end of period | 2,453,666 | 2,802,217 | 2,453,666 | 2,802,217 | ||||||||||||
Losses and loss expenses recoverable | 298,502 | 421,518 | 298,502 | 421,518 | ||||||||||||
Reserve for losses and loss expenses, end of period | $ | 2,752,168 | $ | 3,223,735 | $ | 2,752,168 | $ | 3,223,735 | ||||||||
Incurred losses and loss expenses comprise: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Gross losses and loss expenses | $ | 222,356 | $ | 226,130 | $ | 587,111 | $ | 684,080 | ||||||||
Reinsurance recoverable | 1,769 | (48,165 | ) | (41,570 | ) | (96,300 | ) | |||||||||
Net incurred losses and loss expenses | $ | 224,125 | $ | 177,965 | $ | 545,541 | $ | 587,780 | ||||||||
Reinsurance
Reinsurance | 9 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Reinsurance Disclosures [Abstract] | ' | |||||||||||||
Reinsurance | ' | |||||||||||||
Reinsurance | ||||||||||||||
The Company enters into reinsurance and retrocession agreements in order to mitigate its accumulation of loss, reduce its liability on individual risks, enable it to underwrite policies with higher limits and increase its aggregate capacity. The cession of insurance and reinsurance does not legally discharge the Company from its primary liability for the full amount of the policies, and the Company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance or retrocession agreement. Amounts recoverable from reinsurers are estimated in a manner consistent with the underlying liabilities. | ||||||||||||||
Credit risk | ||||||||||||||
The Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from its exposure to individual reinsurers. The reinsurance program is generally placed with reinsurers whose rating, at the time of placement, was A- or better as rated by Standard & Poor's or the equivalent with other rating agencies. Exposure to a single reinsurer is also controlled with restrictions dependent on rating. At September 30, 2014, 97.3% (December 31, 2013: 96.7%) of reinsurance recoverables (which includes loss reserves recoverable and recoverables on paid losses and $144,414 of total IBNR recoverable (December 31, 2013: $196,840)) were fully collateralized or from reinsurers rated A- or better. | ||||||||||||||
Reinsurance recoverables by reinsurer as at September 30, 2014 and December 31, 2013 are as follows: | ||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||
Reinsurance Recoverable | % of Total | Reinsurance Recoverable | % of Total | |||||||||||
Top 10 reinsurers | $ | 264,131 | 73.1 | % | $ | 340,253 | 75.6 | % | ||||||
Other reinsurers’ balances > $1 million | 89,584 | 24.8 | % | 100,784 | 22.4 | % | ||||||||
Other reinsurers’ balances < $1 million | 7,778 | 2.1 | % | 9,197 | 2 | % | ||||||||
Total | $ | 361,493 | 100 | % | $ | 450,234 | 100 | % | ||||||
September 30, 2014 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 60,218 | 16.7 | % | |||||||||
Everest Re | A+ | 46,765 | 12.9 | % | ||||||||||
Third Point Re | A- | 34,180 | 9.5 | % | ||||||||||
Fully Collateralized | NR | 33,770 | 9.3 | % | ||||||||||
Hannover Re | AA- | 33,124 | 9.2 | % | ||||||||||
Swiss Re | AA- | 13,849 | 3.8 | % | ||||||||||
Transatlantic Re | A+ | 11,649 | 3.2 | % | ||||||||||
XL Re | A+ | 10,334 | 2.9 | % | ||||||||||
Munich Re | AA- | 10,232 | 2.8 | % | ||||||||||
Aioi Nissay Dowa Insurance | A+ | 10,010 | 2.8 | % | ||||||||||
Total | $ | 264,131 | 73.1 | % | ||||||||||
NR: Not rated | ||||||||||||||
December 31, 2013 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 73,398 | 16.3 | % | |||||||||
National Indemnity | AA+ | 51,037 | 11.3 | % | ||||||||||
Everest Re | A+ | 48,055 | 10.7 | % | ||||||||||
Hannover Re | AA- | 41,483 | 9.2 | % | ||||||||||
Fully Collateralized | NR | 36,683 | 8.1 | % | ||||||||||
Third Point Re | A- | 30,428 | 6.8 | % | ||||||||||
Swiss Re | AA- | 20,022 | 4.5 | % | ||||||||||
Transatlantic Re | A+ | 14,114 | 3.1 | % | ||||||||||
XL Re | A+ | 12,673 | 2.8 | % | ||||||||||
Munich Re | AA- | 12,360 | 2.8 | % | ||||||||||
Total | $ | 340,253 | 75.6 | % | ||||||||||
NR: Not rated | ||||||||||||||
At September 30, 2014 and December 31, 2013, the provision for uncollectible reinsurance relating to reinsurance recoverables was $5,380 and $5,794, respectively. To estimate the provision for uncollectible reinsurance, the reinsurance recoverable is first allocated to applicable reinsurers. This determination is based on a process rather than an estimate, although an element of judgment is applied, especially in relation to ceded IBNR. The Company then uses default factors to determine the portion of a reinsurer’s balance deemed to be uncollectible. Default factors require considerable judgment and are determined in part using the current rating, or rating equivalent, of each reinsurer as well as other key considerations and assumptions. |
Share_capital
Share capital | 9 Months Ended | ||
Sep. 30, 2014 | |||
Stockholders' Equity Note [Abstract] | ' | ||
Share capital | ' | ||
Share capital | |||
(a) | Authorized and issued | ||
The Company’s authorized share capital is 571,428,571 common shares with a par value of $0.175 per share. The holders of common shares are entitled to receive dividends. Holders of common shares are allocated one vote per share, provided that, if the controlled shares of any shareholder or group of related shareholders constitute more than 9.09 percent of the outstanding common shares of the Company, their voting power will be reduced to 9.09 percent. | |||
The Company may from time to time repurchase its securities, including common shares, Junior Subordinated Deferrable Debentures and Senior Notes. On February 5, 2014, the Board of Directors of the Company approved an increase in the Company's common share purchase authorization to $500,000. This amount is in addition to the $1,774,436 of common shares repurchased by the Company through February 5, 2014 under its previously authorized share repurchase programs. | |||
The Company has repurchased 64,502,410 common shares for an aggregate purchase price of $2,006,875 from the inception of its share repurchase program to September 30, 2014. The Company had $267,561 remaining under its authorized share repurchase program as of September 30, 2014. | |||
The Company expects the purchases under its share repurchase program to be made from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program will depend on a variety of factors, including market conditions, the Company’s capital position relative to internal and rating agency targets, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board of Directors at any time. | |||
The following table is a summary of the common shares issued and outstanding: | |||
Common Shares | |||
Common shares issued, December 31, 2013 | 154,488,497 | ||
Restricted share awards vested, net of shares withheld | 594,582 | ||
Restricted share units vested, net of shares withheld | 10,265 | ||
Options exercised | 133,385 | ||
Direct issuance of common stock | 1,060 | ||
Performance share awards vested, net of shares withheld | 25,767 | ||
Common shares issued, September 30, 2014 | 155,253,556 | ||
Treasury shares, September 30, 2014 | (66,141,285 | ) | |
Common shares outstanding, September 30, 2014 | 89,112,271 | ||
Common Shares | |||
Common shares issued, December 31, 2012 | 152,698,191 | ||
Restricted share awards vested, net of shares withheld | 768,889 | ||
Restricted share units vested, net of shares withheld | 14,381 | ||
Options exercised | 277,615 | ||
Warrants exercised | 591,480 | ||
Direct issuance of common stock | 928 | ||
Performance share awards vested, net of shares withheld | 31,897 | ||
Deferred share units vested, net of shares withheld | 2,935 | ||
Common shares issued, September 30, 2013 | 154,386,316 | ||
Treasury shares, September 30, 2013 | (54,488,320 | ) | |
Common shares outstanding, September 30, 2013 | 99,897,996 | ||
(b) | Warrants | ||
During the nine months ended September 30, 2014, no warrants were exercised. During the nine months ended September 30, 2013, 1,114,416 warrants were exercised which resulted in the issuance of 591,480 common shares. Holders of the outstanding warrants are entitled to exercise the warrants in whole or in part at any time until the expiration date. The total outstanding warrants at September 30, 2014 were 5,174,114 (December 31, 2013: 5,296,056). No further warrants are anticipated to be issued. | |||
(c) | Deferred share units | ||
Under the terms of the Company’s Director Stock Compensation Plan, non-management directors may elect to receive their director fees in deferred share units rather than cash. The number of share units distributed in case of election under the plan is equal to the amount of the annual retainer fee otherwise payable to the director on such payment date divided by 100% of the fair market value of a share on such payment date. Additional deferred share units are issued in lieu of dividends that accrue on these deferred share units. There were no outstanding deferred share units at September 30, 2014 (December 31, 2013: $nil). | |||
As of February 16, 2013, John Hendrickson became an employee director. As a result, his 5,039 deferred share units vested and 2,935 common shares were issued to him, net of shares withheld for taxes. | |||
(d) | Dividends | ||
On July 29, 2014, the Company announced a quarterly cash dividend of $0.30 (2013: $0.30) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on September 30, 2014 to holders of record on September 15, 2014. | |||
On April 30, 2014, the Company announced a quarterly cash dividend of $0.30 (2013: $0.30) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on June 30, 2014 to holders of record on June 13, 2014. | |||
On February 5, 2014, the Company announced a quarterly cash dividend of $0.30 (2013: $0.30) per common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable. This dividend was paid on March 31, 2014 to holders of record on March 14, 2014. | |||
On February 6, 2013, the Company announced a special dividend in the amount of $2.00 per common share and $2.00 per common share equivalent for which each outstanding warrant is exercisable (the "2013 Special Dividend"). The 2013 Special Dividend was paid on February 26, 2013 to shareholders and warrant holders of record as of February 19, 2013. |
Stock_plans
Stock plans | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Stock plans | ' | |||||||||||||||
Stock plans | ||||||||||||||||
(a) | Long Term Incentive Plan and Short Term Incentive Plan | |||||||||||||||
The Company’s Amended and Restated 2005 Long Term Incentive Plan (“LTIP”) provides for grants to employees of options, stock appreciation rights (“SARs”), restricted shares, restricted share units, performance shares, dividend equivalents or other share-based awards. In addition, the Company may issue restricted share awards or restricted share units in connection with awards issued under its annual Short Term Incentive Plan (“STIP”). The total number of shares reserved for issuance under the LTIP and STIP are 13,126,896 shares of which 1,018,998 shares are remaining. The LTIP and STIP are administered by the Compensation Committee of the Board of Directors. No SARs have been granted to date. Grant prices are established at the fair market value of the Company’s common shares at the date of grant. | ||||||||||||||||
i. | Options | |||||||||||||||
Options may be exercised for voting common shares upon vesting. Options have a life of 10 years and vest either pro rata or at the end of the required service period from the date of grant. Fair value of the option awards at the date of grant is determined using the Black-Scholes option-pricing model. | ||||||||||||||||
Expected volatility is based on stock price volatility of comparable publicly-traded companies. The Company used the simplified method consistent with U.S. GAAP authoritative guidance on stock compensation expenses to estimate expected lives for options granted during the period as historical exercise data was not available and the options met the requirement as set out in the guidance. | ||||||||||||||||
The Company has not granted any stock options since September 4, 2009. | ||||||||||||||||
There were no share compensation expenses in respect of options recognized for the three and nine months ended September 30, 2014 and 2013. | ||||||||||||||||
A modification event was triggered as a result of the 2013 Special Dividend. In accordance with the terms of the LTIP under which the options were issued, an adjustment was required to protect the holders of such stock options from changes in the value of the stock options following the declaration of the 2013 Special Dividend. The modification of the options included a decrease in the exercise price of each stock option and an increase in the number of shares underlying each stock option. The fair value of the options before and after the modification was unchanged. | ||||||||||||||||
Activity with respect to options for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2013 | 1,572,713 | $ | 6.66 | $ | 18.88 | |||||||||||
Options exercised | (133,385 | ) | 3.81 | 25.1 | ||||||||||||
Options outstanding, September 30, 2014 | 1,439,328 | $ | 6.93 | $ | 18.3 | |||||||||||
Activity with respect to options for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options regranted (modified) | 1,833,414 | 6.76 | 19.02 | |||||||||||||
Options exercised | (277,615 | ) | 5.24 | 23.58 | ||||||||||||
Options cancelled (modified) | (1,733,139 | ) | 6.76 | 20.12 | ||||||||||||
Options outstanding, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
At September 30, 2014 and 2013, there were no unrecognized share compensation expenses in respect of options. | ||||||||||||||||
ii. | Restricted share awards | |||||||||||||||
Restricted shares granted under the LTIP and STIP vest either pro rata or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. The Company recognized share compensation expenses during the three and nine months ended September 30, 2014 of $8,180 (2013: $10,041) and $23,101 (2013: $20,035), respectively. The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. | ||||||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2013 | 2,684,745 | $ | 33.74 | |||||||||||||
Restricted share awards granted | 925,610 | 37.33 | ||||||||||||||
Restricted share awards vested | (769,971 | ) | 31.47 | |||||||||||||
Restricted share awards forfeited | (69,117 | ) | 36.28 | |||||||||||||
Restricted share awards outstanding, September 30, 2014 | 2,771,267 | $ | 35.5 | |||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2012 | 2,170,547 | $ | 29.24 | |||||||||||||
Restricted share awards granted | 1,580,117 | 36.06 | ||||||||||||||
Restricted share awards vested | (930,296 | ) | 28.08 | |||||||||||||
Restricted share awards forfeited | (110,912 | ) | 28.34 | |||||||||||||
Restricted share awards outstanding, September 30, 2013 | 2,709,456 | $ | 33.65 | |||||||||||||
At September 30, 2014, there were $77,920 (December 31, 2013: $69,219) of total unrecognized share compensation expenses in respect of restricted share awards that are expected to be recognized over a weighted-average period of 3.0 years (December 31, 2013: 3.2 years). | ||||||||||||||||
iii. | Restricted share units | |||||||||||||||
Restricted share units under the LTIP and STIP vest either ratably or at the end of the required service period and contain certain restrictions during the vesting period, relating to, among other things, forfeiture in the event of termination of employment and transferability. The Company recognized share compensation expenses during the three and nine months ended September 30, 2014 of $269 (2013: $168) and $602 (2013: $419), respectively. The expenses represent the proportionate accrual of the fair value of each grant based on the remaining vesting period. | ||||||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2013 | 66,518 | $ | 33.74 | |||||||||||||
Restricted share units granted | 53,025 | 38.1 | ||||||||||||||
Restricted share units vested | (18,325 | ) | 30.71 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 1,479 | 34.19 | ||||||||||||||
Restricted share units outstanding, September 30, 2014 | 102,697 | $ | 36.54 | |||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2012 | 47,238 | $ | 29.61 | |||||||||||||
Restricted share units granted | 36,635 | 36.11 | ||||||||||||||
Restricted share units vested | (21,814 | ) | 28.17 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 3,924 | 30.29 | ||||||||||||||
Restricted share units outstanding, September 30, 2013 | 65,983 | $ | 33.74 | |||||||||||||
At September 30, 2014, there were $3,038 (December 31, 2013: $1,678) of total unrecognized share compensation expenses in respect of restricted share units that are expected to be recognized over a weighted-average period of 3.3 years (December 31, 2013: 3.4 years). | ||||||||||||||||
iv. | Performance share awards | |||||||||||||||
The performance share awards contain a performance based component. The performance component relates to the compounded growth in the Dividend Adjusted Diluted Book Value per Share (“DBVPS”) over a three year period relative to the Company's peer group. For performance share awards granted during the period, the grant date Diluted Book Value per Share is based on the DBVPS at the end of the most recent financial reporting year. The Dividend Adjusted Performance Period End DBVPS will be the DBVPS three years after the grant date DBVPS. The fair value estimate earns over the requisite attribution period and the estimate will be reassessed at the end of each performance period which will reflect any adjustments in the consolidated statements of comprehensive income in the period in which they are determined. | ||||||||||||||||
The Company recognized share compensation expenses during the three and nine months ended September 30, 2014 of $315 (2013: $318) and $549 (2013: ($971)), respectively. The negative expense is due to a reversal of expenses on unvested performance share awards based on a review of current and projected performance criteria. | ||||||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2013 | 101,820 | $ | 33.56 | |||||||||||||
Performance share awards granted | 52,639 | 37.33 | ||||||||||||||
Performance share awards vested | (32,746 | ) | 32.62 | |||||||||||||
Performance share awards conversion adjustment | (15,344 | ) | 31.38 | |||||||||||||
Performance share awards outstanding, September 30, 2014 | 106,369 | $ | 36.03 | |||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2012 | 220,845 | $ | 31.81 | |||||||||||||
Performance share awards granted | 38,386 | 36.11 | ||||||||||||||
Performance share awards vested | (39,094 | ) | 28.7 | |||||||||||||
Performance share awards forfeited | (18,701 | ) | 31.05 | |||||||||||||
Performance share awards conversion adjustment | (99,616 | ) | $ | 33.05 | ||||||||||||
Performance share awards outstanding, September 30, 2013 | 101,820 | $ | 33.56 | |||||||||||||
At September 30, 2014, there were $2,527 (December 31, 2013: $1,642) of total unrecognized share compensation expenses in respect of performance share awards that are expected to be recognized over a weighted-average period of 2.3 years (December 31, 2013: 2.0 years). | ||||||||||||||||
(b) | Total share compensation expenses | |||||||||||||||
The breakdown of share compensation expenses by award type was as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Restricted share awards | 8,180 | 10,041 | 23,101 | 20,035 | ||||||||||||
Restricted share units | 269 | 168 | 602 | 419 | ||||||||||||
Performance share awards | 315 | 318 | 549 | (971 | ) | |||||||||||
Total | $ | 8,764 | $ | 10,527 | $ | 24,252 | $ | 19,483 | ||||||||
Debt_and_financing_arrangement
Debt and financing arrangements | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Debt Disclosure [Abstract] | ' | |||||||||||||||
Debt and financing arrangements | ' | |||||||||||||||
Debt and financing arrangements | ||||||||||||||||
(a) | Financing structure | |||||||||||||||
The financing structure at September 30, 2014 was: | ||||||||||||||||
Commitment | Issued and outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 136,403 | 136,403 | 136,403 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total debentures payable | 600,153 | 539,953 | 539,953 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,279 | |||||||||||||
Total debentures and senior notes payable | 850,153 | 789,953 | 787,232 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 301,340 | — | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 19,743 | — | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 30,000 | 30,000 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 16,975 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 288,739 | — | |||||||||||||
Total credit and other facilities | 1,605,000 | 682,091 | — | |||||||||||||
Total debt and financing arrangements | $ | 2,455,153 | $ | 1,472,044 | $ | 787,232 | ||||||||||
The financing structure at December 31, 2013 was: | ||||||||||||||||
Commitment | Issued and outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,866 | 137,866 | 137,866 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total debentures payable | 601,616 | 541,416 | 541,416 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,198 | |||||||||||||
Total debentures and senior notes payable | 851,616 | 791,416 | 788,614 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 358,567 | — | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 16,726 | — | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 24,800 | 24,800 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 20,177 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 305,686 | — | |||||||||||||
Total credit and other facilities | 1,599,800 | 751,250 | — | |||||||||||||
Total debt and financing arrangements | $ | 2,451,416 | $ | 1,542,666 | $ | 788,614 | ||||||||||
(a) | Indicates utilization of commitment amount, not necessarily drawn borrowings. | |||||||||||||||
(b) | Senior notes and junior subordinated deferrable debentures | |||||||||||||||
The following table summarizes the key terms of the Company's senior notes and junior subordinated deferrable debentures as at the issuance date for each placement. | ||||||||||||||||
Description | Issuance date | Commitment | Maturity date | Fixed/Spread | Interest payments due | |||||||||||
2006 Junior Subordinated Deferrable Debentures | June 15, 2006 | $ | 150,000 | June 15, 2036 | 9.069 | % | (a) | Quarterly | ||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | August 23, 2006 | $ | 136,403 | September 15, 2036 | 3.54 | % | (b) | Quarterly | ||||||||
2007 Junior Subordinated Deferrable Debentures | June 21, 2007 | $ | 200,000 | June 15, 2037 | 8.48 | % | (a) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | June 8, 2007 | $ | 88,750 | July 30, 2037 | 3 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | September 20, 2007 | $ | 25,000 | September 15, 2037 | 3.1 | % | (b) | Quarterly | ||||||||
2010 Senior Notes due 2040 | January 26, 2010 | $ | 250,000 | January 26, 2040 | 8.875 | % | (a) | Semi-annually in arrears | ||||||||
(a) | Fixed interest rate. | |||||||||||||||
(b) | Variable interest rate is the three-month LIBOR, reset quarterly, plus spread as noted in the table. | |||||||||||||||
The following table summarizes the key terms of the Company's senior notes and junior subordinated deferrable debentures as at September 30, 2014: | ||||||||||||||||
Description | Issuance date | Commitment | Maturity date | Fixed/Spread | Interest payments due | |||||||||||
2006 Junior Subordinated Deferrable Debentures | June 15, 2006 | $ | 150,000 | June 15, 2036 | 5.831 | % | (b) | Quarterly | ||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | August 23, 2006 | $ | 136,403 | September 15, 2036 | 6.463 | % | (b) | Quarterly | ||||||||
2007 Junior Subordinated Deferrable Debentures | June 21, 2007 | $ | 200,000 | June 15, 2037 | 5.18 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 8-Jun-07 | $ | 88,750 | July 30, 2037 | 5.9 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 20-Sep-07 | $ | 25,000 | September 15, 2037 | 5.983 | % | (b) | Quarterly | ||||||||
2010 Senior Notes due 2040 | 26-Jan-10 | $ | 250,000 | January 26, 2040 | 8.875 | % | (a) | Semi-annually in arrears | ||||||||
(a) | Fixed interest rate. | |||||||||||||||
(b) | Interest rate has been fixed as a result of interest rate swap contracts entered into by the Company. | |||||||||||||||
Senior Notes | ||||||||||||||||
The Senior Notes due 2040 (the “2010 Senior Notes”) were part of a registered public offering. The 2010 Senior Notes mature on January 26, 2040. The Company may redeem the notes, in whole at any time, or in part from time to time, at the Company's option on not less than 30 nor more than 60 days’ notice, at a make-whole redemption price as described in “Description of the Notes - Optional Redemption” in the 2010 Senior Notes prospectus supplement. In addition, the Company may redeem the notes, in whole, but not in part, at any time upon the occurrence of certain tax events as described in “Description of the Notes - Redemption for Tax Purposes’ in the prospectus supplement. | ||||||||||||||||
Debt issuance costs were deferred as an asset and are amortized over the life of the 2010 Senior Notes. There were no redemptions made during the three and nine months ended September 30, 2014 and 2013. | ||||||||||||||||
The 2010 Senior Notes are unsecured and unsubordinated obligations of the Company and rank equally in right of payment with all of the Company’s existing and future unsecured and unsubordinated indebtedness. The 2010 Senior Notes will be effectively junior to all of the Company’s future secured debt, to the extent of the value of the collateral securing such debt, and will rank senior to all our existing and future subordinated debt. The 2010 Senior Notes are structurally subordinated to all obligations of the Company’s subsidiaries. | ||||||||||||||||
Future payments of principal of $250,000 on the 2010 Senior Notes are all expected to be after 2019. | ||||||||||||||||
Junior subordinated deferrable debentures | ||||||||||||||||
The Company participated in private placements of junior subordinated deferrable interest debentures due 2036 and 2037 (respectively, the “2006 Junior Subordinated Deferrable Debentures” and “2007 Junior Subordinated Deferrable Debentures”). | ||||||||||||||||
Debt issuance costs for the 2006 and 2007 Junior Subordinated Deferrable Debentures were deferred as an asset and were amortized to income over the five year optional redemption periods. They are redeemable at the Company's option at par. There were no redemptions made during the three and nine months ended September 30, 2014 and 2013. | ||||||||||||||||
As part of the acquisition of Flagstone, the Company assumed junior subordinated deferrable debentures due 2036 and 2037 (respectively, the “Flagstone 2006 Junior Subordinated Deferrable Debentures” and “Flagstone 2007 Junior Subordinated Deferrable Debentures”). These debentures are redeemable quarterly at par. There were no redemptions made during the three and nine months ended September 30, 2014 and 2013. | ||||||||||||||||
Future payments of principal of $539,953 on the debentures discussed above are all expected to be after 2019. | ||||||||||||||||
(c) | Credit facilities | |||||||||||||||
i. | $400,000 syndicated unsecured letter of credit facility and $525,000 syndicated secured letter of credit facility | |||||||||||||||
On March 9, 2012, the Company entered into a $400,000 four-year unsecured credit facility with Deutsche Bank Securities Inc., as syndication agent, JPMorgan Chase Bank, N.A. as administrative agent, Lloyds Securities Inc. and Suntrust Bank, as co-documentation agents and the lenders party thereto, which provides for letter of credit and revolving credit availability for the Company (the “Four Year Unsecured Facility”) (the full $400,000 of which is available for letters of credit and/or revolving loans). The Four Year Unsecured Facility was provided by a syndicate of commercial banks. Letters of credit under the Four Year Unsecured Facility are available to support obligations in connection with the insurance business of the Company and its subsidiaries. Loans under the Four Year Unsecured Facility are available for the general corporate and working capital purposes of the Company. The Company may request that existing lenders under the Four Year Unsecured Facility or prospective additional lenders agree to make available additional commitments from time to time so long as the aggregate commitments under the Four Year Unsecured Facility do not exceed $500,000. | ||||||||||||||||
Also on March 9, 2012, the Company entered into a $525,000 four-year secured credit facility, with the same parties, which provides for letter of credit availability for the Company (the “Four Year Secured Facility” and together with the Four Year Unsecured Facility, the “Credit Facilities”). The Four Year Secured Facility was also provided by a syndicate of commercial banks. Letters of credit under the Four Year Secured Facility will be available to support obligations in connection with the insurance business of the Company. The Company may request that existing lenders under the Four Year Secured Facility or prospective additional lenders agree to make available additional commitments from time to time so long as the aggregate commitments under the Four Year Secured Facility do not exceed $700,000. The obligations of the Company under the Four Year Secured Facility are secured by cash and securities deposited into cash collateral accounts from time to time with The Bank of New York Mellon. | ||||||||||||||||
As of September 30, 2014, there were $301,340 in outstanding letters of credit under the Four Year Secured Facility (December 31, 2013: $358,567) and $nil outstanding under the Four Year Unsecured Facility. | ||||||||||||||||
The Credit Facilities contain covenants that include, among other things (i) the requirement that the Company initially maintain a minimum level of consolidated net worth of at least $2,600,000 and, commencing with the end of the fiscal quarter ending March 31, 2012, to be increased quarterly by an amount equal to 50.0% of the Company’s consolidated net income (if positive) for such quarter plus 50.0% of the aggregate increases in the consolidated shareholders’ equity of the Company during such fiscal quarter by reason of the issuance and sale of common equity interests of the Company, including upon any conversion of debt securities of the Company into such equity interests, (ii) the requirement that the Company maintain at all times a consolidated total debt to consolidated total capital ratio not greater than 0.35:1.00, and (iii) the requirement that Validus Reinsurance, Ltd. and any other material insurance subsidiaries maintain a financial strength rating by A.M. Best of not less than “B++” (Fair). In addition, the Credit Facilities contain customary negative covenants applicable to the Company, including limitations on the ability to pay dividends and other payments in respect of equity interests at any time that the Company is otherwise in default with respect to certain provisions under the respective Credit Facilities, limitations on the ability to incur liens, sell assets, merge or consolidate with others, enter into transactions with affiliates, and limitations on the ability of its subsidiaries to incur indebtedness. The Credit Facilities also contain customary affirmative covenants, representations and warranties and events of default for credit facilities of its type. As of September 30, 2014, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Credit Facilities. | ||||||||||||||||
ii. | $25,000 Talbot FAL facility | |||||||||||||||
Talbot holds a standby Letter of Credit facility (the “Talbot FAL facility”) to provide Funds at Lloyd’s to support the 2012, 2013, 2014 and 2015 underwriting years of account. As of September 30, 2014 the Company had $25,000 (December 31, 2013: $25,000) in outstanding letters of credit under the Talbot FAL facility. | ||||||||||||||||
The Talbot FAL facility contains affirmative covenants that include requirements for consolidated net worth and debt to capital ratios in line with those in place for the Credit Facilities and discussed above. The Talbot FAL facility also contains restrictions on the Company's ability to incur debt at our subsidiaries, incur liens, sell assets and merge or consolidate with others. Other than in respect of existing and future preferred and hybrid securities, the payment of dividends and other payments in respect of equity interests are not permitted at any time that we are in default with respect to certain provisions under the Talbot FAL facility. As of September 30, 2014 and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Talbot FAL facility. | ||||||||||||||||
iii. | $40,000 IPC bi-lateral facility | |||||||||||||||
The Company assumed an existing evergreen letter of credit facility through the acquisition of IPC Holdings, Ltd. (the "IPC bi-lateral facility"). As of September 30, 2014, there were $16,975 outstanding letters of credit issued under the IPC bi-lateral facility (December 31, 2013: $20,177). As of September 30, 2014 and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the IPC bi-lateral facility. | ||||||||||||||||
iv. | $200,000 secured bi-lateral letter of credit facility | |||||||||||||||
The Company holds an uncommitted secured bi-lateral letter of credit facility with Citibank Europe plc (the “Secured bi-lateral letter of credit facility”). As of September 30, 2014, $19,743 (December 31, 2013: $16,726) of letters of credit were outstanding under the Secured bi-lateral letter of credit facility. The Secured bi-lateral letter of credit facility has no fixed termination date and as of September 30, 2014, and throughout the reporting periods presented, the Company is in compliance with all terms and covenants thereof. | ||||||||||||||||
v. | $10,000 PaCRe senior secured letter of credit facility | |||||||||||||||
On May 11, 2012, PaCRe and its subsidiary, PaCRe Investments, Ltd. entered into a secured evergreen credit and letter of credit facility with JPMorgan Chase Bank, N.A. This facility provides for revolving borrowings by PaCRe and for letters of credit issued by PaCRe to be used to support its reinsurance obligations in aggregate amount of $10,000. As of September 30, 2014, $294 (December 31, 2013: $294) of letters of credit were outstanding under this facility. As of September 30, 2014, and throughout the reporting periods presented, PaCRe was in compliance with all covenants and restrictions thereof. | ||||||||||||||||
vi. | $30,000 AlphaCat Re secured letter of credit facility | |||||||||||||||
On January 2, 2013, AlphaCat Re entered into a secured evergreen letter of credit facility with Comerica Bank. This facility provides for letters of credit issued by AlphaCat Re to be used to support its reinsurance obligations in the aggregate amount of $24,800. During the period ended March 31, 2014 the size of the facility was increased to $30,000 from $24,800. As of September 30, 2014, $30,000 (December 31, 2013: $24,800) of letters of credit were outstanding under this facility. As of September 30, 2014, and throughout the reporting periods presented, AlphaCat Re was in compliance with all covenants and restrictions thereof. | ||||||||||||||||
vii. | $375,000 Flagstone bi-lateral facility | |||||||||||||||
As part of the Flagstone Acquisition, the Company assumed an evergreen Letters of Credit Master Agreement between Citibank Europe Plc and Flagstone Reassurance Suisse, S.A. (the “Flagstone Bi-Lateral Facility”). At September 30, 2014, the Flagstone Bi-Lateral Facility had $288,739 (December 31, 2013: $305,686) letters of credit issued and outstanding. As of September 30, 2014, and throughout the reporting periods presented, the Company was in compliance with all covenants and restrictions under the Flagstone Bi-Lateral Facility. | ||||||||||||||||
(d) | Finance expenses | |||||||||||||||
Finance expenses consist of interest on the junior subordinated deferrable debentures and senior notes, the amortization of debt offering costs, credit facilities fees, bank charges, AlphaCat financing fees and Talbot FAL costs as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 2,235 | $ | 2,235 | $ | 6,633 | $ | 6,633 | ||||||||
2007 Junior Subordinated Deferrable Debentures | 1,848 | 1,848 | 5,492 | 5,492 | ||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 2,269 | 2,285 | 6,736 | 5,988 | ||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 1,807 | 1,807 | 5,335 | 4,426 | ||||||||||||
2010 Senior Notes due 2040 | 5,597 | 5,597 | 16,791 | 16,791 | ||||||||||||
Credit facilities | 1,295 | 1,248 | 4,225 | 5,001 | ||||||||||||
Bank charges | 88 | 187 | 303 | 420 | ||||||||||||
AlphaCat ILS funds fees (a) | 384 | 78 | 2,030 | 2,406 | ||||||||||||
Talbot FAL Facility | (169 | ) | 32 | (165 | ) | 95 | ||||||||||
Total finance expenses | $ | 15,354 | $ | 15,317 | $ | 47,380 | $ | 47,252 | ||||||||
(a) | Includes finance expenses incurred by AlphaCat Managers, Ltd. in relation to fund raising for the AlphaCat ILS funds, AlphaCat 2014 and AlphaCat 2013. |
Accumulated_other_comprehensiv
Accumulated other comprehensive (loss) income | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | |||||||||||||||
Accumulated other comprehensive (loss) income | ' | |||||||||||||||
Accumulated other comprehensive (loss) income | ||||||||||||||||
The changes in accumulated other comprehensive (loss) income, by component for the three and nine months ended September 30, 2014 and 2013 is as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Balance - Beginning of period | $ | 2,460 | $ | (8,262 | ) | $ | (617 | ) | $ | (2,953 | ) | |||||
Amounts reclassified to retained earnings | — | — | — | 4,290 | ||||||||||||
Other comprehensive (loss) income | (5,198 | ) | 4,390 | (2,121 | ) | (5,209 | ) | |||||||||
Balance - End of period | $ | (2,738 | ) | $ | (3,872 | ) | $ | (2,738 | ) | $ | (3,872 | ) |
Commitments_and_contingencies
Commitments and contingencies | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||||
Commitments and contingencies | ' | |||||||
Commitments and contingencies | ||||||||
(a) | Concentrations of credit risk | |||||||
The Company’s investments are managed following prudent standards of diversification. The Company attempts to limit its credit exposure by purchasing high quality fixed income investments to maintain a minimum weighted-average portfolio credit rating of A+. In addition, the portfolio limits the amount of “risk assets”, such as non-investment grade debt and equity securities, to a maximum of 35% of shareholders’ equity. The Company also limits its exposure to any single issuer to 3.5% of its investment portfolio or less, excluding government and agency securities, depending on the credit rating of the issuer. With the exception of the Company's bank loan portfolio, which represents 6.8% of the Company's total investments as at September 30, 2014, and certain capital securities issued by investment grade corporations, the minimum credit rating of any security purchased is Baa3/BBB-. In total, investments in below investment grade securities are limited to no more than 10% of the Company's investment portfolio. Excluding bank loans, 1.7% of the portfolio had a split rating below Baa3/BBB- as at September 30, 2014. The Company did not have an aggregate exposure to any single issuer of more than 0.9% of its investment portfolio, other than with respect to government and agency securities as at September 30, 2014. | ||||||||
(b) | Funds at Lloyd's | |||||||
The amounts provided under the Talbot FAL Facility would become a liability of the Company in the event of Syndicate 1183 declaring a loss at a level which would call on this arrangement. | ||||||||
Talbot operates in Lloyd’s through a corporate member, Talbot 2002 Underwriting Capital Ltd (“T02”), which is the sole participant in Syndicate 1183. Lloyd’s sets T02’s required capital annually based on Syndicate 1183’s business plan, rating environment and reserving environment together with input arising from Lloyd’s discussions with, inter alia, regulatory and rating agencies. Such capital, called Funds at Lloyd’s (“FAL”), comprises: cash, investments and undrawn letters of credit provided by various banks. | ||||||||
The amounts of cash, investments and letters of credit provided for each year of account as follows: | ||||||||
2014 Underwriting Year | 2013 Underwriting Year | |||||||
Talbot FAL facility | $ | 25,000 | $ | 25,000 | ||||
Group funds | 450,000 | 403,700 | ||||||
Total | $ | 475,000 | $ | 428,700 | ||||
The amounts which are provided as FAL are not available for distribution to the Company for the payment of dividends. Talbot’s corporate member may also be required to maintain funds under the control of Lloyd’s in excess of its capital requirement and such funds also may not be available for distribution to the Company for the payment of dividends. See Note 3 (d) for investments pledged as collateral. | ||||||||
(c) | Lloyd's Central Fund | |||||||
Whenever a member of Lloyd's is unable to pay its debts to policyholders, such debts may be payable by the Lloyd's Central Fund. If Lloyd's determines that the Central Fund needs to be increased, it has the power to assess premium levies on current Lloyd's members up to 3% of a member's underwriting capacity in any one year. The Company does not believe that any assessment is likely in the foreseeable future and has not provided any allowance for such an assessment. However, based on the Company's 2014 estimated premium income at Lloyd's of £625,000, at the September 30, 2014 exchange rate of £1 equals $1.6195 and assuming the maximum 3% assessment, the Company would be assessed approximately $30,366. | ||||||||
(d) | Aquiline commitment | |||||||
As discussed in Note 5 "Investments in affiliates," the Company entered into an Assignment and Assumption Agreement with Aquiline Capital Partners LLC, pursuant to which it assumed a total capital commitment of $50,000 which will expire on July 2, 2015. The Company's remaining commitment at September 30, 2014 was $17,890 (December 31, 2013: $17,890). | ||||||||
(e) | Other investment commitments | |||||||
At September 30, 2014, the Company had capital commitments to five other investments of $105,000 (December 31, 2013: $30,000). The Company's remaining commitment to these investments at September 30, 2014 was $79,259 (December 31, 2013: $5,045). |
Related_party_transactions
Related party transactions | 9 Months Ended |
Sep. 30, 2014 | |
Related Party Transactions [Abstract] | ' |
Related party transactions | ' |
Related party transactions | |
The transactions listed below are classified as related party transactions as each counter party has either a direct or indirect shareholding in the Company. | |
Aquiline Capital Partners, LLC and its related companies ("Aquiline"), which own 3,446,643 shares in the Company, hold warrants to purchase 2,756,088 shares, and have two employees on the Company's Board of Directors who do not receive compensation from the Company, are shareholders of Group Ark Insurance Holdings Ltd. ("Group Ark"). Christopher E. Watson, a director of the Company, serves as a director of Group Ark. Pursuant to reinsurance agreements with a subsidiary of Group Ark, the Company recognized gross premiums written during the three and nine months ended September 30, 2014 of $246 (2013: $nil) and $2,190 (2013: $2,848) respectively, with $733 included in premiums receivable at September 30, 2014 (December 31, 2013: $238). The Company also recognized reinsurance premiums ceded during the three and nine months ended September 30, 2014 of $127 (2013: $23) and had reinsurance balances payable of $4 at September 30, 2014 (December 31, 2013: $4). The Company recorded $2,005 of loss reserves recoverable at September 30, 2014 (December 31, 2013: $3,698). Earned premium adjustments of $694 (2013: $718) and $1,653 (2013: $2,147) were recorded during the three and nine months ended September 30, 2014, respectively. | |
On November 24, 2009, the Company entered into an Investment Management Agreement with Conning, Inc. ("Conning") to manage a portion of the Company's investment portfolio. Aquiline acquired Conning on June 16, 2009. Jeffrey W. Greenberg, a director of the Company, serves as a director of Conning Holdings Corp., the parent company of Conning. Investment management fees earned by Conning for the three and nine months ended September 30, 2014 were $(7) (2013: $165) and $219 (2013: $396) respectively, with $239 included in accounts payable and accrued expenses at September 30, 2014 (December 31, 2013: $283). | |
On December 20, 2011, the Company entered into an Assignment and Assumption Agreement (the "Agreement") with Aquiline Capital Partners LLC, a Delaware limited liability company (the "Assignor") and Aquiline Capital Partners II GP (Offshore) Ltd., a Cayman Islands company limited by shares (the "General Partner") pursuant to which the Company has assumed 100% of the Assignor's interest in Aquiline Financial Services Fund II L.P. (the "Partnership") representing a total capital commitment of $50,000 (the "Commitment"), as a limited partner in the Partnership (the "Transferred Interest"). Messrs. Greenberg and Watson, directors of the Company, serve as managing principal and senior principal, respectively, of Aquiline Capital Partners LLC. For the three months ended September 30, 2014, the Company incurred $nil (2013: $505) in partnership fees and made capital contributions of $nil (2013: $6,185). For the nine months ended September 30, 2014, the Company incurred $nil (2013: $625) in partnership fees and made $nil (2013: $13,089) of capital contributions. There were no amounts included in accounts payable and accrued expenses at September 30, 2014 or December 31, 2013. | |
Certain shareholders of the Company and their affiliates, as well as employers of entities associated with directors or officers have purchased insurance and/or reinsurance from the Company in the ordinary course of business. The Company believes these transactions were settled for arm's length consideration. |
Earnings_per_share
Earnings per share | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Earnings per share | ' | |||||||||||||||
Earnings per share | ||||||||||||||||
The following table sets forth the computation of basic and earnings per diluted share for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Basic earnings per share | ||||||||||||||||
Net (loss) income | $ | (13,397 | ) | $ | 229,063 | $ | 381,172 | $ | 419,503 | |||||||
Loss (income) attributable to noncontrolling interest | 53,069 | (45,694 | ) | (25,745 | ) | 17,831 | ||||||||||
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | (1,552 | ) | (4,656 | ) | (17,662 | ) | ||||||||
Income available to common shareholders | $ | 38,120 | $ | 181,817 | $ | 350,771 | $ | 419,672 | ||||||||
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 | ||||||||||||
Basic earnings per share available to common shareholders | $ | 0.42 | $ | 1.82 | $ | 3.83 | $ | 4.06 | ||||||||
Earnings per diluted share | ||||||||||||||||
Net (loss) income | $ | (13,397 | ) | $ | 229,063 | $ | 381,172 | $ | 419,503 | |||||||
Loss (income) attributable to noncontrolling interest | 53,069 | (45,694 | ) | (25,745 | ) | 17,831 | ||||||||||
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | — | — | (17,662 | ) | ||||||||||
Income available to common shareholders | $ | 38,120 | $ | 183,369 | $ | 355,427 | $ | 419,672 | ||||||||
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 | ||||||||||||
Share equivalents: | ||||||||||||||||
Warrants | — | 2,606,669 | 2,747,399 | — | ||||||||||||
Stock options | 760,267 | 782,158 | 752,145 | 1,090,298 | ||||||||||||
Unvested restricted shares | 586,014 | 390,376 | 772,147 | 723,219 | ||||||||||||
Weighted average number of diluted common shares outstanding | 91,939,610 | 103,613,766 | 95,937,641 | 105,264,913 | ||||||||||||
Earnings per diluted share available to common shareholders | $ | 0.41 | $ | 1.77 | $ | 3.7 | $ | 3.99 | ||||||||
Share equivalents that would result in the issuance of common shares of 4,712 (2013: 125,728) and 235,460 (2013: 464,516) were outstanding for the three and nine months ended September 30, 2014, respectively, but were not included in the computation of earnings per diluted share because the effect would be antidilutive. |
Segment_information
Segment information | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||||
Segment information | ' | ||||||||||||||||||||||
Segment information | |||||||||||||||||||||||
The Company conducts its operations worldwide through three operating segments, which have been determined under U.S. GAAP segment reporting to be Validus Re, AlphaCat and Talbot. The Company’s operating segments are strategic business units that offer different products and services. They are managed and have capital allocated separately because each segment requires different strategies. | |||||||||||||||||||||||
Validus Re Segment | |||||||||||||||||||||||
The Validus Re segment is focused on short-tail lines of reinsurance. The primary lines in which the segment conducts business are property, marine and specialty which includes agriculture, aerospace and aviation, financial lines of business, nuclear, terrorism, life, accident & health, workers’ compensation, crisis management, contingency, motor, technical lines, composite and trade credit. | |||||||||||||||||||||||
AlphaCat Segment | |||||||||||||||||||||||
The AlphaCat segment manages strategic relationships that leverage the Company’s underwriting and investment expertise and earns management, performance and underwriting fees primarily from the Company’s operating affiliates, AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013 and AlphaCat 2014, as well as PaCRe and the AlphaCat ILS funds. | |||||||||||||||||||||||
Talbot Segment | |||||||||||||||||||||||
The Talbot segment focuses on a wide range of marine and energy, war, political violence, commercial property, financial institutions, contingency, accident & health and aviation classes of business on an insurance or facultative reinsurance basis and principally property, aerospace and marine classes of business on a treaty reinsurance basis. | |||||||||||||||||||||||
Corporate and eliminations | |||||||||||||||||||||||
The Company has a corporate function ("corporate"), which includes the activities of the parent company, and which carries out certain functions for the group. Corporate includes ‘non-core’ underwriting expenses, predominantly general and administrative and stock compensation expenses. Corporate also denotes the activities of certain key executives such as the Chief Executive Officer and Chief Financial Officer. For internal reporting purposes, corporate is reflected separately, however corporate is not considered an operating segment under these circumstances. Other reconciling items include, but are not limited to, the elimination of inter segment revenues and expenses and unusual items that are not allocated to segments. | |||||||||||||||||||||||
The following tables summarize the results of our operating segments and "Corporate": | |||||||||||||||||||||||
Three Months Ended September 30, 2014 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 114,897 | $ | 6,936 | $ | 245,685 | $ | (8,544 | ) | $ | 358,974 | ||||||||||||
Reinsurance premiums ceded | (10,899 | ) | (648 | ) | (27,134 | ) | 8,544 | (30,137 | ) | ||||||||||||||
Net premiums written | 103,998 | 6,288 | 218,551 | — | 328,837 | ||||||||||||||||||
Change in unearned premiums | 122,712 | 28,850 | 14,297 | — | 165,859 | ||||||||||||||||||
Net premiums earned | 226,710 | 35,138 | 232,848 | — | 494,696 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 102,005 | 3,738 | 118,382 | — | 224,125 | ||||||||||||||||||
Policy acquisition costs | 36,177 | 3,378 | 47,862 | (1,013 | ) | 86,404 | |||||||||||||||||
General and administrative expenses | 18,522 | 7,719 | 37,709 | 19,369 | 83,319 | ||||||||||||||||||
Share compensation expenses | 2,582 | 179 | 2,990 | 3,013 | 8,764 | ||||||||||||||||||
Total underwriting deductions | 159,286 | 15,014 | 206,943 | 21,369 | 402,612 | ||||||||||||||||||
Underwriting income (loss) | $ | 67,424 | $ | 20,124 | $ | 25,905 | $ | (21,369 | ) | $ | 92,084 | ||||||||||||
Net investment income | 20,762 | 837 | 4,965 | (1,303 | ) | 25,261 | |||||||||||||||||
Other (loss) income | (6,827 | ) | 5,980 | 109 | (3,342 | ) | (4,080 | ) | |||||||||||||||
Finance expenses | (3,622 | ) | (385 | ) | 162 | (11,509 | ) | (15,354 | ) | ||||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 77,737 | 26,556 | 31,141 | (37,523 | ) | 97,911 | |||||||||||||||||
Tax benefit (expense) | 1,058 | — | 332 | (437 | ) | 953 | |||||||||||||||||
Income from operating affiliates | — | 3,761 | — | — | 3,761 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (25,807 | ) | — | — | (25,807 | ) | ||||||||||||||||
Net operating income (loss) | $ | 78,795 | $ | 4,510 | $ | 31,473 | $ | (37,960 | ) | $ | 76,818 | ||||||||||||
Net realized gains on investments | 1,641 | 2,563 | 391 | — | 4,595 | ||||||||||||||||||
Change in net unrealized (losses) on investments | (20,149 | ) | (60,253 | ) | (3,097 | ) | (1,475 | ) | (84,974 | ) | |||||||||||||
Income from investment affiliate | 1,754 | — | — | — | 1,754 | ||||||||||||||||||
Foreign exchange (losses) gains | (6,056 | ) | (51 | ) | (7,114 | ) | 1,780 | (11,441 | ) | ||||||||||||||
Transaction expenses (b) | — | — | — | (149 | ) | (149 | ) | ||||||||||||||||
Net income (loss) | $ | 55,985 | $ | (53,231 | ) | $ | 21,653 | $ | (37,804 | ) | $ | (13,397 | ) | ||||||||||
Net loss attributable to noncontrolling interest | — | 53,069 | — | — | 53,069 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 55,985 | $ | (162 | ) | $ | 21,653 | $ | (37,804 | ) | $ | 39,672 | |||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.5 | % | 90.7 | % | 89 | % | 91.6 | % | |||||||||||||||
Losses and loss expenses | 45 | % | 10.6 | % | 50.8 | % | 45.3 | % | |||||||||||||||
Policy acquisition costs | 16 | % | 9.6 | % | 20.6 | % | 17.5 | % | |||||||||||||||
General and administrative expenses (c) | 9.3 | % | 22.5 | % | 17.5 | % | 18.6 | % | |||||||||||||||
Expense ratio | 25.3 | % | 32.1 | % | 38.1 | % | 36.1 | % | |||||||||||||||
Combined ratio | 70.3 | % | 42.7 | % | 88.9 | % | 81.4 | % | |||||||||||||||
Total assets | $ | 4,716,426 | $ | 1,688,191 | $ | 2,898,755 | $ | 749,678 | $ | 10,053,050 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the three months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. | ||||||||||||||||||||||
(c) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Three Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | ||||||||||||
Reinsurance premiums ceded | (13,006 | ) | (525 | ) | (49,998 | ) | 24,114 | (39,415 | ) | ||||||||||||||
Net premiums written | 117,919 | 2,956 | 196,470 | — | 317,345 | ||||||||||||||||||
Change in unearned premiums | 157,873 | 34,210 | 21,860 | — | 213,943 | ||||||||||||||||||
Net premiums earned | 275,792 | 37,166 | 218,330 | — | 531,288 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 62,250 | 15,615 | 100,100 | — | 177,965 | ||||||||||||||||||
Policy acquisition costs | 47,662 | 3,787 | 44,899 | (1,448 | ) | 94,900 | |||||||||||||||||
General and administrative expenses | 19,785 | 5,728 | 37,402 | 18,174 | 81,089 | ||||||||||||||||||
Share compensation expenses | 2,479 | 152 | 2,992 | 4,904 | 10,527 | ||||||||||||||||||
Total underwriting deductions | 132,176 | 25,282 | 185,393 | 21,630 | 364,481 | ||||||||||||||||||
Underwriting income (loss) | $ | 143,616 | $ | 11,884 | $ | 32,937 | $ | (21,630 | ) | $ | 166,807 | ||||||||||||
Net investment income | 15,628 | 967 | 4,395 | (981 | ) | 20,009 | |||||||||||||||||
Other (loss) income | (1,892 | ) | 3,791 | 73 | (4,778 | ) | (2,806 | ) | |||||||||||||||
Finance expenses | (3,640 | ) | (80 | ) | (107 | ) | (11,490 | ) | (15,317 | ) | |||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 153,712 | 16,562 | 37,298 | (38,879 | ) | 168,693 | |||||||||||||||||
Tax benefit (expense) | 143 | — | (513 | ) | 365 | (5 | ) | ||||||||||||||||
Income from operating affiliates | — | 1,463 | — | — | 1,463 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (11,815 | ) | — | — | (11,815 | ) | ||||||||||||||||
Net operating income (loss) | $ | 153,855 | $ | 6,210 | $ | 36,785 | $ | (38,514 | ) | $ | 158,336 | ||||||||||||
Net realized (losses) gains on investments | (10,137 | ) | 4,084 | (267 | ) | — | (6,320 | ) | |||||||||||||||
Change in net unrealized gains on investments | 23,144 | 44,145 | 2,678 | — | 69,967 | ||||||||||||||||||
Income from investment affiliate | 1,044 | — | — | — | 1,044 | ||||||||||||||||||
Foreign exchange gains (losses) | 2,168 | 388 | 4,238 | (758 | ) | 6,036 | |||||||||||||||||
Net income (loss) | $ | 170,074 | $ | 54,827 | $ | 43,434 | $ | (39,272 | ) | $ | 229,063 | ||||||||||||
Net income attributable to noncontrolling interest | — | (45,694 | ) | — | — | (45,694 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 170,074 | $ | 9,133 | $ | 43,434 | $ | (39,272 | ) | $ | 183,369 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.1 | % | 84.9 | % | 79.7 | % | 89 | % | |||||||||||||||
Losses and loss expenses | 22.6 | % | 42 | % | 45.8 | % | 33.5 | % | |||||||||||||||
Policy acquisition costs | 17.3 | % | 10.2 | % | 20.6 | % | 17.9 | % | |||||||||||||||
General and administrative expenses (b) | 8.1 | % | 15.8 | % | 18.5 | % | 17.2 | % | |||||||||||||||
Expense ratio | 25.4 | % | 26 | % | 39.1 | % | 35.1 | % | |||||||||||||||
Combined ratio | 48 | % | 68 | % | 84.9 | % | 68.6 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2014 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,104,169 | $ | 135,073 | $ | 854,324 | $ | (66,927 | ) | $ | 2,026,639 | ||||||||||||
Reinsurance premiums ceded | (184,074 | ) | (4,348 | ) | (154,115 | ) | 66,927 | (275,610 | ) | ||||||||||||||
Net premiums written | 920,095 | 130,725 | 700,209 | — | 1,751,029 | ||||||||||||||||||
Change in unearned premiums | (233,271 | ) | (32,444 | ) | (41,658 | ) | — | (307,373 | ) | ||||||||||||||
Net premiums earned | 686,824 | 98,281 | 658,551 | — | 1,443,656 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 247,848 | (7,155 | ) | 304,848 | — | 545,541 | |||||||||||||||||
Policy acquisition costs | 106,547 | 9,414 | 138,383 | (3,338 | ) | 251,006 | |||||||||||||||||
General and administrative expenses | 53,757 | 15,627 | 107,031 | 55,191 | 231,606 | ||||||||||||||||||
Share compensation expenses | 7,126 | 330 | 8,434 | 8,362 | 24,252 | ||||||||||||||||||
Total underwriting deductions | 415,278 | 18,216 | 558,696 | 60,215 | 1,052,405 | ||||||||||||||||||
Underwriting income (loss) | $ | 271,546 | $ | 80,065 | $ | 99,855 | $ | (60,215 | ) | $ | 391,251 | ||||||||||||
Net investment income | 56,285 | 2,546 | 14,322 | (3,244 | ) | 69,909 | |||||||||||||||||
Other income (loss) | 912 | 21,482 | 384 | (7,793 | ) | 14,985 | |||||||||||||||||
Finance expenses | (11,131 | ) | (2,039 | ) | 68 | (34,278 | ) | (47,380 | ) | ||||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 317,612 | 102,054 | 114,629 | (105,530 | ) | 428,765 | |||||||||||||||||
Tax benefit (expense) | 1,176 | — | (902 | ) | (672 | ) | (398 | ) | |||||||||||||||
Income from operating affiliates | — | 13,580 | — | — | 13,580 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (82,833 | ) | — | — | (82,833 | ) | ||||||||||||||||
Net operating income (loss) | $ | 318,788 | $ | 32,801 | $ | 113,727 | $ | (106,202 | ) | $ | 359,114 | ||||||||||||
Net realized gains on investments | 5,411 | 10,230 | 552 | — | 16,193 | ||||||||||||||||||
Change in net unrealized gains (losses) on investments | 5,279 | 15,706 | 2,159 | (6,998 | ) | 16,146 | |||||||||||||||||
Income from investment affiliate | 7,881 | — | — | — | 7,881 | ||||||||||||||||||
Foreign exchange (losses) gains | (9,384 | ) | (204 | ) | (5,897 | ) | 724 | (14,761 | ) | ||||||||||||||
Transaction expenses (b) | — | — | — | (3,401 | ) | (3,401 | ) | ||||||||||||||||
Net income (loss) | $ | 327,975 | $ | 58,533 | $ | 110,541 | $ | (115,877 | ) | $ | 381,172 | ||||||||||||
Net (income) attributable to noncontrolling interest | — | (25,745 | ) | — | — | (25,745 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 327,975 | $ | 32,788 | $ | 110,541 | $ | (115,877 | ) | $ | 355,427 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 83.3 | % | 96.8 | % | 82 | % | 86.4 | % | |||||||||||||||
Losses and loss expenses | 36.1 | % | (7.3 | )% | 46.3 | % | 37.8 | % | |||||||||||||||
Policy acquisition costs | 15.5 | % | 9.6 | % | 21 | % | 17.4 | % | |||||||||||||||
General and administrative expenses (c) | 8.9 | % | 16.2 | % | 17.5 | % | 17.7 | % | |||||||||||||||
Expense ratio | 24.4 | % | 25.8 | % | 38.5 | % | 35.1 | % | |||||||||||||||
Combined ratio | 60.5 | % | 18.5 | % | 84.8 | % | 72.9 | % | |||||||||||||||
Total assets | $ | 4,716,426 | $ | 1,688,191 | $ | 2,898,755 | $ | 749,678 | $ | 10,053,050 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the nine months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. | ||||||||||||||||||||||
(c) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | ||||||||||||
Reinsurance premiums ceded | (226,292 | ) | (525 | ) | (191,922 | ) | 70,712 | (348,027 | ) | ||||||||||||||
Net premiums written | 1,005,980 | 146,232 | 663,594 | — | 1,815,806 | ||||||||||||||||||
Change in unearned premiums | (122,303 | ) | (46,459 | ) | (37,237 | ) | — | (205,999 | ) | ||||||||||||||
Net premiums earned | 883,677 | 99,773 | 626,357 | — | 1,609,807 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 319,298 | 16,928 | 251,554 | — | 587,780 | ||||||||||||||||||
Policy acquisition costs | 142,195 | 10,011 | 127,092 | (3,635 | ) | 275,663 | |||||||||||||||||
General and administrative expenses | 69,649 | 13,757 | 100,506 | 48,423 | 232,335 | ||||||||||||||||||
Share compensation expenses | 5,421 | 314 | 6,754 | 6,994 | 19,483 | ||||||||||||||||||
Total underwriting deductions | 536,563 | 41,010 | 485,906 | 51,782 | 1,115,261 | ||||||||||||||||||
Underwriting income (loss) | $ | 347,114 | $ | 58,763 | $ | 140,451 | $ | (51,782 | ) | $ | 494,546 | ||||||||||||
Net investment income | 61,770 | 2,821 | 13,496 | (6,219 | ) | 71,868 | |||||||||||||||||
Other income (loss) | 11,237 | 17,439 | 564 | (24,943 | ) | 4,297 | |||||||||||||||||
Finance expenses | (12,133 | ) | (4,273 | ) | (256 | ) | (30,590 | ) | (47,252 | ) | |||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 407,988 | 74,750 | 154,255 | (113,534 | ) | 523,459 | |||||||||||||||||
Tax benefit (expense) | 1,755 | — | (1,184 | ) | (351 | ) | 220 | ||||||||||||||||
Income from operating affiliates | — | 8,779 | — | — | 8,779 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (42,156 | ) | — | — | (42,156 | ) | ||||||||||||||||
Net operating income (loss) | $ | 409,743 | $ | 41,373 | $ | 153,071 | $ | (113,885 | ) | $ | 490,302 | ||||||||||||
Net realized (losses) gains on investments | (5,790 | ) | 4,084 | 516 | — | (1,190 | ) | ||||||||||||||||
Change in net unrealized losses on investments | (36,883 | ) | (31,029 | ) | (10,706 | ) | — | (78,618 | ) | ||||||||||||||
Income from investment affiliate | 4,274 | — | — | — | 4,274 | ||||||||||||||||||
Foreign exchange gains (losses) | 7,448 | (663 | ) | (1,877 | ) | (173 | ) | 4,735 | |||||||||||||||
Net income (loss) | $ | 378,792 | $ | 13,765 | $ | 141,004 | $ | (114,058 | ) | $ | 419,503 | ||||||||||||
Net loss attributable to noncontrolling interest | — | 17,831 | — | — | 17,831 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 378,792 | $ | 31,596 | $ | 141,004 | $ | (114,058 | ) | $ | 437,334 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 81.6 | % | 99.6 | % | 77.6 | % | 83.9 | % | |||||||||||||||
Losses and loss expenses | 36.1 | % | 17 | % | 40.2 | % | 36.5 | % | |||||||||||||||
Policy acquisition costs | 16.1 | % | 10 | % | 20.3 | % | 17.2 | % | |||||||||||||||
General and administrative expenses (b) | 8.5 | % | 14.1 | % | 17.1 | % | 15.6 | % | |||||||||||||||
Expense ratio | 24.6 | % | 24.1 | % | 37.4 | % | 32.8 | % | |||||||||||||||
Combined ratio | 60.7 | % | 41.1 | % | 77.6 | % | 69.3 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
The Company’s exposures are generally diversified across geographic zones. The following tables set forth the gross premiums written allocated to the territory of coverage exposure for the periods indicated: | |||||||||||||||||||||||
Three Months Ended September 30, 2014 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 28,665 | $ | 2,206 | $ | 17,003 | $ | (874 | ) | $ | 47,000 | 13.1 | % | ||||||||||
Worldwide excluding United States (a) | 10,639 | (81 | ) | 29,781 | (973 | ) | 39,366 | 10.9 | % | ||||||||||||||
Australia and New Zealand | 610 | — | 3,312 | (139 | ) | 3,783 | 1.1 | % | |||||||||||||||
Europe | 8,560 | 312 | 9,821 | (311 | ) | 18,382 | 5.1 | % | |||||||||||||||
Latin America and Caribbean | 12,945 | — | 24,740 | (819 | ) | 36,866 | 10.3 | % | |||||||||||||||
Japan | 1,664 | 22 | 1,274 | (73 | ) | 2,887 | 0.8 | % | |||||||||||||||
Canada | 188 | — | 2,430 | (80 | ) | 2,538 | 0.7 | % | |||||||||||||||
Rest of the world (b) | 1,527 | — | 27,145 | (1,073 | ) | 27,599 | 7.7 | % | |||||||||||||||
Sub-total, non United States | 36,133 | 253 | 98,503 | (3,468 | ) | 131,421 | 36.6 | % | |||||||||||||||
Worldwide including United States (a) | 28,747 | 4,477 | 18,611 | (560 | ) | 51,275 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 21,352 | — | 111,568 | (3,642 | ) | 129,278 | 36 | % | |||||||||||||||
Total | $ | 114,897 | $ | 6,936 | $ | 245,685 | $ | (8,544 | ) | $ | 358,974 | 100 | % | ||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 38,881 | $ | 2,546 | $ | 21,573 | $ | (2,105 | ) | $ | 60,895 | 17 | % | ||||||||||
Worldwide excluding United States (a) | 16,973 | — | 34,751 | (4,138 | ) | 47,586 | 13.3 | % | |||||||||||||||
Australia and New Zealand | (9,482 | ) | 33 | 2,905 | (236 | ) | (6,780 | ) | (1.9 | )% | |||||||||||||
Europe | 4,252 | 377 | 9,778 | (986 | ) | 13,421 | 3.8 | % | |||||||||||||||
Latin America and Caribbean | 5,902 | — | 38,084 | (3,353 | ) | 40,633 | 11.4 | % | |||||||||||||||
Japan | (2,637 | ) | — | 1,066 | (117 | ) | (1,688 | ) | (0.5 | )% | |||||||||||||
Canada | 1,469 | 500 | 2,749 | (740 | ) | 3,978 | 1.1 | % | |||||||||||||||
Rest of the world (b) | 5,641 | — | 22,167 | (1,830 | ) | 25,978 | 7.3 | % | |||||||||||||||
Sub-total, non United States | 22,118 | 910 | 111,500 | (11,400 | ) | 123,128 | 34.5 | % | |||||||||||||||
Worldwide including United States (a) | 29,611 | 25 | 18,246 | (1,665 | ) | 46,217 | 13 | % | |||||||||||||||
Other location non-specific (c) | 40,315 | — | 95,149 | (8,944 | ) | 126,520 | 35.5 | % | |||||||||||||||
Total | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | 100 | % | ||||||||||
Nine Months Ended September 30, 2014 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 452,470 | $ | 31,160 | $ | 85,465 | $ | (10,662 | ) | $ | 558,433 | 27.5 | % | ||||||||||
Worldwide excluding United States (a) | 80,671 | 7,331 | 105,397 | (6,741 | ) | 186,658 | 9.2 | % | |||||||||||||||
Australia and New Zealand | 20,025 | 1,019 | 7,615 | (391 | ) | 28,268 | 1.4 | % | |||||||||||||||
Europe | 57,884 | 3,005 | 36,110 | (4,157 | ) | 92,842 | 4.6 | % | |||||||||||||||
Latin America and Caribbean | 22,167 | — | 86,111 | (4,418 | ) | 103,860 | 5.1 | % | |||||||||||||||
Japan | 41,137 | 608 | 3,404 | (784 | ) | 44,365 | 2.2 | % | |||||||||||||||
Canada | 3,508 | 215 | 8,325 | (641 | ) | 11,407 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 23,870 | — | 70,702 | (3,627 | ) | 90,945 | 4.5 | % | |||||||||||||||
Sub-total, non United States | 249,262 | 12,178 | 317,664 | (20,759 | ) | 558,345 | 27.6 | % | |||||||||||||||
Worldwide including United States (a) | 168,337 | 91,735 | 71,147 | (11,365 | ) | 319,854 | 15.8 | % | |||||||||||||||
Other location non-specific (c) | 234,100 | — | 380,048 | (24,141 | ) | 590,007 | 29.1 | % | |||||||||||||||
Total | $ | 1,104,169 | $ | 135,073 | $ | 854,324 | $ | (66,927 | ) | $ | 2,026,639 | 100 | % | ||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 542,692 | $ | 50,935 | $ | 77,630 | $ | (10,599 | ) | $ | 660,658 | 30.6 | % | ||||||||||
Worldwide excluding United States (a) | 69,482 | 14,801 | 109,562 | (9,065 | ) | 184,780 | 8.4 | % | |||||||||||||||
Australia and New Zealand | 21,116 | 2,216 | 7,930 | (467 | ) | 30,795 | 1.4 | % | |||||||||||||||
Europe | 64,986 | 2,514 | 41,523 | (3,892 | ) | 105,131 | 4.9 | % | |||||||||||||||
Latin America and Caribbean | 5,885 | — | 124,120 | (7,312 | ) | 122,693 | 5.7 | % | |||||||||||||||
Japan | 41,939 | 653 | 5,258 | (963 | ) | 46,887 | 2.2 | % | |||||||||||||||
Canada | 4,503 | 818 | 8,790 | (1,336 | ) | 12,775 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 29,211 | — | 62,803 | (3,700 | ) | 88,314 | 4.1 | % | |||||||||||||||
Sub-total, non United States | 237,122 | 21,002 | 359,986 | (26,735 | ) | 591,375 | 27.3 | % | |||||||||||||||
Worldwide including United States (a) | 180,621 | 74,820 | 63,998 | (10,214 | ) | 309,225 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 271,837 | — | 353,902 | (23,164 | ) | 602,575 | 27.8 | % | |||||||||||||||
Total | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable, such as marine and aerospace risks, since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Subsequent_events
Subsequent events | 9 Months Ended |
Sep. 30, 2014 | |
Subsequent Events [Abstract] | ' |
Subsequent events | ' |
Subsequent events | |
Western World Insurance Group acquisition | |
On June 23, 2014, the Company entered into a stock purchase agreement to acquire all of the issued and outstanding capital stock of Western World Insurance Group, Inc. ("Western World"), a specialty excess and surplus lines insurance company. On October 2, 2014, the Company completed its acquisition of Western World for an aggregate purchase price of $690,000 in cash, subject to adjustment based on pre-closing payments to shareholders, transaction expenses and the timing of closing as further described in the stock purchase agreement. The results of Western World have not been included in the Company’s Consolidated Financial Statements as at September 30, 2014. | |
Quarterly Dividend | |
On November 5, 2014, the Company announced a quarterly cash dividend of $0.30 per each common share and $0.30 per common share equivalent for which each outstanding warrant is exercisable, payable on December 31, 2014 to holders of record on December 15, 2014. |
Significant_accounting_policie
Significant accounting policies (Policies) | 9 Months Ended |
Sep. 30, 2014 | |
Accounting Policies [Abstract] | ' |
Basis of preparation | ' |
These unaudited Consolidated Financial Statements (the "Consolidated Financial Statements") include Validus Holdings, Ltd. and its wholly and majority owned subsidiaries (together the "Company") and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 in Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the U.S. Securities and Exchange Commission (the "SEC"). | |
In the opinion of management, these Consolidated Financial Statements reflect all adjustments (including normal recurring adjustments) considered necessary for a fair presentation of the Company's financial position and results of operations as at the end of and for the periods presented. To facilitate comparison of information, certain amounts in prior periods have been reclassified to conform to current period presentation. The consolidated statement of cash flows for the nine months ended September 30, 2013 includes a reclassification of $19,400 that increased net cash flows used in financing activities and net cash flows provided by operating activities to revise the presentation of subscriptions received in advance from third party investors. For the three and nine months ended September 30, 2013, $11,815 and $42,156 respectively, have been reclassified into income attributable to operating affiliate investors from finance expenses to conform to current period presentation. All significant intercompany accounts and transactions have been eliminated. | |
Use of estimates | ' |
The preparation of these financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While management believes that the amounts included in the Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ materially from those estimates. The Company’s principal estimates include: | |
•reserve for losses and loss expenses; | |
•premium estimates for business written on a line slip or proportional basis; | |
•the valuation of goodwill and intangible assets; | |
•reinsurance recoverable balances including the provision for uncollectible amounts; and | |
•investment valuation of financial assets. | |
Reserves for losses and loss expenses | ' |
Reserves for losses and loss expenses are based in part upon the estimation of case reserves from broker, insured and ceding company reported data. The Company also uses statistical and actuarial methods to estimate ultimate expected losses and loss expenses, from which incurred but not reported losses can be calculated. The period of time from the occurrence of a loss to the reporting of a loss to the Company and to the settlement of the Company's liability may be several months or years. During this period, additional facts and trends may be revealed. As these factors become apparent, reserves will be adjusted, sometimes requiring an increase or decrease in the overall reserves of the Company, and at other times requiring a reallocation of incurred but not reported reserves to specific case reserves. These estimates are reviewed and adjusted regularly, and such adjustments, if any, are reflected in earnings in the period in which they become known. While management believes that it has made a reasonable estimate of ultimate losses, there can be no assurances that ultimate losses and loss expenses will not exceed this estimate. | |
Reinsurance | ' |
To estimate the provision for uncollectible reinsurance, the reinsurance recoverable is first allocated to applicable reinsurers. This determination is based on a process rather than an estimate, although an element of judgment is applied, especially in relation to ceded IBNR. The Company then uses default factors to determine the portion of a reinsurer’s balance deemed to be uncollectible. Default factors require considerable judgment and are determined in part using the current rating, or rating equivalent, of each reinsurer as well as other key considerations and assumptions. |
Investments_Tables
Investments (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Investments [Abstract] | ' | |||||||||||||||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at September 30, 2014 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 786,318 | $ | 1,735 | $ | (1,798 | ) | $ | 786,255 | |||||||
Non-U.S. government and government agency | 383,378 | 1,775 | (3,956 | ) | 381,197 | |||||||||||
U.S. states, municipalities and political subdivisions | 73,996 | 557 | (188 | ) | 74,365 | |||||||||||
Agency residential mortgage-backed securities | 368,646 | 7,877 | (1,296 | ) | 375,227 | |||||||||||
Non-agency residential mortgage-backed securities | 17,370 | 238 | (409 | ) | 17,199 | |||||||||||
U.S. corporate | 1,168,304 | 5,601 | (4,987 | ) | 1,168,918 | |||||||||||
Non-U.S. corporate | 593,619 | 4,071 | (3,055 | ) | 594,635 | |||||||||||
Bank loans | 488,904 | 616 | (5,732 | ) | 483,788 | |||||||||||
Catastrophe bonds | 47,574 | 1,305 | (541 | ) | 48,338 | |||||||||||
Asset-backed securities | 566,135 | 981 | (664 | ) | 566,452 | |||||||||||
Commercial mortgage-backed securities | 174,341 | 48 | (590 | ) | 173,799 | |||||||||||
Total fixed maturities | 4,668,585 | 24,804 | (23,216 | ) | 4,670,173 | |||||||||||
Total short-term investments (b) | 1,684,997 | 4 | (19 | ) | 1,684,982 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 2,802 | 162 | (921 | ) | 2,043 | |||||||||||
Hedge funds (a) | 570,372 | 101,610 | (104,142 | ) | 567,840 | |||||||||||
Private equity investments | 11,295 | 3,832 | (108 | ) | 15,019 | |||||||||||
Investment funds | 123,840 | 350 | — | 124,190 | ||||||||||||
Mutual funds | 6,199 | 3,342 | — | 9,541 | ||||||||||||
Total other investments | 714,508 | 109,296 | (105,171 | ) | 718,633 | |||||||||||
Total investments including noncontrolling interests | $ | 7,068,090 | $ | 134,104 | $ | (128,406 | ) | $ | 7,073,788 | |||||||
Noncontrolling interest (a) | $ | (502,830 | ) | $ | (86,263 | ) | $ | 93,728 | $ | (495,365 | ) | |||||
Redeemable noncontrolling interest (b) | $ | (11,637 | ) | $ | — | $ | — | $ | (11,637 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 6,553,623 | $ | 47,841 | $ | (34,678 | ) | $ | 6,566,786 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
The amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments at December 31, 2013 were as follows: | ||||||||||||||||
Amortized Cost or Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
U.S. government and government agency | $ | 1,368,826 | $ | 2,589 | $ | (6,736 | ) | $ | 1,364,679 | |||||||
Non-U.S. government and government agency | 454,578 | 6,511 | (2,021 | ) | 459,068 | |||||||||||
U.S. states, municipalities and political subdivisions | 42,978 | 459 | (317 | ) | 43,120 | |||||||||||
Agency residential mortgage-backed securities | 305,450 | 8,310 | (2,261 | ) | 311,499 | |||||||||||
Non-agency residential mortgage-backed securities | 16,530 | 143 | (914 | ) | 15,759 | |||||||||||
U.S. corporate | 1,328,960 | 9,208 | (5,684 | ) | 1,332,484 | |||||||||||
Non-U.S. corporate | 711,581 | 5,917 | (3,173 | ) | 714,325 | |||||||||||
Bank loans | 712,859 | 5,659 | (1,402 | ) | 717,116 | |||||||||||
Catastrophe bonds | 72,000 | 2,551 | — | 74,551 | ||||||||||||
Asset-backed securities | 509,091 | 1,409 | (843 | ) | 509,657 | |||||||||||
Total fixed maturities | 5,522,853 | 42,756 | (23,351 | ) | 5,542,258 | |||||||||||
Total short-term investments (b) | 751,734 | 45 | (1 | ) | 751,778 | |||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | 3,141 | 83 | (921 | ) | 2,303 | |||||||||||
Hedge funds (a) | 584,518 | 71,641 | (95,076 | ) | 561,083 | |||||||||||
Private equity investments | 12,333 | 1,410 | (258 | ) | 13,485 | |||||||||||
Investment funds | 31,537 | 92 | — | 31,629 | ||||||||||||
Mutual funds | 6,199 | 3,617 | — | 9,816 | ||||||||||||
Total other investments | 637,728 | 76,843 | (96,255 | ) | 618,316 | |||||||||||
Total investments including noncontrolling interests | $ | 6,912,315 | $ | 119,644 | $ | (119,607 | ) | $ | 6,912,352 | |||||||
Noncontrolling interest (a) | (512,121 | ) | (62,850 | ) | 85,569 | (489,402 | ) | |||||||||
Redeemable noncontrolling interest (b) | $ | (18,365 | ) | $ | — | $ | — | $ | (18,365 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 6,381,829 | $ | 56,794 | $ | (34,038 | ) | $ | 6,404,585 | |||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
Investment ratings on fixed maturities | ' | |||||||||||||||
The following table sets forth certain information regarding the investment ratings of the Company’s fixed maturities portfolio as at September 30, 2014 and December 31, 2013. | ||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||
Estimated Fair Value | % of Total | Estimated Fair Value | % of Total | |||||||||||||
AAA | $ | 2,174,861 | 46.6 | % | $ | 2,510,781 | 45.3 | % | ||||||||
AA | 594,858 | 12.7 | % | 696,998 | 12.6 | % | ||||||||||
A | 960,153 | 20.6 | % | 1,233,716 | 22.3 | % | ||||||||||
BBB | 363,626 | 7.8 | % | 323,085 | 5.8 | % | ||||||||||
Total investment-grade fixed maturities | 4,093,498 | 87.7 | % | 4,764,580 | 86 | % | ||||||||||
BB | 283,954 | 6.1 | % | 354,992 | 6.4 | % | ||||||||||
B | 269,380 | 5.8 | % | 383,639 | 6.9 | % | ||||||||||
CCC | 1,341 | — | % | 2,453 | — | % | ||||||||||
CC | 2,330 | — | % | 2,496 | 0.1 | % | ||||||||||
C | 146 | — | % | 235 | — | % | ||||||||||
D/NR | 19,524 | 0.4 | % | 33,863 | 0.6 | % | ||||||||||
Total non-investment grade fixed maturities | 576,675 | 12.3 | % | 777,678 | 14 | % | ||||||||||
Total fixed maturities | $ | 4,670,173 | 100 | % | $ | 5,542,258 | 100 | % | ||||||||
Fixed maturities investments by contractual maturity | ' | |||||||||||||||
The amortized cost and estimated fair value amounts for fixed maturities held at September 30, 2014 and December 31, 2013 are shown below by contractual maturity. Actual maturity may differ from contractual maturity because certain borrowers may have the right to call or prepay certain obligations with or without call or prepayment penalties. | ||||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||||
Amortized Cost | Estimated Fair Value | Amortized Cost | Estimated Fair Value | |||||||||||||
Due in one year or less | $ | 277,213 | $ | 278,507 | $ | 688,855 | $ | 692,768 | ||||||||
Due after one year through five years | 2,678,792 | 2,679,938 | 3,603,459 | 3,613,847 | ||||||||||||
Due after five years through ten years | 496,922 | 491,364 | 396,389 | 395,633 | ||||||||||||
Due after ten years | 89,166 | 87,687 | 3,079 | 3,095 | ||||||||||||
3,542,093 | 3,537,496 | 4,691,782 | 4,705,343 | |||||||||||||
Asset-backed and mortgage-backed securities | 1,126,492 | 1,132,677 | 831,071 | 836,915 | ||||||||||||
Total fixed maturities | $ | 4,668,585 | $ | 4,670,173 | $ | 5,522,853 | $ | 5,542,258 | ||||||||
Net investment income | ' | |||||||||||||||
Net investment income was derived from the following sources: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||
Fixed maturities and short-term investments | $ | 22,544 | $ | 20,936 | $ | 68,048 | $ | 74,618 | ||||||||
Other investments | 2,879 | — | 2,879 | — | ||||||||||||
Cash and cash equivalents | 1,581 | 1,079 | 4,534 | 3,241 | ||||||||||||
Securities lending income | 1 | 3 | 5 | 3 | ||||||||||||
Total gross investment income | 27,005 | 22,018 | 75,466 | 77,862 | ||||||||||||
Investment expenses | (1,744 | ) | (2,009 | ) | (5,557 | ) | (5,994 | ) | ||||||||
Total net investment income | $ | 25,261 | $ | 20,009 | $ | 69,909 | $ | 71,868 | ||||||||
Analysis of net realized gains (losses) and the change in net unrealized (losses) gains on investments | ' | |||||||||||||||
The following represents an analysis of net realized gains (losses) and the change in net unrealized (losses) gains on investments: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||
Fixed maturities, short-term and other investments | ||||||||||||||||
Gross realized gains (a) | $ | 8,075 | $ | 7,706 | $ | 23,184 | $ | 25,578 | ||||||||
Gross realized (losses) | (3,480 | ) | (14,026 | ) | (6,991 | ) | (26,768 | ) | ||||||||
Net realized gains (losses) on investments | 4,595 | (6,320 | ) | 16,193 | (1,190 | ) | ||||||||||
Change in net unrealized (losses) gains on investments (a) | (84,974 | ) | 69,967 | 16,146 | (78,618 | ) | ||||||||||
Total net realized gains (losses) and change in net unrealized (losses) gains on investments including noncontrolling interest | (80,379 | ) | 63,647 | 32,339 | (79,808 | ) | ||||||||||
Noncontrolling interest (a) | 52,595 | (42,579 | ) | (22,613 | ) | 25,766 | ||||||||||
Total net realized gains (losses) and change in net unrealized (losses) gains on investments excluding noncontrolling interest | $ | (27,784 | ) | $ | 21,068 | $ | 9,726 | $ | (54,042 | ) | ||||||
(a) | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. | |||||||||||||||
Investments pledged as collateral under credit facilities | ' | |||||||||||||||
The following tables outline investments pledged as collateral under the Company's credit facilities. For further details on the credit facilities, please refer to Note 12: “Debt and financing arrangements.” | ||||||||||||||||
September 30, 2014 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments and cash pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 301,340 | 393,720 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 19,743 | 35,414 | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | 31,054 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 30,000 | 30,000 | 30,059 | |||||||||||||
IPC bi-lateral facility | 40,000 | 16,975 | 96,633 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 288,739 | 456,458 | |||||||||||||
Total | $ | 1,605,000 | $ | 682,091 | $ | 1,043,338 | ||||||||||
December 31, 2013 | ||||||||||||||||
Description | Commitment | Issued and Outstanding | Investments and cash pledged as collateral | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | $ | 400,000 | $ | — | $ | — | ||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 358,567 | 507,620 | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 16,726 | 130,256 | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | 30,801 | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 24,800 | 24,800 | 24,806 | |||||||||||||
IPC bi-lateral facility | 40,000 | 20,177 | 98,465 | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 305,686 | 454,458 | |||||||||||||
Total | $ | 1,599,800 | $ | 751,250 | $ | 1,246,406 | ||||||||||
Fair_value_measurements_Tables
Fair value measurements (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair value hierarchy - allocation of investments | ' | |||||||||||||||
At September 30, 2014, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 786,255 | $ | — | $ | 786,255 | ||||||||
Non-U.S. government and government agency | — | 381,197 | — | 381,197 | ||||||||||||
U.S. states, municipalities and political subdivisions | — | 74,365 | — | 74,365 | ||||||||||||
Agency residential mortgage-backed securities | — | 375,227 | — | 375,227 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 17,199 | — | 17,199 | ||||||||||||
U.S. corporate | — | 1,168,918 | — | 1,168,918 | ||||||||||||
Non-U.S. corporate | — | 594,635 | — | 594,635 | ||||||||||||
Bank loans | — | 483,788 | — | 483,788 | ||||||||||||
Catastrophe bonds | — | 43,337 | 5,001 | 48,338 | ||||||||||||
Asset-backed securities | — | 566,452 | — | 566,452 | ||||||||||||
Commercial mortgage-backed securities | — | 173,799 | — | 173,799 | ||||||||||||
Total fixed maturities | — | 4,665,172 | 5,001 | 4,670,173 | ||||||||||||
Total short-term investments (b) | 1,671,911 | 13,071 | — | 1,684,982 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,043 | 2,043 | ||||||||||||
Hedge funds (a) | — | — | 567,840 | 567,840 | ||||||||||||
Private equity investments | — | — | 15,019 | 15,019 | ||||||||||||
Investment funds | — | 21,310 | 102,880 | 124,190 | ||||||||||||
Mutual funds | — | 9,541 | — | 9,541 | ||||||||||||
Total other investments | — | 30,851 | 687,782 | 718,633 | ||||||||||||
Total investments including noncontrolling interests | $ | 1,671,911 | $ | 4,709,094 | $ | 692,783 | $ | 7,073,788 | ||||||||
Noncontrolling interest (a) | $ | — | $ | — | $ | (495,365 | ) | $ | (495,365 | ) | ||||||
Redeemable noncontrolling interest (b) | $ | (11,637 | ) | $ | — | $ | — | $ | (11,637 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 1,660,274 | $ | 4,709,094 | $ | 197,418 | $ | 6,566,786 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
At December 31, 2013, the Company’s investments were allocated between Levels 1, 2 and 3 as follows: | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
U.S. government and government agency | $ | — | $ | 1,364,679 | $ | — | $ | 1,364,679 | ||||||||
Non-U.S. government and government agency | — | 459,068 | — | 459,068 | ||||||||||||
U.S. states, municipalities and political subdivisions | — | 43,120 | — | 43,120 | ||||||||||||
Agency residential mortgage-backed securities | — | 311,499 | — | 311,499 | ||||||||||||
Non-agency residential mortgage-backed securities | — | 15,759 | — | 15,759 | ||||||||||||
U.S. corporate | — | 1,332,484 | — | 1,332,484 | ||||||||||||
Non-U.S. corporate | — | 714,325 | — | 714,325 | ||||||||||||
Bank loans | — | 717,116 | — | 717,116 | ||||||||||||
Catastrophe bonds | — | 74,551 | — | 74,551 | ||||||||||||
Asset-backed securities | — | 509,657 | — | 509,657 | ||||||||||||
Total fixed maturities | — | 5,542,258 | — | 5,542,258 | ||||||||||||
Total short-term investments (b) | 747,215 | 4,563 | — | 751,778 | ||||||||||||
Other investments | ||||||||||||||||
Fund of hedge funds | — | — | 2,303 | 2,303 | ||||||||||||
Hedge funds (a) | — | — | 561,083 | 561,083 | ||||||||||||
Private equity investments | — | — | 13,485 | 13,485 | ||||||||||||
Investment fund | — | 31,629 | — | 31,629 | ||||||||||||
Mutual funds | — | 9,816 | — | 9,816 | ||||||||||||
Total other investments | — | 41,445 | 576,871 | 618,316 | ||||||||||||
Total investments including noncontrolling interests | $ | 747,215 | $ | 5,588,266 | $ | 576,871 | $ | 6,912,352 | ||||||||
Noncontrolling interest (a) | $ | — | $ | — | $ | (489,402 | ) | $ | (489,402 | ) | ||||||
Redeemable noncontrolling interest (b) | $ | (18,365 | ) | $ | — | $ | — | $ | (18,365 | ) | ||||||
Total investments excluding noncontrolling interests | $ | 728,850 | $ | 5,588,266 | $ | 87,469 | $ | 6,404,585 | ||||||||
(a) | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||||||||
(b) | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||||||||||||
Reconciliation of beginning and ending balances for all Level 3 investments measured at fair value on recurring basis | ' | |||||||||||||||
The following table presents a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs during the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
30-Sep-14 | 30-Sep-13 | 30-Sep-14 | 30-Sep-13 | |||||||||||||
Level 3 investments - Beginning of period | $ | 746,396 | $ | 505,158 | $ | 576,871 | $ | 556,234 | ||||||||
Purchases | 25,784 | 33,154 | 125,784 | 98,669 | ||||||||||||
Sales | (24,175 | ) | (35,264 | ) | (49,508 | ) | (80,095 | ) | ||||||||
Settlements | — | — | (1,500 | ) | — | |||||||||||
Net realized gains | 2,554 | 4,503 | 8,198 | 4,843 | ||||||||||||
Change in net unrealized gains (losses) | (57,776 | ) | 42,917 | 26,235 | (29,183 | ) | ||||||||||
Transfers into Level 3 | — | — | 6,703 | — | ||||||||||||
Level 3 investments - End of period | $ | 692,783 | $ | 550,468 | $ | 692,783 | $ | 550,468 | ||||||||
Noncontrolling interest (a) | (495,365 | ) | (465,472 | ) | (495,365 | ) | (465,472 | ) | ||||||||
Level 3 investments excluding noncontrolling interest | $ | 197,418 | $ | 84,996 | $ | 197,418 | $ | 84,996 | ||||||||
(a) | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. |
Investments_in_affiliates_Tabl
Investments in affiliates (Tables) | 9 Months Ended | |||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | |||||||||||||||||||||||
Schedule of equity method investments | ' | |||||||||||||||||||||||
The following table presents the Company's investments in affiliates as at September 30, 2014 and December 31, 2013: | ||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | |||||||||||||||||||||||
Investment affiliate | $ | 42,381 | $ | 34,500 | ||||||||||||||||||||
Operating affiliates | 175,231 | 106,743 | ||||||||||||||||||||||
Investments in affiliates | $ | 217,612 | $ | 141,243 | ||||||||||||||||||||
Summary of notes payable to operating affiliates | ' | |||||||||||||||||||||||
The following tables present a reconciliation of the beginning and ending notes payable to operating affiliates for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||||
As at June 30, 2014 | $ | — | $ | 157,992 | $ | 464,958 | $ | 622,950 | ||||||||||||||||
Issuance of notes payable to operating affiliates | — | — | 53,498 | 53,498 | ||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | — | (13,990 | ) | (13,990 | ) | ||||||||||||||||||
Foreign exchange gain | — | (410 | ) | (6,072 | ) | (6,482 | ) | |||||||||||||||||
As at September 30, 2014 | $ | — | $ | 157,582 | $ | 498,394 | $ | 655,976 | ||||||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||||||||
As at June 30, 2013 | $ | 222,135 | $ | 208,958 | $ | 431,093 | ||||||||||||||||||
Issuance of notes payable to operating affiliates | — | 6,733 | 6,733 | |||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | (3,553 | ) | (3,553 | ) | |||||||||||||||||||
Foreign exchange loss | 1,196 | 2,501 | 3,697 | |||||||||||||||||||||
As at September 30, 2013 | $ | 223,331 | $ | 214,639 | $ | 437,970 | ||||||||||||||||||
Nine Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||||
As at December 31, 2013 | $ | 223,809 | $ | — | $ | 215,463 | $ | 439,272 | ||||||||||||||||
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | — | — | 178,837 | 178,837 | ||||||||||||||||||||
Issuance of notes payable to operating affiliates | — | 157,914 | 487,329 | 645,243 | ||||||||||||||||||||
Redemption of notes payable to operating affiliates | (223,512 | ) | — | (378,556 | ) | (602,068 | ) | |||||||||||||||||
Foreign exchange gain | (297 | ) | (332 | ) | (4,679 | ) | (5,308 | ) | ||||||||||||||||
As at September 30, 2014 | $ | — | $ | 157,582 | $ | 498,394 | $ | 655,976 | ||||||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat 2013 | AlphaCat ILS funds | Total | ||||||||||||||||||||||
As at December 31, 2012 | $ | — | $ | — | $ | — | ||||||||||||||||||
Issuance of notes payable to operating affiliates | 223,082 | 218,044 | 441,126 | |||||||||||||||||||||
Redemption of notes payable to operating affiliates | — | (3,553 | ) | (3,553 | ) | |||||||||||||||||||
Foreign exchange loss | 249 | 148 | 397 | |||||||||||||||||||||
As at September 30, 2013 | $ | 223,331 | $ | 214,639 | $ | 437,970 | ||||||||||||||||||
Schedule of (income) attributable to operating affiliate investors | ' | |||||||||||||||||||||||
The following table presents the (income) attributable to operating affiliate investors for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
AlphaCat 2013 | $ | (98 | ) | $ | (4,074 | ) | $ | (14,218 | ) | $ | (29,357 | ) | ||||||||||||
AlphaCat 2014 | (11,309 | ) | — | (32,990 | ) | — | ||||||||||||||||||
AlphaCat ILS funds | (14,400 | ) | (7,741 | ) | (35,625 | ) | (12,799 | ) | ||||||||||||||||
(Income) attributable to operating affiliate investors | $ | (25,807 | ) | $ | (11,815 | ) | $ | (82,833 | ) | $ | (42,156 | ) | ||||||||||||
Investment affiliate | ' | |||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | |||||||||||||||||||||||
Reconciliation of the beginning and ending non-consolidated affiliate balance | ' | |||||||||||||||||||||||
The following table presents a reconciliation of the beginning and ending investment in the Company's investment affiliate balance for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Investment affiliate, beginning of period | $ | 40,627 | $ | 25,352 | $ | 34,500 | $ | 15,218 | ||||||||||||||||
Capital contributions | — | 6,185 | — | 13,089 | ||||||||||||||||||||
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 | ||||||||||||||||||||
Investment affiliate, end of period | $ | 42,381 | $ | 32,581 | $ | 42,381 | $ | 32,581 | ||||||||||||||||
Schedule of equity method investments | ' | |||||||||||||||||||||||
The following table presents the Company's investment in the Partnership as at September 30, 2014: | ||||||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | $ | 32,110 | — | % | 6.7 | % | $ | 42,381 | ||||||||||||||||
The following table presents the Company's investment in the Partnership as at December 31, 2013: | ||||||||||||||||||||||||
Investment in investment affiliate | ||||||||||||||||||||||||
Investment at cost | Voting ownership % | Equity Ownership | Carrying Value | |||||||||||||||||||||
Aquiline Financial Services Fund II L.P. | $ | 32,110 | — | % | 6.7 | % | $ | 34,500 | ||||||||||||||||
Operating affiliates | ' | |||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | |||||||||||||||||||||||
Reconciliation of the beginning and ending non-consolidated affiliate balance | ' | |||||||||||||||||||||||
The following tables present a reconciliation of the beginning and ending investment in operating affiliates for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||
As at June 30, 2014 | $ | 4,172 | $ | 2,204 | $ | 2,580 | $ | 25,014 | $ | 139,022 | $ | 172,992 | ||||||||||||
Return of investment | — | (1,516 | ) | (6 | ) | — | — | (1,522 | ) | |||||||||||||||
(Loss) income from operating affiliates | (5 | ) | (9 | ) | 7 | 1,367 | 2,401 | 3,761 | ||||||||||||||||
As at September 30, 2014 | $ | 4,167 | $ | 679 | $ | 2,581 | $ | 26,381 | $ | 141,423 | $ | 175,231 | ||||||||||||
Three Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS fund | Total | ||||||||||||||||||||
As at June 30, 2013 | $ | 11,054 | $ | 5,204 | $ | 48,536 | $ | 20,326 | $ | 85,120 | ||||||||||||||
Return of investment | (2,800 | ) | (4,550 | ) | — | — | (7,350 | ) | ||||||||||||||||
(Loss) income from operating affiliates | (270 | ) | (7 | ) | 585 | 1,155 | 1,463 | |||||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||||||
Nine Months Ended September 30, 2014 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat 2014 | AlphaCat ILS funds | Total | |||||||||||||||||||
As at December 31, 2013 | $ | 9,809 | $ | 1,313 | $ | 51,744 | $ | 21,982 | $ | 21,895 | $ | 106,743 | ||||||||||||
Return of investment | (5,825 | ) | (1,516 | ) | (51,206 | ) | — | — | (58,547 | ) | ||||||||||||||
Fair value of retained interest on deconsolidation of AlphaCat ILS fund | — | — | — | — | 113,455 | 113,455 | ||||||||||||||||||
Income from operating affiliates | 183 | 882 | 2,043 | 4,399 | 6,073 | 13,580 | ||||||||||||||||||
As at September 30, 2014 | $ | 4,167 | $ | 679 | $ | 2,581 | $ | 26,381 | $ | 141,423 | $ | 175,231 | ||||||||||||
Nine Months Ended September 30, 2013 | ||||||||||||||||||||||||
AlphaCat Re 2011 | AlphaCat Re 2012 | AlphaCat 2013 | AlphaCat ILS fund | Total | ||||||||||||||||||||
As at December 31, 2012 | $ | 62,792 | $ | 29,319 | $ | 45,000 | $ | 20,000 | $ | 157,111 | ||||||||||||||
Return of investment | (54,914 | ) | (31,743 | ) | — | — | (86,657 | ) | ||||||||||||||||
Income from operating affiliates | 106 | 3,071 | 4,121 | 1,481 | 8,779 | |||||||||||||||||||
As at September 30, 2013 | $ | 7,984 | $ | 647 | $ | 49,121 | $ | 21,481 | $ | 79,233 | ||||||||||||||
Schedule of equity method investments | ' | |||||||||||||||||||||||
The following table presents the Company's investments in AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS funds in the Consolidated Financial Statements as at September 30, 2014: | ||||||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||||||
Cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||||||
AlphaCat Re 2011 | $ | 4,167 | 43.7 | % | 22.3 | % | $ | 4,167 | ||||||||||||||||
AlphaCat Re 2012 | 679 | 49 | % | 37.9 | % | 679 | ||||||||||||||||||
AlphaCat 2013 | 2,581 | 40.9 | % | 19.7 | % | 2,581 | ||||||||||||||||||
AlphaCat 2014 | 22,000 | 42.3 | % | 19.6 | % | 26,381 | ||||||||||||||||||
AlphaCat ILS funds | 133,455 | n/a | (a) | 141,423 | ||||||||||||||||||||
Total | $ | 162,882 | $ | 175,231 | ||||||||||||||||||||
(a) | Equity ownership in the two funds were 7.9% and 49.0% respectively as at September 30, 2014. | |||||||||||||||||||||||
The following table presents the Company's investments in AlphaCat Re 2011, AlphaCat Re 2012, AlphaCat 2013, AlphaCat 2014 and the AlphaCat ILS fund in the Consolidated Financial Statements as at December 31, 2013: | ||||||||||||||||||||||||
Investment in operating affiliates | ||||||||||||||||||||||||
Cost | Voting ownership % | Equity ownership % | Carrying value | |||||||||||||||||||||
AlphaCat Re 2011 | $ | 9,882 | 43.7 | % | 22.3 | % | $ | 9,809 | ||||||||||||||||
AlphaCat Re 2012 | 654 | 49 | % | 37.9 | % | 1,313 | ||||||||||||||||||
AlphaCat 2013 | 45,000 | 40.9 | % | 19.7 | % | 51,744 | ||||||||||||||||||
AlphaCat 2014 | 22,000 | 42.3 | % | 19.6 | % | 21,982 | ||||||||||||||||||
AlphaCat ILS fund | 20,000 | n/a | 9.1 | % | 21,895 | |||||||||||||||||||
Total | $ | 97,536 | $ | 106,743 | ||||||||||||||||||||
Noncontrolling_interest_Tables
Noncontrolling interest (Tables) | 9 Months Ended | |||||||||||
Sep. 30, 2014 | ||||||||||||
Noncontrolling Interest [Abstract] | ' | |||||||||||
Noncontrolling interest | ' | |||||||||||
The following tables present a reconciliation of the beginning and ending balances of redeemable noncontrolling interest and noncontrolling interest for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||
Three Months Ended September 30, 2014 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at June 30, 2014 | $ | 66,282 | $ | 575,347 | $ | 641,629 | ||||||
Issuance of shares | 4,200 | — | 4,200 | |||||||||
Loss attributable to noncontrolling interest | (9 | ) | (53,060 | ) | (53,069 | ) | ||||||
As at September 30, 2014 | $ | 70,473 | $ | 522,287 | $ | 592,760 | ||||||
Three Months Ended September 30, 2013 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at June 30, 2013 | $ | 70,690 | $ | 427,755 | $ | 498,445 | ||||||
Issuance of shares | 13,000 | — | 13,000 | |||||||||
Income attributable to noncontrolling interest | 1,516 | 44,178 | 45,694 | |||||||||
Redemption of shares | (10,207 | ) | — | (10,207 | ) | |||||||
As at September 30, 2013 | $ | 74,999 | $ | 471,933 | $ | 546,932 | ||||||
Nine Months Ended September 30, 2014 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at December 31, 2013 | $ | 86,512 | $ | 497,657 | $ | 584,169 | ||||||
Issuance of shares | 61,200 | — | 61,200 | |||||||||
Income attributable to noncontrolling interest | 1,115 | 24,630 | 25,745 | |||||||||
Adjustment to noncontrolling interest as a result of deconsolidation | (78,354 | ) | — | (78,354 | ) | |||||||
As at September 30, 2014 | $ | 70,473 | $ | 522,287 | $ | 592,760 | ||||||
Nine Months Ended September 30, 2013 | ||||||||||||
Redeemable noncontrolling interest | Noncontrolling interest | Total | ||||||||||
As at December 31, 2012 | $ | — | $ | 434,280 | $ | 434,280 | ||||||
Issuance of shares | 82,190 | 58,500 | 140,690 | |||||||||
Income (loss) attributable to noncontrolling interest | 3,016 | (20,847 | ) | (17,831 | ) | |||||||
Redemption of shares | (10,207 | ) | — | (10,207 | ) | |||||||
As at September 30, 2013 | $ | 74,999 | $ | 471,933 | $ | 546,932 | ||||||
Derivative_instruments_Tables
Derivative instruments (Tables) | 9 Months Ended | ||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||||||
Location and fair value amount of derivative instruments reported on the balance sheet | ' | ||||||||||||||||||||||||
The following table summarizes information on the classification and amount of the fair value of derivatives designated as hedging instruments on the Consolidated Balance Sheets at September 30, 2014 and December 31, 2013: | |||||||||||||||||||||||||
As at September 30, 2014 | As at December 31, 2013 | ||||||||||||||||||||||||
Derivatives designated as hedging instruments: | Net Notional Exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | Net Notional Exposure | Asset Derivative at Fair Value (a) | Liability Derivative at Fair Value (a) | |||||||||||||||||||
Foreign currency forward contracts | $ | 246,638 | $ | 592 | $ | 16,672 | $ | 163,576 | $ | 1,167 | $ | 2,313 | |||||||||||||
Interest rate swap contracts | $ | 552,263 | $ | 25 | $ | 912 | $ | 552,263 | $ | 28 | $ | 911 | |||||||||||||
(a) | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. | ||||||||||||||||||||||||
Derivative instruments designated as a fair value hedge | ' | ||||||||||||||||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ' | ||||||||||||||||||||||||
Location and amount of gains and losses related to derivative instruments reported on in the income statement | ' | ||||||||||||||||||||||||
The following table provides the total impact on earnings, recognized in income within foreign exchange gains (losses), relating to the derivative instruments formally designated as fair value hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
Foreign currency forward contracts | September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||||||||||
Amount of (loss) gain recognized in income on derivative | $ | (14,817 | ) | $ | 3,116 | $ | (9,979 | ) | $ | 2,670 | |||||||||||||||
Amount of gain (loss) on hedged item recognized in income attributable to risk being hedged | $ | 14,817 | $ | (3,116 | ) | $ | 9,979 | $ | (2,670 | ) | |||||||||||||||
Amount of gain (loss) recognized in income on derivative (ineffective portion) | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
Derivative instruments designated as a cash flow hedge | ' | ||||||||||||||||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ' | ||||||||||||||||||||||||
Location and amount of gains and losses related to derivative instruments reported on in the income statement | ' | ||||||||||||||||||||||||
The following table provides the total impact on other comprehensive income (loss) and earnings relating to the derivative instruments formally designated as cash flow hedges along with the impact of the related hedged items for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
Interest rate swap contracts | September 30, 2014 | September 30, 2013 | September 30, 2014 | September 30, 2013 | |||||||||||||||||||||
Amount of effective portion recognized in other comprehensive income | $ | 3,302 | $ | 3,268 | $ | 9,762 | $ | 7,838 | |||||||||||||||||
Amount of effective portion subsequently reclassified to earnings | $ | (3,302 | ) | $ | (3,268 | ) | $ | (9,762 | ) | $ | (7,838 | ) | |||||||||||||
Amount of ineffective portion excluded from effectiveness testing | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||
Reserve_for_losses_and_loss_ex1
Reserve for losses and loss expenses (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract] | ' | |||||||||||||||
Reserve for losses and loss expenses | ' | |||||||||||||||
The following table represents an analysis of paid and unpaid losses and loss expenses incurred and a reconciliation of the beginning and ending unpaid losses and loss expenses for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Reserve for losses and loss expenses, beginning of period | $ | 2,867,307 | $ | 3,283,450 | $ | 3,030,399 | $ | 3,517,573 | ||||||||
Losses and loss expenses recoverable | (338,734 | ) | (418,693 | ) | (370,154 | ) | (439,967 | ) | ||||||||
Net reserves for losses and loss expenses, beginning of period | 2,528,573 | 2,864,757 | 2,660,245 | 3,077,606 | ||||||||||||
Net reserves disposed | — | — | — | (18,591 | ) | |||||||||||
Increase (decrease) in net reserves for losses and loss expenses in respect of losses occurring in: | ||||||||||||||||
Current year | 279,690 | 243,015 | 713,177 | 759,617 | ||||||||||||
Prior years | (55,565 | ) | (65,050 | ) | (167,636 | ) | (171,837 | ) | ||||||||
Total incurred losses and loss expenses | 224,125 | 177,965 | 545,541 | 587,780 | ||||||||||||
Less net losses and loss expenses paid in respect of losses occurring in: | ||||||||||||||||
Current year | (74,618 | ) | (59,701 | ) | (99,326 | ) | (95,535 | ) | ||||||||
Prior years | (183,697 | ) | (215,167 | ) | (633,048 | ) | (732,118 | ) | ||||||||
Total net paid losses | (258,315 | ) | (274,868 | ) | (732,374 | ) | (827,653 | ) | ||||||||
Foreign exchange | (40,717 | ) | 34,363 | (19,746 | ) | (16,925 | ) | |||||||||
Net reserve for losses and loss expenses, end of period | 2,453,666 | 2,802,217 | 2,453,666 | 2,802,217 | ||||||||||||
Losses and loss expenses recoverable | 298,502 | 421,518 | 298,502 | 421,518 | ||||||||||||
Reserve for losses and loss expenses, end of period | $ | 2,752,168 | $ | 3,223,735 | $ | 2,752,168 | $ | 3,223,735 | ||||||||
Incurred losses and loss expenses comprise: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Gross losses and loss expenses | $ | 222,356 | $ | 226,130 | $ | 587,111 | $ | 684,080 | ||||||||
Reinsurance recoverable | 1,769 | (48,165 | ) | (41,570 | ) | (96,300 | ) | |||||||||
Net incurred losses and loss expenses | $ | 224,125 | $ | 177,965 | $ | 545,541 | $ | 587,780 | ||||||||
Reinsurance_Tables
Reinsurance (Tables) | 9 Months Ended | |||||||||||||
Sep. 30, 2014 | ||||||||||||||
Reinsurance Disclosures [Abstract] | ' | |||||||||||||
Reinsurance recoverables by reinsurer | ' | |||||||||||||
Reinsurance recoverables by reinsurer as at September 30, 2014 and December 31, 2013 are as follows: | ||||||||||||||
September 30, 2014 | December 31, 2013 | |||||||||||||
Reinsurance Recoverable | % of Total | Reinsurance Recoverable | % of Total | |||||||||||
Top 10 reinsurers | $ | 264,131 | 73.1 | % | $ | 340,253 | 75.6 | % | ||||||
Other reinsurers’ balances > $1 million | 89,584 | 24.8 | % | 100,784 | 22.4 | % | ||||||||
Other reinsurers’ balances < $1 million | 7,778 | 2.1 | % | 9,197 | 2 | % | ||||||||
Total | $ | 361,493 | 100 | % | $ | 450,234 | 100 | % | ||||||
September 30, 2014 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 60,218 | 16.7 | % | |||||||||
Everest Re | A+ | 46,765 | 12.9 | % | ||||||||||
Third Point Re | A- | 34,180 | 9.5 | % | ||||||||||
Fully Collateralized | NR | 33,770 | 9.3 | % | ||||||||||
Hannover Re | AA- | 33,124 | 9.2 | % | ||||||||||
Swiss Re | AA- | 13,849 | 3.8 | % | ||||||||||
Transatlantic Re | A+ | 11,649 | 3.2 | % | ||||||||||
XL Re | A+ | 10,334 | 2.9 | % | ||||||||||
Munich Re | AA- | 10,232 | 2.8 | % | ||||||||||
Aioi Nissay Dowa Insurance | A+ | 10,010 | 2.8 | % | ||||||||||
Total | $ | 264,131 | 73.1 | % | ||||||||||
NR: Not rated | ||||||||||||||
December 31, 2013 | ||||||||||||||
Top 10 Reinsurers | Rating | Reinsurance Recoverable | % of Total | |||||||||||
Lloyd's Syndicates | A+ | $ | 73,398 | 16.3 | % | |||||||||
National Indemnity | AA+ | 51,037 | 11.3 | % | ||||||||||
Everest Re | A+ | 48,055 | 10.7 | % | ||||||||||
Hannover Re | AA- | 41,483 | 9.2 | % | ||||||||||
Fully Collateralized | NR | 36,683 | 8.1 | % | ||||||||||
Third Point Re | A- | 30,428 | 6.8 | % | ||||||||||
Swiss Re | AA- | 20,022 | 4.5 | % | ||||||||||
Transatlantic Re | A+ | 14,114 | 3.1 | % | ||||||||||
XL Re | A+ | 12,673 | 2.8 | % | ||||||||||
Munich Re | AA- | 12,360 | 2.8 | % | ||||||||||
Total | $ | 340,253 | 75.6 | % | ||||||||||
NR: Not rated |
Share_capital_Tables
Share capital (Tables) | 9 Months Ended | ||
Sep. 30, 2014 | |||
Stockholders' Equity Note [Abstract] | ' | ||
Summary of common shares issued and outstanding | ' | ||
The following table is a summary of the common shares issued and outstanding: | |||
Common Shares | |||
Common shares issued, December 31, 2013 | 154,488,497 | ||
Restricted share awards vested, net of shares withheld | 594,582 | ||
Restricted share units vested, net of shares withheld | 10,265 | ||
Options exercised | 133,385 | ||
Direct issuance of common stock | 1,060 | ||
Performance share awards vested, net of shares withheld | 25,767 | ||
Common shares issued, September 30, 2014 | 155,253,556 | ||
Treasury shares, September 30, 2014 | (66,141,285 | ) | |
Common shares outstanding, September 30, 2014 | 89,112,271 | ||
Common Shares | |||
Common shares issued, December 31, 2012 | 152,698,191 | ||
Restricted share awards vested, net of shares withheld | 768,889 | ||
Restricted share units vested, net of shares withheld | 14,381 | ||
Options exercised | 277,615 | ||
Warrants exercised | 591,480 | ||
Direct issuance of common stock | 928 | ||
Performance share awards vested, net of shares withheld | 31,897 | ||
Deferred share units vested, net of shares withheld | 2,935 | ||
Common shares issued, September 30, 2013 | 154,386,316 | ||
Treasury shares, September 30, 2013 | (54,488,320 | ) | |
Common shares outstanding, September 30, 2013 | 99,897,996 | ||
Stock_plans_Tables
Stock plans (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Options, activity during the period | ' | |||||||||||||||
Activity with respect to options for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2013 | 1,572,713 | $ | 6.66 | $ | 18.88 | |||||||||||
Options exercised | (133,385 | ) | 3.81 | 25.1 | ||||||||||||
Options outstanding, September 30, 2014 | 1,439,328 | $ | 6.93 | $ | 18.3 | |||||||||||
Activity with respect to options for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Options | Weighted Average Grant Date Fair Value | Weighted Average Grant Date Exercise Price | ||||||||||||||
Options outstanding, December 31, 2012 | 1,823,947 | $ | 6.52 | $ | 20.69 | |||||||||||
Options regranted (modified) | 1,833,414 | 6.76 | 19.02 | |||||||||||||
Options exercised | (277,615 | ) | 5.24 | 23.58 | ||||||||||||
Options cancelled (modified) | (1,733,139 | ) | 6.76 | 20.12 | ||||||||||||
Options outstanding, September 30, 2013 | 1,646,607 | $ | 6.75 | $ | 18.94 | |||||||||||
Restricted shares awards, activity during the period | ' | |||||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2013 | 2,684,745 | $ | 33.74 | |||||||||||||
Restricted share awards granted | 925,610 | 37.33 | ||||||||||||||
Restricted share awards vested | (769,971 | ) | 31.47 | |||||||||||||
Restricted share awards forfeited | (69,117 | ) | 36.28 | |||||||||||||
Restricted share awards outstanding, September 30, 2014 | 2,771,267 | $ | 35.5 | |||||||||||||
Activity with respect to unvested restricted share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share awards outstanding, December 31, 2012 | 2,170,547 | $ | 29.24 | |||||||||||||
Restricted share awards granted | 1,580,117 | 36.06 | ||||||||||||||
Restricted share awards vested | (930,296 | ) | 28.08 | |||||||||||||
Restricted share awards forfeited | (110,912 | ) | 28.34 | |||||||||||||
Restricted share awards outstanding, September 30, 2013 | 2,709,456 | $ | 33.65 | |||||||||||||
Restricted share units, activity during the period | ' | |||||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2013 | 66,518 | $ | 33.74 | |||||||||||||
Restricted share units granted | 53,025 | 38.1 | ||||||||||||||
Restricted share units vested | (18,325 | ) | 30.71 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 1,479 | 34.19 | ||||||||||||||
Restricted share units outstanding, September 30, 2014 | 102,697 | $ | 36.54 | |||||||||||||
Activity with respect to unvested restricted share units for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Restricted Share Units | Weighted Average Grant Date Fair Value | |||||||||||||||
Restricted share units outstanding, December 31, 2012 | 47,238 | $ | 29.61 | |||||||||||||
Restricted share units granted | 36,635 | 36.11 | ||||||||||||||
Restricted share units vested | (21,814 | ) | 28.17 | |||||||||||||
Restricted share units issued in lieu of cash dividends | 3,924 | 30.29 | ||||||||||||||
Restricted share units outstanding, September 30, 2013 | 65,983 | $ | 33.74 | |||||||||||||
Performance share awards, activity during the period | ' | |||||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2014 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2013 | 101,820 | $ | 33.56 | |||||||||||||
Performance share awards granted | 52,639 | 37.33 | ||||||||||||||
Performance share awards vested | (32,746 | ) | 32.62 | |||||||||||||
Performance share awards conversion adjustment | (15,344 | ) | 31.38 | |||||||||||||
Performance share awards outstanding, September 30, 2014 | 106,369 | $ | 36.03 | |||||||||||||
Activity with respect to unvested performance share awards for the nine months ended September 30, 2013 was as follows: | ||||||||||||||||
Performance Share Awards | Weighted Average Grant Date Fair Value | |||||||||||||||
Performance share awards outstanding, December 31, 2012 | 220,845 | $ | 31.81 | |||||||||||||
Performance share awards granted | 38,386 | 36.11 | ||||||||||||||
Performance share awards vested | (39,094 | ) | 28.7 | |||||||||||||
Performance share awards forfeited | (18,701 | ) | 31.05 | |||||||||||||
Performance share awards conversion adjustment | (99,616 | ) | $ | 33.05 | ||||||||||||
Performance share awards outstanding, September 30, 2013 | 101,820 | $ | 33.56 | |||||||||||||
Total share compensation expenses | ' | |||||||||||||||
The breakdown of share compensation expenses by award type was as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Restricted share awards | 8,180 | 10,041 | 23,101 | 20,035 | ||||||||||||
Restricted share units | 269 | 168 | 602 | 419 | ||||||||||||
Performance share awards | 315 | 318 | 549 | (971 | ) | |||||||||||
Total | $ | 8,764 | $ | 10,527 | $ | 24,252 | $ | 19,483 | ||||||||
Debt_and_financing_arrangement1
Debt and financing arrangements (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Debt Disclosure [Abstract] | ' | |||||||||||||||
Schedule of financing structure | ' | |||||||||||||||
The financing structure at September 30, 2014 was: | ||||||||||||||||
Commitment | Issued and outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 136,403 | 136,403 | 136,403 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total debentures payable | 600,153 | 539,953 | 539,953 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,279 | |||||||||||||
Total debentures and senior notes payable | 850,153 | 789,953 | 787,232 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 301,340 | — | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 19,743 | — | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 30,000 | 30,000 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 16,975 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 288,739 | — | |||||||||||||
Total credit and other facilities | 1,605,000 | 682,091 | — | |||||||||||||
Total debt and financing arrangements | $ | 2,455,153 | $ | 1,472,044 | $ | 787,232 | ||||||||||
The financing structure at December 31, 2013 was: | ||||||||||||||||
Commitment | Issued and outstanding (a) | Drawn | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 150,000 | $ | 150,000 | $ | 150,000 | ||||||||||
2007 Junior Subordinated Deferrable Debentures | 200,000 | 139,800 | 139,800 | |||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 137,866 | 137,866 | 137,866 | |||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 113,750 | 113,750 | 113,750 | |||||||||||||
Total debentures payable | 601,616 | 541,416 | 541,416 | |||||||||||||
2010 Senior Notes due 2040 | 250,000 | 250,000 | 247,198 | |||||||||||||
Total debentures and senior notes payable | 851,616 | 791,416 | 788,614 | |||||||||||||
$400,000 syndicated unsecured letter of credit facility | 400,000 | — | — | |||||||||||||
$525,000 syndicated secured letter of credit facility | 525,000 | 358,567 | — | |||||||||||||
$200,000 secured bi-lateral letter of credit facility | 200,000 | 16,726 | — | |||||||||||||
Talbot FAL facility | 25,000 | 25,000 | — | |||||||||||||
PaCRe senior secured letter of credit facility | 10,000 | 294 | — | |||||||||||||
AlphaCat Re secured letter of credit facility | 24,800 | 24,800 | — | |||||||||||||
IPC bi-lateral facility | 40,000 | 20,177 | — | |||||||||||||
$375,000 Flagstone bi-lateral facility | 375,000 | 305,686 | — | |||||||||||||
Total credit and other facilities | 1,599,800 | 751,250 | — | |||||||||||||
Total debt and financing arrangements | $ | 2,451,416 | $ | 1,542,666 | $ | 788,614 | ||||||||||
(a) | Indicates utilization of commitment amount, not necessarily drawn borrowings. | |||||||||||||||
Debt Instruments [Line Items] | ' | |||||||||||||||
Components of finance expenses | ' | |||||||||||||||
Finance expenses consist of interest on the junior subordinated deferrable debentures and senior notes, the amortization of debt offering costs, credit facilities fees, bank charges, AlphaCat financing fees and Talbot FAL costs as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
2006 Junior Subordinated Deferrable Debentures | $ | 2,235 | $ | 2,235 | $ | 6,633 | $ | 6,633 | ||||||||
2007 Junior Subordinated Deferrable Debentures | 1,848 | 1,848 | 5,492 | 5,492 | ||||||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | 2,269 | 2,285 | 6,736 | 5,988 | ||||||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 1,807 | 1,807 | 5,335 | 4,426 | ||||||||||||
2010 Senior Notes due 2040 | 5,597 | 5,597 | 16,791 | 16,791 | ||||||||||||
Credit facilities | 1,295 | 1,248 | 4,225 | 5,001 | ||||||||||||
Bank charges | 88 | 187 | 303 | 420 | ||||||||||||
AlphaCat ILS funds fees (a) | 384 | 78 | 2,030 | 2,406 | ||||||||||||
Talbot FAL Facility | (169 | ) | 32 | (165 | ) | 95 | ||||||||||
Total finance expenses | $ | 15,354 | $ | 15,317 | $ | 47,380 | $ | 47,252 | ||||||||
(a) | Includes finance expenses incurred by AlphaCat Managers, Ltd. in relation to fund raising for the AlphaCat ILS funds, AlphaCat 2014 and AlphaCat 2013. | |||||||||||||||
Debt Information At Issuance [Member] | ' | |||||||||||||||
Debt Instruments [Line Items] | ' | |||||||||||||||
Schedule of long-term debt instruments [Table Text Block] | ' | |||||||||||||||
The following table summarizes the key terms of the Company's senior notes and junior subordinated deferrable debentures as at the issuance date for each placement. | ||||||||||||||||
Description | Issuance date | Commitment | Maturity date | Fixed/Spread | Interest payments due | |||||||||||
2006 Junior Subordinated Deferrable Debentures | June 15, 2006 | $ | 150,000 | June 15, 2036 | 9.069 | % | (a) | Quarterly | ||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | August 23, 2006 | $ | 136,403 | September 15, 2036 | 3.54 | % | (b) | Quarterly | ||||||||
2007 Junior Subordinated Deferrable Debentures | June 21, 2007 | $ | 200,000 | June 15, 2037 | 8.48 | % | (a) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | June 8, 2007 | $ | 88,750 | July 30, 2037 | 3 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | September 20, 2007 | $ | 25,000 | September 15, 2037 | 3.1 | % | (b) | Quarterly | ||||||||
2010 Senior Notes due 2040 | January 26, 2010 | $ | 250,000 | January 26, 2040 | 8.875 | % | (a) | Semi-annually in arrears | ||||||||
(a) | Fixed interest rate. | |||||||||||||||
(b) | Variable interest rate is the three-month LIBOR, reset quarterly, plus spread as noted in the table. | |||||||||||||||
Debt Outstanding [Member] | ' | |||||||||||||||
Debt Instruments [Line Items] | ' | |||||||||||||||
Schedule of long-term debt instruments [Table Text Block] | ' | |||||||||||||||
The following table summarizes the key terms of the Company's senior notes and junior subordinated deferrable debentures as at September 30, 2014: | ||||||||||||||||
Description | Issuance date | Commitment | Maturity date | Fixed/Spread | Interest payments due | |||||||||||
2006 Junior Subordinated Deferrable Debentures | June 15, 2006 | $ | 150,000 | June 15, 2036 | 5.831 | % | (b) | Quarterly | ||||||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | August 23, 2006 | $ | 136,403 | September 15, 2036 | 6.463 | % | (b) | Quarterly | ||||||||
2007 Junior Subordinated Deferrable Debentures | June 21, 2007 | $ | 200,000 | June 15, 2037 | 5.18 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 8-Jun-07 | $ | 88,750 | July 30, 2037 | 5.9 | % | (b) | Quarterly | ||||||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | 20-Sep-07 | $ | 25,000 | September 15, 2037 | 5.983 | % | (b) | Quarterly | ||||||||
2010 Senior Notes due 2040 | 26-Jan-10 | $ | 250,000 | January 26, 2040 | 8.875 | % | (a) | Semi-annually in arrears | ||||||||
(a) | Fixed interest rate. | |||||||||||||||
(b) | Interest rate has been fixed as a result of interest rate swap contracts entered into by the Company. |
Accumulated_other_comprehensiv1
Accumulated other comprehensive (loss) income (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | |||||||||||||||
Schedule of changes in accumulated other comprehensive (loss) income | ' | |||||||||||||||
The changes in accumulated other comprehensive (loss) income, by component for the three and nine months ended September 30, 2014 and 2013 is as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Balance - Beginning of period | $ | 2,460 | $ | (8,262 | ) | $ | (617 | ) | $ | (2,953 | ) | |||||
Amounts reclassified to retained earnings | — | — | — | 4,290 | ||||||||||||
Other comprehensive (loss) income | (5,198 | ) | 4,390 | (2,121 | ) | (5,209 | ) | |||||||||
Balance - End of period | $ | (2,738 | ) | $ | (3,872 | ) | $ | (2,738 | ) | $ | (3,872 | ) |
Commitments_and_contingencies_
Commitments and contingencies (Tables) | 9 Months Ended | |||||||
Sep. 30, 2014 | ||||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||||
Components of required capital | ' | |||||||
The amounts of cash, investments and letters of credit provided for each year of account as follows: | ||||||||
2014 Underwriting Year | 2013 Underwriting Year | |||||||
Talbot FAL facility | $ | 25,000 | $ | 25,000 | ||||
Group funds | 450,000 | 403,700 | ||||||
Total | $ | 475,000 | $ | 428,700 | ||||
Earnings_per_share_Tables
Earnings per share (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ' | |||||||||||||||
Computation of basic and earnings per diluted share | ' | |||||||||||||||
The following table sets forth the computation of basic and earnings per diluted share for the three and nine months ended September 30, 2014 and 2013: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Basic earnings per share | ||||||||||||||||
Net (loss) income | $ | (13,397 | ) | $ | 229,063 | $ | 381,172 | $ | 419,503 | |||||||
Loss (income) attributable to noncontrolling interest | 53,069 | (45,694 | ) | (25,745 | ) | 17,831 | ||||||||||
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | (1,552 | ) | (4,656 | ) | (17,662 | ) | ||||||||
Income available to common shareholders | $ | 38,120 | $ | 181,817 | $ | 350,771 | $ | 419,672 | ||||||||
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 | ||||||||||||
Basic earnings per share available to common shareholders | $ | 0.42 | $ | 1.82 | $ | 3.83 | $ | 4.06 | ||||||||
Earnings per diluted share | ||||||||||||||||
Net (loss) income | $ | (13,397 | ) | $ | 229,063 | $ | 381,172 | $ | 419,503 | |||||||
Loss (income) attributable to noncontrolling interest | 53,069 | (45,694 | ) | (25,745 | ) | 17,831 | ||||||||||
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ||||||||||||
Less: Dividends and distributions declared on outstanding warrants | (1,552 | ) | — | — | (17,662 | ) | ||||||||||
Income available to common shareholders | $ | 38,120 | $ | 183,369 | $ | 355,427 | $ | 419,672 | ||||||||
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 | ||||||||||||
Share equivalents: | ||||||||||||||||
Warrants | — | 2,606,669 | 2,747,399 | — | ||||||||||||
Stock options | 760,267 | 782,158 | 752,145 | 1,090,298 | ||||||||||||
Unvested restricted shares | 586,014 | 390,376 | 772,147 | 723,219 | ||||||||||||
Weighted average number of diluted common shares outstanding | 91,939,610 | 103,613,766 | 95,937,641 | 105,264,913 | ||||||||||||
Earnings per diluted share available to common shareholders | $ | 0.41 | $ | 1.77 | $ | 3.7 | $ | 3.99 | ||||||||
Segment_information_Tables
Segment information (Tables) | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||||
Summary of results of operating segments and Corporate | ' | ||||||||||||||||||||||
The following tables summarize the results of our operating segments and "Corporate": | |||||||||||||||||||||||
Three Months Ended September 30, 2014 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 114,897 | $ | 6,936 | $ | 245,685 | $ | (8,544 | ) | $ | 358,974 | ||||||||||||
Reinsurance premiums ceded | (10,899 | ) | (648 | ) | (27,134 | ) | 8,544 | (30,137 | ) | ||||||||||||||
Net premiums written | 103,998 | 6,288 | 218,551 | — | 328,837 | ||||||||||||||||||
Change in unearned premiums | 122,712 | 28,850 | 14,297 | — | 165,859 | ||||||||||||||||||
Net premiums earned | 226,710 | 35,138 | 232,848 | — | 494,696 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 102,005 | 3,738 | 118,382 | — | 224,125 | ||||||||||||||||||
Policy acquisition costs | 36,177 | 3,378 | 47,862 | (1,013 | ) | 86,404 | |||||||||||||||||
General and administrative expenses | 18,522 | 7,719 | 37,709 | 19,369 | 83,319 | ||||||||||||||||||
Share compensation expenses | 2,582 | 179 | 2,990 | 3,013 | 8,764 | ||||||||||||||||||
Total underwriting deductions | 159,286 | 15,014 | 206,943 | 21,369 | 402,612 | ||||||||||||||||||
Underwriting income (loss) | $ | 67,424 | $ | 20,124 | $ | 25,905 | $ | (21,369 | ) | $ | 92,084 | ||||||||||||
Net investment income | 20,762 | 837 | 4,965 | (1,303 | ) | 25,261 | |||||||||||||||||
Other (loss) income | (6,827 | ) | 5,980 | 109 | (3,342 | ) | (4,080 | ) | |||||||||||||||
Finance expenses | (3,622 | ) | (385 | ) | 162 | (11,509 | ) | (15,354 | ) | ||||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 77,737 | 26,556 | 31,141 | (37,523 | ) | 97,911 | |||||||||||||||||
Tax benefit (expense) | 1,058 | — | 332 | (437 | ) | 953 | |||||||||||||||||
Income from operating affiliates | — | 3,761 | — | — | 3,761 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (25,807 | ) | — | — | (25,807 | ) | ||||||||||||||||
Net operating income (loss) | $ | 78,795 | $ | 4,510 | $ | 31,473 | $ | (37,960 | ) | $ | 76,818 | ||||||||||||
Net realized gains on investments | 1,641 | 2,563 | 391 | — | 4,595 | ||||||||||||||||||
Change in net unrealized (losses) on investments | (20,149 | ) | (60,253 | ) | (3,097 | ) | (1,475 | ) | (84,974 | ) | |||||||||||||
Income from investment affiliate | 1,754 | — | — | — | 1,754 | ||||||||||||||||||
Foreign exchange (losses) gains | (6,056 | ) | (51 | ) | (7,114 | ) | 1,780 | (11,441 | ) | ||||||||||||||
Transaction expenses (b) | — | — | — | (149 | ) | (149 | ) | ||||||||||||||||
Net income (loss) | $ | 55,985 | $ | (53,231 | ) | $ | 21,653 | $ | (37,804 | ) | $ | (13,397 | ) | ||||||||||
Net loss attributable to noncontrolling interest | — | 53,069 | — | — | 53,069 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 55,985 | $ | (162 | ) | $ | 21,653 | $ | (37,804 | ) | $ | 39,672 | |||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.5 | % | 90.7 | % | 89 | % | 91.6 | % | |||||||||||||||
Losses and loss expenses | 45 | % | 10.6 | % | 50.8 | % | 45.3 | % | |||||||||||||||
Policy acquisition costs | 16 | % | 9.6 | % | 20.6 | % | 17.5 | % | |||||||||||||||
General and administrative expenses (c) | 9.3 | % | 22.5 | % | 17.5 | % | 18.6 | % | |||||||||||||||
Expense ratio | 25.3 | % | 32.1 | % | 38.1 | % | 36.1 | % | |||||||||||||||
Combined ratio | 70.3 | % | 42.7 | % | 88.9 | % | 81.4 | % | |||||||||||||||
Total assets | $ | 4,716,426 | $ | 1,688,191 | $ | 2,898,755 | $ | 749,678 | $ | 10,053,050 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the three months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. | ||||||||||||||||||||||
(c) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Three Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | ||||||||||||
Reinsurance premiums ceded | (13,006 | ) | (525 | ) | (49,998 | ) | 24,114 | (39,415 | ) | ||||||||||||||
Net premiums written | 117,919 | 2,956 | 196,470 | — | 317,345 | ||||||||||||||||||
Change in unearned premiums | 157,873 | 34,210 | 21,860 | — | 213,943 | ||||||||||||||||||
Net premiums earned | 275,792 | 37,166 | 218,330 | — | 531,288 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 62,250 | 15,615 | 100,100 | — | 177,965 | ||||||||||||||||||
Policy acquisition costs | 47,662 | 3,787 | 44,899 | (1,448 | ) | 94,900 | |||||||||||||||||
General and administrative expenses | 19,785 | 5,728 | 37,402 | 18,174 | 81,089 | ||||||||||||||||||
Share compensation expenses | 2,479 | 152 | 2,992 | 4,904 | 10,527 | ||||||||||||||||||
Total underwriting deductions | 132,176 | 25,282 | 185,393 | 21,630 | 364,481 | ||||||||||||||||||
Underwriting income (loss) | $ | 143,616 | $ | 11,884 | $ | 32,937 | $ | (21,630 | ) | $ | 166,807 | ||||||||||||
Net investment income | 15,628 | 967 | 4,395 | (981 | ) | 20,009 | |||||||||||||||||
Other (loss) income | (1,892 | ) | 3,791 | 73 | (4,778 | ) | (2,806 | ) | |||||||||||||||
Finance expenses | (3,640 | ) | (80 | ) | (107 | ) | (11,490 | ) | (15,317 | ) | |||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 153,712 | 16,562 | 37,298 | (38,879 | ) | 168,693 | |||||||||||||||||
Tax benefit (expense) | 143 | — | (513 | ) | 365 | (5 | ) | ||||||||||||||||
Income from operating affiliates | — | 1,463 | — | — | 1,463 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (11,815 | ) | — | — | (11,815 | ) | ||||||||||||||||
Net operating income (loss) | $ | 153,855 | $ | 6,210 | $ | 36,785 | $ | (38,514 | ) | $ | 158,336 | ||||||||||||
Net realized (losses) gains on investments | (10,137 | ) | 4,084 | (267 | ) | — | (6,320 | ) | |||||||||||||||
Change in net unrealized gains on investments | 23,144 | 44,145 | 2,678 | — | 69,967 | ||||||||||||||||||
Income from investment affiliate | 1,044 | — | — | — | 1,044 | ||||||||||||||||||
Foreign exchange gains (losses) | 2,168 | 388 | 4,238 | (758 | ) | 6,036 | |||||||||||||||||
Net income (loss) | $ | 170,074 | $ | 54,827 | $ | 43,434 | $ | (39,272 | ) | $ | 229,063 | ||||||||||||
Net income attributable to noncontrolling interest | — | (45,694 | ) | — | — | (45,694 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 170,074 | $ | 9,133 | $ | 43,434 | $ | (39,272 | ) | $ | 183,369 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 90.1 | % | 84.9 | % | 79.7 | % | 89 | % | |||||||||||||||
Losses and loss expenses | 22.6 | % | 42 | % | 45.8 | % | 33.5 | % | |||||||||||||||
Policy acquisition costs | 17.3 | % | 10.2 | % | 20.6 | % | 17.9 | % | |||||||||||||||
General and administrative expenses (b) | 8.1 | % | 15.8 | % | 18.5 | % | 17.2 | % | |||||||||||||||
Expense ratio | 25.4 | % | 26 | % | 39.1 | % | 35.1 | % | |||||||||||||||
Combined ratio | 48 | % | 68 | % | 84.9 | % | 68.6 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2014 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,104,169 | $ | 135,073 | $ | 854,324 | $ | (66,927 | ) | $ | 2,026,639 | ||||||||||||
Reinsurance premiums ceded | (184,074 | ) | (4,348 | ) | (154,115 | ) | 66,927 | (275,610 | ) | ||||||||||||||
Net premiums written | 920,095 | 130,725 | 700,209 | — | 1,751,029 | ||||||||||||||||||
Change in unearned premiums | (233,271 | ) | (32,444 | ) | (41,658 | ) | — | (307,373 | ) | ||||||||||||||
Net premiums earned | 686,824 | 98,281 | 658,551 | — | 1,443,656 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 247,848 | (7,155 | ) | 304,848 | — | 545,541 | |||||||||||||||||
Policy acquisition costs | 106,547 | 9,414 | 138,383 | (3,338 | ) | 251,006 | |||||||||||||||||
General and administrative expenses | 53,757 | 15,627 | 107,031 | 55,191 | 231,606 | ||||||||||||||||||
Share compensation expenses | 7,126 | 330 | 8,434 | 8,362 | 24,252 | ||||||||||||||||||
Total underwriting deductions | 415,278 | 18,216 | 558,696 | 60,215 | 1,052,405 | ||||||||||||||||||
Underwriting income (loss) | $ | 271,546 | $ | 80,065 | $ | 99,855 | $ | (60,215 | ) | $ | 391,251 | ||||||||||||
Net investment income | 56,285 | 2,546 | 14,322 | (3,244 | ) | 69,909 | |||||||||||||||||
Other income (loss) | 912 | 21,482 | 384 | (7,793 | ) | 14,985 | |||||||||||||||||
Finance expenses | (11,131 | ) | (2,039 | ) | 68 | (34,278 | ) | (47,380 | ) | ||||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 317,612 | 102,054 | 114,629 | (105,530 | ) | 428,765 | |||||||||||||||||
Tax benefit (expense) | 1,176 | — | (902 | ) | (672 | ) | (398 | ) | |||||||||||||||
Income from operating affiliates | — | 13,580 | — | — | 13,580 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (82,833 | ) | — | — | (82,833 | ) | ||||||||||||||||
Net operating income (loss) | $ | 318,788 | $ | 32,801 | $ | 113,727 | $ | (106,202 | ) | $ | 359,114 | ||||||||||||
Net realized gains on investments | 5,411 | 10,230 | 552 | — | 16,193 | ||||||||||||||||||
Change in net unrealized gains (losses) on investments | 5,279 | 15,706 | 2,159 | (6,998 | ) | 16,146 | |||||||||||||||||
Income from investment affiliate | 7,881 | — | — | — | 7,881 | ||||||||||||||||||
Foreign exchange (losses) gains | (9,384 | ) | (204 | ) | (5,897 | ) | 724 | (14,761 | ) | ||||||||||||||
Transaction expenses (b) | — | — | — | (3,401 | ) | (3,401 | ) | ||||||||||||||||
Net income (loss) | $ | 327,975 | $ | 58,533 | $ | 110,541 | $ | (115,877 | ) | $ | 381,172 | ||||||||||||
Net (income) attributable to noncontrolling interest | — | (25,745 | ) | — | — | (25,745 | ) | ||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 327,975 | $ | 32,788 | $ | 110,541 | $ | (115,877 | ) | $ | 355,427 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 83.3 | % | 96.8 | % | 82 | % | 86.4 | % | |||||||||||||||
Losses and loss expenses | 36.1 | % | (7.3 | )% | 46.3 | % | 37.8 | % | |||||||||||||||
Policy acquisition costs | 15.5 | % | 9.6 | % | 21 | % | 17.4 | % | |||||||||||||||
General and administrative expenses (c) | 8.9 | % | 16.2 | % | 17.5 | % | 17.7 | % | |||||||||||||||
Expense ratio | 24.4 | % | 25.8 | % | 38.5 | % | 35.1 | % | |||||||||||||||
Combined ratio | 60.5 | % | 18.5 | % | 84.8 | % | 72.9 | % | |||||||||||||||
Total assets | $ | 4,716,426 | $ | 1,688,191 | $ | 2,898,755 | $ | 749,678 | $ | 10,053,050 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the nine months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. | ||||||||||||||||||||||
(c) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Nine Months Ended September 30, 2013 | Validus Re Segment | AlphaCat Segment | Talbot Segment | Corporate & Eliminations | Total | ||||||||||||||||||
Underwriting income | |||||||||||||||||||||||
Gross premiums written | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | ||||||||||||
Reinsurance premiums ceded | (226,292 | ) | (525 | ) | (191,922 | ) | 70,712 | (348,027 | ) | ||||||||||||||
Net premiums written | 1,005,980 | 146,232 | 663,594 | — | 1,815,806 | ||||||||||||||||||
Change in unearned premiums | (122,303 | ) | (46,459 | ) | (37,237 | ) | — | (205,999 | ) | ||||||||||||||
Net premiums earned | 883,677 | 99,773 | 626,357 | — | 1,609,807 | ||||||||||||||||||
Underwriting deductions | |||||||||||||||||||||||
Losses and loss expenses | 319,298 | 16,928 | 251,554 | — | 587,780 | ||||||||||||||||||
Policy acquisition costs | 142,195 | 10,011 | 127,092 | (3,635 | ) | 275,663 | |||||||||||||||||
General and administrative expenses | 69,649 | 13,757 | 100,506 | 48,423 | 232,335 | ||||||||||||||||||
Share compensation expenses | 5,421 | 314 | 6,754 | 6,994 | 19,483 | ||||||||||||||||||
Total underwriting deductions | 536,563 | 41,010 | 485,906 | 51,782 | 1,115,261 | ||||||||||||||||||
Underwriting income (loss) | $ | 347,114 | $ | 58,763 | $ | 140,451 | $ | (51,782 | ) | $ | 494,546 | ||||||||||||
Net investment income | 61,770 | 2,821 | 13,496 | (6,219 | ) | 71,868 | |||||||||||||||||
Other income (loss) | 11,237 | 17,439 | 564 | (24,943 | ) | 4,297 | |||||||||||||||||
Finance expenses | (12,133 | ) | (4,273 | ) | (256 | ) | (30,590 | ) | (47,252 | ) | |||||||||||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 407,988 | 74,750 | 154,255 | (113,534 | ) | 523,459 | |||||||||||||||||
Tax benefit (expense) | 1,755 | — | (1,184 | ) | (351 | ) | 220 | ||||||||||||||||
Income from operating affiliates | — | 8,779 | — | — | 8,779 | ||||||||||||||||||
(Income) attributable to operating affiliate investors | — | (42,156 | ) | — | — | (42,156 | ) | ||||||||||||||||
Net operating income (loss) | $ | 409,743 | $ | 41,373 | $ | 153,071 | $ | (113,885 | ) | $ | 490,302 | ||||||||||||
Net realized (losses) gains on investments | (5,790 | ) | 4,084 | 516 | — | (1,190 | ) | ||||||||||||||||
Change in net unrealized losses on investments | (36,883 | ) | (31,029 | ) | (10,706 | ) | — | (78,618 | ) | ||||||||||||||
Income from investment affiliate | 4,274 | — | — | — | 4,274 | ||||||||||||||||||
Foreign exchange gains (losses) | 7,448 | (663 | ) | (1,877 | ) | (173 | ) | 4,735 | |||||||||||||||
Net income (loss) | $ | 378,792 | $ | 13,765 | $ | 141,004 | $ | (114,058 | ) | $ | 419,503 | ||||||||||||
Net loss attributable to noncontrolling interest | — | 17,831 | — | — | 17,831 | ||||||||||||||||||
Net income (loss) available (attributable) to Validus | $ | 378,792 | $ | 31,596 | $ | 141,004 | $ | (114,058 | ) | $ | 437,334 | ||||||||||||
Selected ratios (a): | |||||||||||||||||||||||
Net premiums written / Gross premiums written | 81.6 | % | 99.6 | % | 77.6 | % | 83.9 | % | |||||||||||||||
Losses and loss expenses | 36.1 | % | 17 | % | 40.2 | % | 36.5 | % | |||||||||||||||
Policy acquisition costs | 16.1 | % | 10 | % | 20.3 | % | 17.2 | % | |||||||||||||||
General and administrative expenses (b) | 8.5 | % | 14.1 | % | 17.1 | % | 15.6 | % | |||||||||||||||
Expense ratio | 24.6 | % | 24.1 | % | 37.4 | % | 32.8 | % | |||||||||||||||
Combined ratio | 60.7 | % | 41.1 | % | 77.6 | % | 69.3 | % | |||||||||||||||
Total assets | $ | 5,854,354 | $ | 1,446,941 | $ | 2,892,477 | $ | 123,596 | $ | 10,317,368 | |||||||||||||
(a) | Ratios are based on net premiums earned. | ||||||||||||||||||||||
(b) | The general and administrative expense ratio includes share compensation expenses. | ||||||||||||||||||||||
Gross premiums written allocated to the territory of coverage exposure | ' | ||||||||||||||||||||||
The following tables set forth the gross premiums written allocated to the territory of coverage exposure for the periods indicated: | |||||||||||||||||||||||
Three Months Ended September 30, 2014 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 28,665 | $ | 2,206 | $ | 17,003 | $ | (874 | ) | $ | 47,000 | 13.1 | % | ||||||||||
Worldwide excluding United States (a) | 10,639 | (81 | ) | 29,781 | (973 | ) | 39,366 | 10.9 | % | ||||||||||||||
Australia and New Zealand | 610 | — | 3,312 | (139 | ) | 3,783 | 1.1 | % | |||||||||||||||
Europe | 8,560 | 312 | 9,821 | (311 | ) | 18,382 | 5.1 | % | |||||||||||||||
Latin America and Caribbean | 12,945 | — | 24,740 | (819 | ) | 36,866 | 10.3 | % | |||||||||||||||
Japan | 1,664 | 22 | 1,274 | (73 | ) | 2,887 | 0.8 | % | |||||||||||||||
Canada | 188 | — | 2,430 | (80 | ) | 2,538 | 0.7 | % | |||||||||||||||
Rest of the world (b) | 1,527 | — | 27,145 | (1,073 | ) | 27,599 | 7.7 | % | |||||||||||||||
Sub-total, non United States | 36,133 | 253 | 98,503 | (3,468 | ) | 131,421 | 36.6 | % | |||||||||||||||
Worldwide including United States (a) | 28,747 | 4,477 | 18,611 | (560 | ) | 51,275 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 21,352 | — | 111,568 | (3,642 | ) | 129,278 | 36 | % | |||||||||||||||
Total | $ | 114,897 | $ | 6,936 | $ | 245,685 | $ | (8,544 | ) | $ | 358,974 | 100 | % | ||||||||||
Three Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 38,881 | $ | 2,546 | $ | 21,573 | $ | (2,105 | ) | $ | 60,895 | 17 | % | ||||||||||
Worldwide excluding United States (a) | 16,973 | — | 34,751 | (4,138 | ) | 47,586 | 13.3 | % | |||||||||||||||
Australia and New Zealand | (9,482 | ) | 33 | 2,905 | (236 | ) | (6,780 | ) | (1.9 | )% | |||||||||||||
Europe | 4,252 | 377 | 9,778 | (986 | ) | 13,421 | 3.8 | % | |||||||||||||||
Latin America and Caribbean | 5,902 | — | 38,084 | (3,353 | ) | 40,633 | 11.4 | % | |||||||||||||||
Japan | (2,637 | ) | — | 1,066 | (117 | ) | (1,688 | ) | (0.5 | )% | |||||||||||||
Canada | 1,469 | 500 | 2,749 | (740 | ) | 3,978 | 1.1 | % | |||||||||||||||
Rest of the world (b) | 5,641 | — | 22,167 | (1,830 | ) | 25,978 | 7.3 | % | |||||||||||||||
Sub-total, non United States | 22,118 | 910 | 111,500 | (11,400 | ) | 123,128 | 34.5 | % | |||||||||||||||
Worldwide including United States (a) | 29,611 | 25 | 18,246 | (1,665 | ) | 46,217 | 13 | % | |||||||||||||||
Other location non-specific (c) | 40,315 | — | 95,149 | (8,944 | ) | 126,520 | 35.5 | % | |||||||||||||||
Total | $ | 130,925 | $ | 3,481 | $ | 246,468 | $ | (24,114 | ) | $ | 356,760 | 100 | % | ||||||||||
Nine Months Ended September 30, 2014 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 452,470 | $ | 31,160 | $ | 85,465 | $ | (10,662 | ) | $ | 558,433 | 27.5 | % | ||||||||||
Worldwide excluding United States (a) | 80,671 | 7,331 | 105,397 | (6,741 | ) | 186,658 | 9.2 | % | |||||||||||||||
Australia and New Zealand | 20,025 | 1,019 | 7,615 | (391 | ) | 28,268 | 1.4 | % | |||||||||||||||
Europe | 57,884 | 3,005 | 36,110 | (4,157 | ) | 92,842 | 4.6 | % | |||||||||||||||
Latin America and Caribbean | 22,167 | — | 86,111 | (4,418 | ) | 103,860 | 5.1 | % | |||||||||||||||
Japan | 41,137 | 608 | 3,404 | (784 | ) | 44,365 | 2.2 | % | |||||||||||||||
Canada | 3,508 | 215 | 8,325 | (641 | ) | 11,407 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 23,870 | — | 70,702 | (3,627 | ) | 90,945 | 4.5 | % | |||||||||||||||
Sub-total, non United States | 249,262 | 12,178 | 317,664 | (20,759 | ) | 558,345 | 27.6 | % | |||||||||||||||
Worldwide including United States (a) | 168,337 | 91,735 | 71,147 | (11,365 | ) | 319,854 | 15.8 | % | |||||||||||||||
Other location non-specific (c) | 234,100 | — | 380,048 | (24,141 | ) | 590,007 | 29.1 | % | |||||||||||||||
Total | $ | 1,104,169 | $ | 135,073 | $ | 854,324 | $ | (66,927 | ) | $ | 2,026,639 | 100 | % | ||||||||||
Nine Months Ended September 30, 2013 | |||||||||||||||||||||||
Gross Premiums Written | |||||||||||||||||||||||
Validus Re | AlphaCat | Talbot | Eliminations | Total | % | ||||||||||||||||||
United States | $ | 542,692 | $ | 50,935 | $ | 77,630 | $ | (10,599 | ) | $ | 660,658 | 30.6 | % | ||||||||||
Worldwide excluding United States (a) | 69,482 | 14,801 | 109,562 | (9,065 | ) | 184,780 | 8.4 | % | |||||||||||||||
Australia and New Zealand | 21,116 | 2,216 | 7,930 | (467 | ) | 30,795 | 1.4 | % | |||||||||||||||
Europe | 64,986 | 2,514 | 41,523 | (3,892 | ) | 105,131 | 4.9 | % | |||||||||||||||
Latin America and Caribbean | 5,885 | — | 124,120 | (7,312 | ) | 122,693 | 5.7 | % | |||||||||||||||
Japan | 41,939 | 653 | 5,258 | (963 | ) | 46,887 | 2.2 | % | |||||||||||||||
Canada | 4,503 | 818 | 8,790 | (1,336 | ) | 12,775 | 0.6 | % | |||||||||||||||
Rest of the world (b) | 29,211 | — | 62,803 | (3,700 | ) | 88,314 | 4.1 | % | |||||||||||||||
Sub-total, non United States | 237,122 | 21,002 | 359,986 | (26,735 | ) | 591,375 | 27.3 | % | |||||||||||||||
Worldwide including United States (a) | 180,621 | 74,820 | 63,998 | (10,214 | ) | 309,225 | 14.3 | % | |||||||||||||||
Other location non-specific (c) | 271,837 | — | 353,902 | (23,164 | ) | 602,575 | 27.8 | % | |||||||||||||||
Total | $ | 1,232,272 | $ | 146,757 | $ | 855,516 | $ | (70,712 | ) | $ | 2,163,833 | 100 | % | ||||||||||
(a) | Represents risks in two or more geographic zones. | ||||||||||||||||||||||
(b) | Represents risks in one geographic zone. | ||||||||||||||||||||||
(c) | The other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable, such as marine and aerospace risks, since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Basis_of_preparation_and_conso1
Basis of preparation and consolidation (Details) (USD $) | 3 Months Ended | 9 Months Ended |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 |
Reclassification From Operating Cash To Financing Flows [Member] | ' | ' |
Reclassification adjustment | ' | $19,400 |
Reclassification Into Income Attributable To Operating Affiliate Investors From Finance Expenses [Member] | ' | ' |
Reclassification adjustment | $11,815 | $42,156 |
Investments_Gross_unrealized_g
Investments (Gross unrealized gains and losses on fixed maturities) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Thousands, unless otherwise specified | ||||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | $4,668,585 | $5,522,853 | ||
Short-term investments, at amortized cost or cost | 1,684,997 | [1] | 751,734 | [2] |
Other investments, at amortized cost or cost | 714,508 | 637,728 | ||
Total investments including noncontrolling interests | 7,068,090 | 6,912,315 | ||
Noncontrolling interest, amortized cost or cost | -502,830 | [3] | -512,121 | [3] |
Redeemable noncontrolling interest, amortized cost or cost | -11,637 | [1] | -18,365 | [2] |
Total investments excluding non-controlling interests, amortized cost or cost | 6,553,623 | 6,381,829 | ||
Fixed maturities, gross unrealized gains | 24,804 | 42,756 | ||
Short term investments, gross unrealized gains | 4 | [1] | 45 | [2] |
Other investments, gross unrealized gains | 109,296 | 76,843 | ||
Gross unrealized gains | 134,104 | 119,644 | ||
Noncontrolling interest share of unrealized gains other investments | -86,263 | [3] | -62,850 | [3] |
Total investments excluding non-controlling interest, unrealized gains | 47,841 | 56,794 | ||
Fixed maturities, gross unrealized losses | -23,216 | -23,351 | ||
Short term investments, gross unrealized losses | -19 | [1] | -1 | [2] |
Other investments, gross unrealized losses | -105,171 | -96,255 | ||
Gross unrealized losses | -128,406 | -119,607 | ||
Noncontrolling interest share of unrealized losses | 93,728 | [3] | 85,569 | [3] |
Total investments excluding non-controlling interest, unrealized losses | -34,678 | -34,038 | ||
Total fixed maturities | 4,670,173 | 5,542,258 | ||
Total short-term investments | 1,684,982 | [1] | 751,778 | [2] |
Total other investments | 718,633 | 618,316 | ||
Total | 7,073,788 | 6,912,352 | ||
Noncontrolling interest | -495,365 | [3] | -489,402 | [3] |
Redeemable noncontrolling interest | -11,637 | [1] | -18,365 | [2] |
Total investments excluding noncontrolling interest | 6,566,786 | 6,404,585 | ||
U.S. government and government agency | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 786,318 | 1,368,826 | ||
Fixed maturities, gross unrealized gains | 1,735 | 2,589 | ||
Fixed maturities, gross unrealized losses | -1,798 | -6,736 | ||
Total fixed maturities | 786,255 | 1,364,679 | ||
Non-U.S. government and government agency | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 383,378 | 454,578 | ||
Fixed maturities, gross unrealized gains | 1,775 | 6,511 | ||
Fixed maturities, gross unrealized losses | -3,956 | -2,021 | ||
Total fixed maturities | 381,197 | 459,068 | ||
U.S. states, municipalities and political subdivisions | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 73,996 | 42,978 | ||
Fixed maturities, gross unrealized gains | 557 | 459 | ||
Fixed maturities, gross unrealized losses | -188 | -317 | ||
Total fixed maturities | 74,365 | 43,120 | ||
Agency residential mortgage-backed securities | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 368,646 | 305,450 | ||
Fixed maturities, gross unrealized gains | 7,877 | 8,310 | ||
Fixed maturities, gross unrealized losses | -1,296 | -2,261 | ||
Total fixed maturities | 375,227 | 311,499 | ||
Non-agency residential mortgage-backed securities | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 17,370 | 16,530 | ||
Fixed maturities, gross unrealized gains | 238 | 143 | ||
Fixed maturities, gross unrealized losses | -409 | -914 | ||
Total fixed maturities | 17,199 | 15,759 | ||
U.S. corporate | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 1,168,304 | 1,328,960 | ||
Fixed maturities, gross unrealized gains | 5,601 | 9,208 | ||
Fixed maturities, gross unrealized losses | -4,987 | -5,684 | ||
Total fixed maturities | 1,168,918 | 1,332,484 | ||
Non-U.S. corporate | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 593,619 | 711,581 | ||
Fixed maturities, gross unrealized gains | 4,071 | 5,917 | ||
Fixed maturities, gross unrealized losses | -3,055 | -3,173 | ||
Total fixed maturities | 594,635 | 714,325 | ||
Bank loans | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 488,904 | 712,859 | ||
Fixed maturities, gross unrealized gains | 616 | 5,659 | ||
Fixed maturities, gross unrealized losses | -5,732 | -1,402 | ||
Total fixed maturities | 483,788 | 717,116 | ||
Catastrophe bonds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 47,574 | 72,000 | ||
Fixed maturities, gross unrealized gains | 1,305 | 2,551 | ||
Fixed maturities, gross unrealized losses | -541 | 0 | ||
Total fixed maturities | 48,338 | 74,551 | ||
Asset-backed securities | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 566,135 | 509,091 | ||
Fixed maturities, gross unrealized gains | 981 | 1,409 | ||
Fixed maturities, gross unrealized losses | -664 | -843 | ||
Total fixed maturities | 566,452 | 509,657 | ||
Commercial mortgage-backed securities | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Fixed maturities, at amortized cost or cost | 174,341 | ' | ||
Fixed maturities, gross unrealized gains | 48 | ' | ||
Fixed maturities, gross unrealized losses | -590 | ' | ||
Total fixed maturities | 173,799 | ' | ||
Fund of hedge funds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Other investments, at amortized cost or cost | 2,802 | 3,141 | ||
Other investments, gross unrealized gains | 162 | 83 | ||
Other investments, gross unrealized losses | -921 | -921 | ||
Total other investments | 2,043 | 2,303 | ||
Hedge funds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Other investments, at amortized cost or cost | 570,372 | [3] | 584,518 | [3] |
Other investments, gross unrealized gains | 101,610 | [3] | 71,641 | [3] |
Other investments, gross unrealized losses | -104,142 | [3] | -95,076 | [3] |
Total other investments | 567,840 | [3] | 561,083 | [3] |
Private equity investments | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Other investments, at amortized cost or cost | 11,295 | 12,333 | ||
Other investments, gross unrealized gains | 3,832 | 1,410 | ||
Other investments, gross unrealized losses | -108 | -258 | ||
Total other investments | 15,019 | 13,485 | ||
Investment funds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Other investments, at amortized cost or cost | 123,840 | 31,537 | ||
Other investments, gross unrealized gains | 350 | 92 | ||
Other investments, gross unrealized losses | 0 | 0 | ||
Total other investments | 124,190 | 31,629 | ||
Mutual funds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Other investments, at amortized cost or cost | 6,199 | 6,199 | ||
Other investments, gross unrealized gains | 3,342 | 3,617 | ||
Other investments, gross unrealized losses | 0 | 0 | ||
Total other investments | $9,541 | $9,816 | ||
PaCRe funds | ' | ' | ||
Amortized cost (or cost), gross unrealized gains and (losses) and estimated fair value of investments | ' | ' | ||
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | 10.00% | ||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | 90.00% | ||
[1] | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||
[2] | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||
[3] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. |
Investments_Fixed_maturities_b
Investments (Fixed maturities by investment rating) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Fixed Maturities | ' | ' |
Estimated fair value | $4,670,173 | $5,542,258 |
Percentage of total | 100.00% | 100.00% |
Investment Grade | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 4,093,498 | 4,764,580 |
Percentage of total | 87.70% | 86.00% |
AAA | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 2,174,861 | 2,510,781 |
Percentage of total | 46.60% | 45.30% |
AA | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 594,858 | 696,998 |
Percentage of total | 12.70% | 12.60% |
A | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 960,153 | 1,233,716 |
Percentage of total | 20.60% | 22.30% |
BBB | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 363,626 | 323,085 |
Percentage of total | 7.80% | 5.80% |
Non Investment Grade | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 576,675 | 777,678 |
Percentage of total | 12.30% | 14.00% |
BB | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 283,954 | 354,992 |
Percentage of total | 6.10% | 6.40% |
B | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 269,380 | 383,639 |
Percentage of total | 5.80% | 6.90% |
CCC | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 1,341 | 2,453 |
Percentage of total | 0.00% | 0.00% |
CC | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 2,330 | 2,496 |
Percentage of total | 0.00% | 0.10% |
C | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | 146 | 235 |
Percentage of total | 0.00% | 0.00% |
D/NR | ' | ' |
Fixed Maturities | ' | ' |
Estimated fair value | $19,524 | $33,863 |
Percentage of total | 0.40% | 0.60% |
Investments_Maturity_profile_o
Investments (Maturity profile of fixed maturity investments) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Maturity profile | ' | ' |
Amortized cost or cost | $4,668,585 | $5,522,853 |
Estimated fair value | 4,670,173 | 5,542,258 |
Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 3,542,093 | 4,691,782 |
Estimated fair value | 3,537,496 | 4,705,343 |
Due in one year or less | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 277,213 | 688,855 |
Estimated fair value | 278,507 | 692,768 |
Due after one year through five years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 2,678,792 | 3,603,459 |
Estimated fair value | 2,679,938 | 3,613,847 |
Due after five years through ten years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 496,922 | 396,389 |
Estimated fair value | 491,364 | 395,633 |
Due after ten years | Fixed maturities trading securities allocated to contractual maturity | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 89,166 | 3,079 |
Estimated fair value | 87,687 | 3,095 |
Asset backed and mortgaged backed securities | No single maturity date | ' | ' |
Maturity profile | ' | ' |
Amortized cost or cost | 1,126,492 | 831,071 |
Estimated fair value | $1,132,677 | $836,915 |
Investments_Components_of_net_
Investments (Components of net investment income) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Net investment income | ' | ' | ' | ' |
Total gross investment income | $27,005 | $22,018 | $75,466 | $77,862 |
Investment expenses | -1,744 | -2,009 | -5,557 | -5,994 |
Net investment income | 25,261 | 20,009 | 69,909 | 71,868 |
Fixed maturities and short term investments | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | 22,544 | 20,936 | 68,048 | 74,618 |
Other investments [Member] | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | 2,879 | 0 | 2,879 | 0 |
Cash and cash equivalents | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | 1,581 | 1,079 | 4,534 | 3,241 |
Securities lending income | ' | ' | ' | ' |
Net investment income | ' | ' | ' | ' |
Total gross investment income | $1 | $3 | $5 | $3 |
Investments_Realized_and_unrea
Investments (Realized and unrealized gains) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | ||||
PaCRe funds | PaCRe funds | |||||||||
Fixed maturities, short-term and other investments and cash equivalents | ' | ' | ' | ' | ' | ' | ||||
Gross realized gains | $8,075 | [1] | $7,706 | [1] | $23,184 | [1] | $25,578 | [1] | ' | ' |
Gross realized (losses) | -3,480 | -14,026 | -6,991 | -26,768 | ' | ' | ||||
Net realized gains (losses) on investments | 4,595 | -6,320 | 16,193 | -1,190 | ' | ' | ||||
Change in net unrealized (losses) gains on investments | -84,974 | [1] | 69,967 | [1] | 16,146 | [1] | -78,618 | [1] | ' | ' |
Total net realized gains (losses) and change in net unrealized (losses) gains on investments including noncontrolling interest | -80,379 | 63,647 | 32,339 | -79,808 | ' | ' | ||||
Noncontrolling interest | 52,595 | [1] | -42,579 | [1] | -22,613 | [1] | 25,766 | [1] | ' | ' |
Total net realized gains (losses) and change in net unrealized (losses) gains on investments excluding noncontrolling interest | ($27,784) | $21,068 | $9,726 | ($54,042) | ' | ' | ||||
Noncontrolling Interest, Ownership Percentage by Parent | ' | ' | ' | ' | 10.00% | 10.00% | ||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | ' | ' | ' | ' | 90.00% | 90.00% | ||||
[1] | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. |
Investments_Investments_pledge
Investments (Investments pledged as collateral) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | $1,605,000 | $1,599,800 |
Letters of credit issued and outstanding | 682,091 | 751,250 |
Investments pledged as collateral | 1,043,338 | 1,246,406 |
$400,000 syndicated unsecured letter of credit facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 400,000 | 400,000 |
Letters of credit issued and outstanding | 0 | 0 |
Investments pledged as collateral | 0 | 0 |
$525,000 syndicated secured letter of credit facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 525,000 | 525,000 |
Letters of credit issued and outstanding | 301,340 | 358,567 |
Investments pledged as collateral | 393,720 | 507,620 |
$200,000 secured bi-lateral letter of credit facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 200,000 | 200,000 |
Letters of credit issued and outstanding | 19,743 | 16,726 |
Investments pledged as collateral | 35,414 | 130,256 |
Talbot FAL Facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 25,000 | 25,000 |
Letters of credit issued and outstanding | 25,000 | 25,000 |
Investments pledged as collateral | 31,054 | 30,801 |
PaCRe Senior secured letter of credit facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 10,000 | 10,000 |
Letters of credit issued and outstanding | 294 | 294 |
Investments pledged as collateral | 0 | 0 |
AlphaCat Re secured letter of credit facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 30,000 | 24,800 |
Letters of credit issued and outstanding | 30,000 | 24,800 |
Investments pledged as collateral | 30,059 | 24,806 |
IPC bi-lateral facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 40,000 | 40,000 |
Letters of credit issued and outstanding | 16,975 | 20,177 |
Investments pledged as collateral | 96,633 | 98,465 |
$375,000 Flagstone bi-lateral facility | ' | ' |
Financial Instruments Owned and Pledged as Collateral [Line Items] | ' | ' |
Credit facility, commitment | 375,000 | 375,000 |
Letters of credit issued and outstanding | 288,739 | 305,686 |
Investments pledged as collateral | $456,458 | $454,458 |
Investments_Narrative_Details
Investments (Narrative) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Schedule of Trading Securities and Other Trading Assets [Line Items] | ' | ' |
Cash, cash equivalents and investments pledged as collateral | $3,035,784 | $2,947,475 |
Investments held in trust | $3,030,932 | $2,942,508 |
AlphaCat ILS Funds | ' | ' |
Schedule of Trading Securities and Other Trading Assets [Line Items] | ' | ' |
Other Investments Number Of Funds | 1 | 2 |
Fair_value_measurements_Fair_v
Fair value measurements (Fair value hierarchy) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | |||
In Thousands, unless otherwise specified | ||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | $4,670,173 | $5,542,258 | ' | |||
Short-term investments, at fair value | 1,684,982 | [1] | 751,778 | [2] | ' | |
Other investments, at fair value | 718,633 | 618,316 | ' | |||
Total | 7,073,788 | 6,912,352 | ' | |||
Noncontrolling interest | -495,365 | [3] | -489,402 | [3] | ' | |
Redeemable noncontrolling interest share of VIE investments | -11,637 | [1] | -18,365 | [2] | ' | |
Total investments excluding noncontrolling interest | 6,566,786 | 6,404,585 | ' | |||
U.S. government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 786,255 | 1,364,679 | ' | |||
Non-US government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 381,197 | 459,068 | ' | |||
U.S. states, municipalities and political subdivisions | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 74,365 | 43,120 | ' | |||
Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 375,227 | 311,499 | ' | |||
Non-Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 17,199 | 15,759 | ' | |||
U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 1,168,918 | 1,332,484 | ' | |||
Non-U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 594,635 | 714,325 | ' | |||
Bank loans | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 483,788 | 717,116 | ' | |||
Catastrophe bonds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 48,338 | 74,551 | ' | |||
Asset-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 566,452 | 509,657 | ' | |||
Commercial mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 173,799 | ' | ' | |||
Fund of hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 2,043 | 2,303 | ' | |||
Hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 567,840 | [3] | 561,083 | [3] | ' | |
Private equity investments | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 15,019 | 13,485 | ' | |||
Investment funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 124,190 | 31,629 | ' | |||
Mutual funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 9,541 | 9,816 | ' | |||
PaCRe funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | 10.00% | ' | |||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | 90.00% | ' | |||
Fair Value, Measurements, Recurring [Member] | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 4,670,173 | 5,542,258 | ' | |||
Short-term investments, at fair value | 1,684,982 | [1],[3] | 751,778 | [2] | ' | |
Other investments, at fair value | 718,633 | 618,316 | ' | |||
Total | 7,073,788 | 6,912,352 | ' | |||
Noncontrolling interest | -495,365 | [3] | -489,402 | [3] | ' | |
Redeemable noncontrolling interest share of VIE investments | -11,637 | [1] | -18,365 | [2] | ' | |
Total investments excluding noncontrolling interest | 6,566,786 | 6,404,585 | ' | |||
Fair Value, Measurements, Recurring [Member] | U.S. government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 786,255 | 1,364,679 | ' | |||
Fair Value, Measurements, Recurring [Member] | Non-US government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 381,197 | 459,068 | ' | |||
Fair Value, Measurements, Recurring [Member] | U.S. states, municipalities and political subdivisions | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 74,365 | 43,120 | ' | |||
Fair Value, Measurements, Recurring [Member] | Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 375,227 | 311,499 | ' | |||
Fair Value, Measurements, Recurring [Member] | Non-Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 17,199 | 15,759 | ' | |||
Fair Value, Measurements, Recurring [Member] | U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 1,168,918 | 1,332,484 | ' | |||
Fair Value, Measurements, Recurring [Member] | Non-U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 594,635 | 714,325 | ' | |||
Fair Value, Measurements, Recurring [Member] | Bank loans | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 483,788 | 717,116 | ' | |||
Fair Value, Measurements, Recurring [Member] | Catastrophe bonds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 48,338 | 74,551 | ' | |||
Fair Value, Measurements, Recurring [Member] | Asset-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 566,452 | 509,657 | ' | |||
Fair Value, Measurements, Recurring [Member] | Commercial mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 173,799 | ' | ' | |||
Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 2,043 | 2,303 | ' | |||
Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 567,840 | [3] | 561,083 | [3] | ' | |
Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 15,019 | 13,485 | ' | |||
Fair Value, Measurements, Recurring [Member] | Investment funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 124,190 | 31,629 | ' | |||
Fair Value, Measurements, Recurring [Member] | Mutual funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 9,541 | 9,816 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Short-term investments, at fair value | 1,671,911 | [1],[3] | 747,215 | [2] | ' | |
Other investments, at fair value | 0 | 0 | ' | |||
Total | 1,671,911 | 747,215 | ' | |||
Noncontrolling interest | 0 | [3] | 0 | [3] | ' | |
Redeemable noncontrolling interest share of VIE investments | -11,637 | [1] | -18,365 | [2] | ' | |
Total investments excluding noncontrolling interest | 1,660,274 | 728,850 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | U.S. government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-US government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | U.S. states, municipalities and political subdivisions | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Non-U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Bank loans | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Catastrophe bonds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Asset-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Commercial mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | ' | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Fund of hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | [3] | 0 | [3] | ' | |
Fair Value, Measurements, Recurring [Member] | Level 1 | Private equity investments | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Investment funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 1 | Mutual funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 4,665,172 | 5,542,258 | ' | |||
Short-term investments, at fair value | 13,071 | [1],[3] | 4,563 | [2] | ' | |
Other investments, at fair value | 30,851 | 41,445 | ' | |||
Total | 4,709,094 | 5,588,266 | ' | |||
Noncontrolling interest | 0 | [3] | 0 | [3] | ' | |
Redeemable noncontrolling interest share of VIE investments | 0 | [1] | 0 | [2] | ' | |
Total investments excluding noncontrolling interest | 4,709,094 | 5,588,266 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | U.S. government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 786,255 | 1,364,679 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-US government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 381,197 | 459,068 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | U.S. states, municipalities and political subdivisions | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 74,365 | 43,120 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 375,227 | 311,499 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 17,199 | 15,759 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 1,168,918 | 1,332,484 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Non-U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 594,635 | 714,325 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Bank loans | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 483,788 | 717,116 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Catastrophe bonds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 43,337 | 74,551 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Asset-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 566,452 | 509,657 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Commercial mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 173,799 | ' | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Fund of hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | [3] | 0 | [3] | ' | |
Fair Value, Measurements, Recurring [Member] | Level 2 | Private equity investments | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Investment funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 21,310 | 31,629 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 2 | Mutual funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 9,541 | 9,816 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 5,001 | 0 | ' | |||
Short-term investments, at fair value | 0 | [1],[3] | 0 | [2] | ' | |
Other investments, at fair value | 687,782 | 576,871 | ' | |||
Total | 692,783 | 576,871 | ' | |||
Noncontrolling interest | -495,365 | [3],[4] | -489,402 | [3] | -465,472 | [4] |
Redeemable noncontrolling interest share of VIE investments | 0 | [1] | 0 | [2] | ' | |
Total investments excluding noncontrolling interest | 197,418 | 87,469 | ' | |||
Percentage Of Fair Value Assets Measured On Recurring Basis | 3.00% | 1.40% | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | U.S. government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-US government and government agency | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | U.S. states, municipalities and political subdivisions | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-Agency residential mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Non-U.S. corporate | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Bank loans | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Catastrophe bonds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 5,001 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Asset-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Commercial mortgage-backed securities | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Fixed maturities, at fair value | 0 | ' | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Fund of hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 2,043 | 2,303 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Hedge funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 567,840 | [3] | 561,083 | [3] | ' | |
Fair Value, Measurements, Recurring [Member] | Level 3 | Private equity investments | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 15,019 | 13,485 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Investment funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | 102,880 | 0 | ' | |||
Fair Value, Measurements, Recurring [Member] | Level 3 | Mutual funds | ' | ' | ' | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | |||
Other investments, at fair value | $0 | $0 | ' | |||
[1] | Included in the short-term investments balance are investments held by one AlphaCat ILS fund which is consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||
[2] | Included in the short-term investments balance are investments held by two AlphaCat ILS funds which are consolidated by the Company but in which the Company has an equity interest of less than 100%. The remaining interests are held by third party investors and included in the Consolidated Balance Sheets as redeemable noncontrolling interest. | |||||
[3] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||
[4] | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. |
Fair_value_measurements_Level_
Fair value measurements (Level 3 rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | |||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ' | ' | ' | ' | ' | |||||
Noncontrolling interest | ($495,365) | [1] | ' | ($495,365) | [1] | ' | ($489,402) | [1] | ||
Fair Value, Measurements, Recurring [Member] | ' | ' | ' | ' | ' | |||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ' | ' | ' | ' | ' | |||||
Noncontrolling interest | -495,365 | [1] | ' | -495,365 | [1] | ' | -489,402 | [1] | ||
Level 3 | Fair Value, Measurements, Recurring [Member] | ' | ' | ' | ' | ' | |||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ' | ' | ' | ' | ' | |||||
Level 3 investments - beginning of period | 746,396 | 505,158 | 576,871 | 556,234 | ' | |||||
Purchases | 25,784 | 33,154 | 125,784 | 98,669 | ' | |||||
Sales | -24,175 | -35,264 | -49,508 | -80,095 | ' | |||||
Settlements | 0 | 0 | -1,500 | 0 | ' | |||||
Realized gains | 2,554 | 4,503 | 8,198 | 4,843 | ' | |||||
Unrealized losses | -57,776 | 42,917 | 26,235 | -29,183 | ' | |||||
Transfers | 0 | 0 | 6,703 | 0 | ' | |||||
Level 3 investments - end of period | 692,783 | 550,468 | 692,783 | 550,468 | ' | |||||
Noncontrolling interest | -495,365 | [1],[2] | -465,472 | [2] | -495,365 | [1],[2] | -465,472 | [2] | -489,402 | [1] |
Investments excluding noncontrolling interest level three rollforward | $197,418 | $84,996 | $197,418 | $84,996 | ' | |||||
PaCRe funds | ' | ' | ' | ' | ' | |||||
Reconciliation of beginning and ending balances for all investments measured at fair value on recurring basis | ' | ' | ' | ' | ' | |||||
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | ' | 10.00% | ' | 10.00% | |||||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | ' | 90.00% | ' | 90.00% | |||||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. | |||||||||
[2] | Includes Level 3 investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. |
Fair_value_measurements_Narrat
Fair value measurements (Narrative) (Details) (USD $) | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | $718,633 | $618,316 | ||
Mutual funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 9,541 | 9,816 | ||
Other Investments Number Of Funds | 2 | ' | ||
Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 567,840 | [1] | 561,083 | [1] |
Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 2,043 | 2,303 | ||
Investment Time Lag Reporting | '1 month | ' | ||
Investments assumed in Flagstone acquisition | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '3 months | ' | ||
Other Investments Number Of Funds | 1 | ' | ||
PaCRe funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Noncontrolling Interest, Ownership Percentage by Parent | 10.00% | 10.00% | ||
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | 90.00% | 90.00% | ||
Investment Time Lag Reporting | '1 month | ' | ||
Other Investments Number Of Funds | 5 | ' | ||
Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 124,190 | 31,629 | ||
Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 15,019 | 13,485 | ||
Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 718,633 | 618,316 | ||
Fair Value, Measurements, Recurring [Member] | Mutual funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 9,541 | 9,816 | ||
Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 567,840 | [1] | 561,083 | [1] |
Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 2,043 | 2,303 | ||
Fair Value, Measurements, Recurring [Member] | Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 124,190 | 31,629 | ||
Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 15,019 | 13,485 | ||
Minimum [Member] | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '3 months | ' | ||
Maximum | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '6 months | ' | ||
Fair Value, Inputs, Level 2 [Member] | Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other Investments Number Of Funds | 1 | ' | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 30,851 | 41,445 | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Mutual funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 9,541 | 9,816 | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | [1] | 0 | [1] |
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 21,310 | 31,629 | ||
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Investment Time Lag Reporting | '1 month | ' | ||
Other Investments Number Of Funds | 1 | ' | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 687,782 | 576,871 | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Mutual funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 0 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 567,840 | [1] | 561,083 | [1] |
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Fund of hedge funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 2,043 | 2,303 | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Investment funds | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | 102,880 | 0 | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Private equity investments | ' | ' | ||
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | ' | ' | ||
Other investments, at fair value | $15,019 | $13,485 | ||
[1] | Included in the hedge funds balance are investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and included in the Consolidated Balance Sheets as noncontrolling interest. |
Investments_in_affiliates_Summ
Investments in affiliates (Summary of investments in affiliates) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Schedule of Equity Method Investments [Line Items] | ' | ' |
Investments in affiliates | $217,612 | $141,243 |
Investment affiliate | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' |
Investments in affiliates | 42,381 | 34,500 |
Operating affiliates | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' |
Investments in affiliates | $175,231 | $106,743 |
Investments_in_affiliates_Inve
Investments in affiliates (Investment affiliate rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Income from investment affiliate | $1,754 | $1,044 | $7,881 | $4,274 |
Investment affiliate | Aquiline Financial Services Fund II LP | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Balance, beginning of period | 40,627 | 25,352 | 34,500 | 15,218 |
Capital contributions | 0 | 6,185 | 0 | 13,089 |
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 |
Balance, end of period | $42,381 | $32,581 | $42,381 | $32,581 |
Investments_in_affiliates_Inve1
Investments in affiliates (Investment affiliate details) (Details) (Investment affiliate, Aquiline Financial Services Fund II LP, USD $) | Sep. 30, 2014 | Jun. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||||||
Investment affiliate | Aquiline Financial Services Fund II LP | ' | ' | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' |
Investment at cost | $32,110 | ' | $32,110 | ' | ' | ' |
Voting ownership % | 0.00% | ' | 0.00% | ' | ' | ' |
Equity ownership % | 6.70% | ' | 6.70% | ' | ' | ' |
Carrying value | $42,381 | $40,627 | $34,500 | $32,581 | $25,352 | $15,218 |
Investments_in_affiliates_Oper
Investments in affiliates (Operating affiliates rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Income from operating affiliates | $3,761 | $1,463 | $13,580 | $8,779 | ||
Operating affiliates | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 172,992 | 85,120 | 106,743 | 157,111 | ||
Return of investment | -1,522 | -7,350 | -58,547 | -86,657 | ||
Fair value of retained interest on deconsolidation of AlphaCat ILS fund | ' | ' | 113,455 | ' | ||
Income from operating affiliates | 3,761 | 1,463 | 13,580 | 8,779 | ||
Balance, end of period | 175,231 | 79,233 | 175,231 | 79,233 | ||
Operating affiliates | AlphaCat Re 2011 | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 4,172 | 11,054 | 9,809 | 62,792 | ||
Return of investment | 0 | -2,800 | -5,825 | -54,914 | ||
Income from operating affiliates | -5 | -270 | 183 | 106 | ||
Balance, end of period | 4,167 | 7,984 | 4,167 | 7,984 | ||
Operating affiliates | AlphaCat Re 2012 | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 2,204 | 5,204 | 1,313 | 29,319 | ||
Return of investment | -1,516 | -4,550 | -1,516 | -31,743 | ||
Income from operating affiliates | -9 | -7 | 882 | 3,071 | ||
Balance, end of period | 679 | 647 | 679 | 647 | ||
Operating affiliates | AlphaCat 2013 | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 2,580 | 48,536 | 51,744 | 45,000 | ||
Return of investment | -6 | 0 | -51,206 | 0 | ||
Income from operating affiliates | 7 | 585 | 2,043 | 4,121 | ||
Balance, end of period | 2,581 | 49,121 | 2,581 | 49,121 | ||
Operating affiliates | AlphaCat 2014 | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 25,014 | ' | 21,982 | ' | ||
Return of investment | 0 | ' | 0 | ' | ||
Income from operating affiliates | 1,367 | ' | 4,399 | ' | ||
Balance, end of period | 26,381 | ' | 26,381 | ' | ||
Operating affiliates | AlphaCat ILS Funds | ' | ' | ' | ' | ||
Activity in non-consolidated affiliate balances for the period: | ' | ' | ' | ' | ||
Balance, beginning of period | 139,022 | 20,326 | 21,895 | 20,000 | ||
Return of investment | 0 | 0 | 0 | 0 | ||
Fair value of retained interest on deconsolidation of AlphaCat ILS fund | ' | ' | 113,455 | ' | ||
Income from operating affiliates | 2,401 | 1,155 | 6,073 | 1,481 | ||
Balance, end of period | $141,423 | [1] | $21,481 | $141,423 | [1] | $21,481 |
[1] | Equity ownership in the two funds were 7.9% and 49.0% respectively as at September 30, 2014. |
Investments_in_affiliates_Oper1
Investments in affiliates (Operating affiliates details) (Details) (Operating affiliates, USD $) | Sep. 30, 2014 | Jun. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Dec. 31, 2012 | |
In Thousands, unless otherwise specified | |||||||
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | $162,882 | ' | $97,536 | ' | ' | ' | |
Carrying value | 175,231 | 172,992 | 106,743 | 79,233 | 85,120 | 157,111 | |
AlphaCat Re 2011 | ' | ' | ' | ' | ' | ' | |
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | 4,167 | ' | 9,882 | ' | ' | ' | |
Voting ownership % | 43.70% | ' | 43.70% | ' | ' | ' | |
Equity ownership % | 22.30% | ' | 22.30% | ' | ' | ' | |
Carrying value | 4,167 | 4,172 | 9,809 | 7,984 | 11,054 | 62,792 | |
AlphaCat Re 2012 | ' | ' | ' | ' | ' | ' | |
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | 679 | ' | 654 | ' | ' | ' | |
Voting ownership % | 49.00% | ' | 49.00% | ' | ' | ' | |
Equity ownership % | 37.90% | ' | 37.90% | ' | ' | ' | |
Carrying value | 679 | 2,204 | 1,313 | 647 | 5,204 | 29,319 | |
AlphaCat 2013 | ' | ' | ' | ' | ' | ' | |
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | 2,581 | ' | 45,000 | ' | ' | ' | |
Voting ownership % | 40.90% | ' | 40.90% | ' | ' | ' | |
Equity ownership % | 19.70% | ' | 19.70% | ' | ' | ' | |
Carrying value | 2,581 | 2,580 | 51,744 | 49,121 | 48,536 | 45,000 | |
AlphaCat 2014 | ' | ' | ' | ' | ' | ' | |
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | 22,000 | ' | 22,000 | ' | ' | ' | |
Voting ownership % | 42.30% | ' | 42.30% | ' | ' | ' | |
Equity ownership % | 19.60% | ' | 19.60% | ' | ' | ' | |
Carrying value | 26,381 | 25,014 | 21,982 | ' | ' | ' | |
AlphaCat ILS Funds | ' | ' | ' | ' | ' | ' | |
Investment: | ' | ' | ' | ' | ' | ' | |
Investment at cost | 133,455 | [1] | ' | 20,000 | ' | ' | ' |
Equity ownership % | ' | ' | 9.10% | ' | ' | ' | |
Carrying value | $141,423 | [1] | $139,022 | $21,895 | $21,481 | $20,326 | $20,000 |
[1] | Equity ownership in the two funds were 7.9% and 49.0% respectively as at September 30, 2014. |
Investments_in_affiliates_Note
Investments in affiliates (Notes payable and (income) attributable to operating affiliates) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Variable Funding Notes, Typical Minimum Duration | ' | ' | '12 months | ' |
Notes payable to operating affiliates, beginning of period | ' | ' | $439,272 | ' |
Redemption of notes payable to operating affiliates | ' | -3,553 | ' | -3,553 |
Notes payable to operating affiliates, end of period | 655,976 | ' | 655,976 | ' |
Variable interest entity, not primary beneficiary | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Notes payable to operating affiliates, beginning of period | 622,950 | 431,093 | 439,272 | 0 |
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | ' | ' | 178,837 | ' |
Issuance of notes payable to operating affiliates | 53,498 | 6,733 | 645,243 | 441,126 |
Redemption of notes payable to operating affiliates | -13,990 | ' | -602,068 | ' |
Foreign exchange gain (loss) | -6,482 | 3,697 | -5,308 | 397 |
Notes payable to operating affiliates, end of period | 655,976 | 437,970 | 655,976 | 437,970 |
Variable interest entity, not primary beneficiary | AlphaCat 2013 | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Notes payable to operating affiliates, beginning of period | 0 | 222,135 | 223,809 | 0 |
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | ' | ' | 0 | ' |
Issuance of notes payable to operating affiliates | 0 | 0 | 0 | 223,082 |
Redemption of notes payable to operating affiliates | 0 | 0 | -223,512 | 0 |
Foreign exchange gain (loss) | 0 | 1,196 | -297 | 249 |
Notes payable to operating affiliates, end of period | 0 | 223,331 | 0 | 223,331 |
Variable interest entity, not primary beneficiary | AlphaCat 2014 | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Notes payable to operating affiliates, beginning of period | 157,992 | ' | 0 | ' |
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | ' | ' | 0 | ' |
Issuance of notes payable to operating affiliates | 0 | ' | 157,914 | ' |
Redemption of notes payable to operating affiliates | 0 | ' | 0 | ' |
Foreign exchange gain (loss) | -410 | ' | -332 | ' |
Notes payable to operating affiliates, end of period | 157,582 | ' | 157,582 | ' |
Variable interest entity, not primary beneficiary | AlphaCat ILS Funds | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
Notes payable to operating affiliates, beginning of period | 464,958 | 208,958 | 215,463 | 0 |
Notes payable to operating affiliates recognized on deconsolidation of AlphaCat ILS fund | ' | ' | 178,837 | ' |
Issuance of notes payable to operating affiliates | 53,498 | 6,733 | 487,329 | 218,044 |
Redemption of notes payable to operating affiliates | -13,990 | -3,553 | -378,556 | -3,553 |
Foreign exchange gain (loss) | -6,072 | 2,501 | -4,679 | 148 |
Notes payable to operating affiliates, end of period | $498,394 | $214,639 | $498,394 | $214,639 |
Investments_in_affiliates_Inco
Investments in affiliates (Income attributable to operating affiliates) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
(Income) attributable to operating affiliate investors | ($25,807) | ($11,815) | ($82,833) | ($42,156) |
Variable interest entity, not primary beneficiary | AlphaCat 2013 | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
(Income) attributable to operating affiliate investors | -98 | -4,074 | -14,218 | -29,357 |
Variable interest entity, not primary beneficiary | AlphaCat 2014 | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
(Income) attributable to operating affiliate investors | -11,309 | 0 | -32,990 | 0 |
Variable interest entity, not primary beneficiary | AlphaCat ILS Funds | ' | ' | ' | ' |
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' |
(Income) attributable to operating affiliate investors | ($14,400) | ($7,741) | ($35,625) | ($12,799) |
Investments_in_affiliates_Narr
Investments in affiliates (Narrative) (Details) (USD $) | 3 Months Ended | 9 Months Ended | 0 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Jan. 31, 2014 | Dec. 20, 2011 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 |
AlphaCat ILS Funds | AlphaCat ILS Funds | Aquiline Financial Services Fund II LP | Aquiline Financial Services Fund II LP | Operating affiliates | Operating affiliates | Operating affiliates | Operating affiliates | Operating affiliates | Operating affiliates | Operating affiliates | As investor in third party economic interests | As investor in third party economic interests | As investor in third party economic interests | As investor in third party economic interests | As investor in third party economic interests | Equity Method Investments [Member] | Equity Method Investments [Member] | Equity Method Investments [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | ||||
funds | AlphaCat ILS Funds | AlphaCat ILS Funds | AlphaCat ILS Funds | AlphaCat ILS Funds | Operating affiliates | AlphaCat ILS Funds | Operating affiliates | |||||||||||||||||
funds | funds | AlphaCat ILS Funds | funds | AlphaCat ILS Funds | ||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of Assignor's interest assumed | ' | ' | ' | ' | ' | 100.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total capital commitment | ' | ' | ' | ' | ' | $50,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Investment Time Lag Reporting | ' | ' | ' | ' | ' | ' | '3 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other Investments Number Of Funds | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2 | 1 | ' | 1 | ' |
Third party subscriptions | ' | ' | ' | ' | 35,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Threshold Minimum Consolidation Requirement Percentage | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value of retained interest on deconsolidation of AlphaCat ILS fund | ' | ' | ' | ' | ' | ' | ' | ' | ' | 113,455 | ' | ' | 113,455 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deconsolidation, Gain (Loss), Amount | ' | 1,372 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity ownership % | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.10% | ' | ' | ' | ' | ' | ' | ' | 7.90% | ' | 49.00% |
Variable Interest Entity Redemption Of Notes Payable To Operating Affiliates | 3,553 | ' | 3,553 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Variable Funding Notes, Typical Minimum Duration | ' | '12 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Notes Payable Of Operating Affiliates Portion Due to Company | ' | ' | ' | ' | ' | ' | ' | 164,169 | ' | 164,169 | ' | 63,654 | ' | ' | 491,807 | ' | 491,807 | ' | 375,618 | ' | ' | ' | ' | ' |
Income Attributable To Operating Affiliates Portion Due to Company | ' | ' | ' | ' | ' | ' | ' | $4,993 | $1,505 | $16,552 | $7,114 | ' | ' | ' | $20,814 | $10,310 | $66,281 | $35,042 | ' | ' | ' | ' | ' | ' |
Noncontrolling_interest_Detail
Noncontrolling interest (Details) (USD $) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
PaCRe funds | PaCRe funds | AlphaCat ILS Funds | AlphaCat ILS Funds | Redeemable noncontrolling interest | Redeemable noncontrolling interest | Redeemable noncontrolling interest | Redeemable noncontrolling interest | Noncontrolling interest | Noncontrolling interest | Noncontrolling interest | Noncontrolling interest | |||||
funds | funds | funds | ||||||||||||||
Noncontrolling Interest [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other Investments Number Of Funds | ' | ' | ' | ' | 5 | ' | 1 | 2 | ' | ' | ' | ' | ' | ' | ' | ' |
Noncontrolling Interest, Ownership Percentage by Parent | ' | ' | ' | ' | 10.00% | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | ' | ' | ' | ' | 90.00% | 90.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Redeemable noncontrolling interest and noncontrolling interest, rollforward: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Redeemable noncontrolling interest and noncontrolling interest, beginning of period | $641,629 | $498,445 | $584,169 | $434,280 | ' | ' | ' | ' | $66,282 | $70,690 | $86,512 | $0 | $575,347 | $427,755 | $497,657 | $434,280 |
Issuance of shares | 4,200 | 13,000 | 61,200 | 140,690 | ' | ' | ' | ' | 4,200 | 13,000 | 61,200 | 82,190 | 0 | 0 | 0 | 58,500 |
Income (loss) attributable to noncontrolling interest | -53,069 | 45,694 | 25,745 | -17,831 | ' | ' | ' | ' | -9 | 1,516 | 1,115 | 3,016 | -53,060 | 44,178 | 24,630 | -20,847 |
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests | ' | 10,207 | ' | 10,207 | ' | ' | ' | ' | ' | 10,207 | ' | 10,207 | ' | 0 | ' | 0 |
Noncontrolling Interest, Decrease from Deconsolidation | ' | ' | 78,354 | ' | ' | ' | ' | ' | ' | ' | 78,354 | ' | ' | ' | 0 | ' |
Redeemable noncontrolling interest and noncontrolling interest, end of period | $592,760 | $546,932 | $592,760 | $546,932 | ' | ' | ' | ' | $70,473 | $74,999 | $70,473 | $74,999 | $522,287 | $471,933 | $522,287 | $471,933 |
Derivative_instruments_Amount_
Derivative instruments (Amount and balance sheet location) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Thousands, unless otherwise specified | ||||
Designated as hedging instruments | Foreign exchange contracts | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Net Notional Exposure | $246,638 | $163,576 | ||
Designated as hedging instruments | Foreign exchange contracts | Other assets | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Asset Derivative at Fair Value | 592 | [1] | 1,167 | [1] |
Designated as hedging instruments | Foreign exchange contracts | Accounts payable and accrued expenses | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Liability Derivative at Fair Value | 16,672 | [1] | 2,313 | [1] |
Designated as hedging instruments | Interest rate swap contracts | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Net Notional Exposure | 552,263 | 552,263 | ||
Designated as hedging instruments | Interest rate swap contracts | Other assets | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Asset Derivative at Fair Value | 25 | [1] | 28 | [1] |
Designated as hedging instruments | Interest rate swap contracts | Accounts payable and accrued expenses | ' | ' | ||
Summary of amount of derivatives designated as hedging instruments | ' | ' | ||
Liability Derivative at Fair Value | $912 | [1] | $911 | [1] |
Junior Subordinated Deferrable Debentures | Interest rate swap contracts | ' | ' | ||
Derivatives, Fair Value [Line Items] | ' | ' | ||
Derivative, Number of Instruments Held | 2 | ' | ||
Flagstone Junior Subordinated Deferrable Debentures | Interest rate swap contracts | ' | ' | ||
Derivatives, Fair Value [Line Items] | ' | ' | ||
Derivative, Number of Instruments Held | 3 | ' | ||
Flagstone Junior Subordinated Deferrable Debentures | Cross-currency interest rate swap | ' | ' | ||
Derivatives, Fair Value [Line Items] | ' | ' | ||
Derivative, Number of Instruments Held | 1 | ' | ||
[1] | Asset and liability derivatives are classified within other assets and accounts payable and accrued expenses respectively on the Consolidated Balance Sheets. |
Derivative_instruments_Amount_1
Derivative instruments (Amount included in statement of operations) (Details) (Designated as hedging instruments, USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Fair value hedge | Foreign exchange contracts | Foreign exchange gains (losses) | ' | ' | ' | ' |
Derivatives designated as fair value hedges and related hedged item | ' | ' | ' | ' |
Amount of gain (loss) recognized in income on derivative | ($14,817) | $3,116 | ($9,979) | $2,670 |
Amount of (loss) gain on hedged item recognized in income attributable to risk being hedged | 14,817 | -3,116 | 9,979 | -2,670 |
Amount of gain (loss) recognized in income on derivative (ineffective portion) | 0 | 0 | 0 | 0 |
Cash flow hedge | Interest rate swap contracts | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of ineffective portion excluded from effectiveness testing | 0 | 0 | 0 | 0 |
Cash flow hedge | Interest rate swap contracts | Other comprehensive income | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of effective portion recognized in other comprehensive income | 3,302 | 3,268 | 9,762 | 7,838 |
Cash flow hedge | Interest rate swap contracts | Finance expenses | ' | ' | ' | ' |
Derivative instruments designated as a cash flow hedge | ' | ' | ' | ' |
Amount of effective portion subsequently reclassified to earnings | ($3,302) | ($3,268) | ($9,762) | ($7,838) |
Reserve_for_losses_and_loss_ex2
Reserve for losses and loss expenses (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Reserve for paid losses and unpaid loss expenses | ' | ' | ' | ' |
Reserve for losses and loss expenses, beginning of period | $2,867,307 | $3,283,450 | $3,030,399 | $3,517,573 |
Losses and loss expenses recoverable, beginning of period | -338,734 | -418,693 | -370,154 | -439,967 |
Net reserves for losses and loss expenses, beginning of period | 2,528,573 | 2,864,757 | 2,660,245 | 3,077,606 |
Net reserves disposed | 0 | 0 | 0 | -18,591 |
Increase (decrease) in net losses and loss expenses incurred in respect of losses occurring in: | ' | ' | ' | ' |
Current year | 279,690 | 243,015 | 713,177 | 759,617 |
Prior years | -55,565 | -65,050 | -167,636 | -171,837 |
Total incurred losses and loss expenses | 224,125 | 177,965 | 545,541 | 587,780 |
Less net losses and loss expenses paid in respect of losses occurring in: | ' | ' | ' | ' |
Current year | -74,618 | -59,701 | -99,326 | -95,535 |
Prior years | -183,697 | -215,167 | -633,048 | -732,118 |
Total net paid losses | -258,315 | -274,868 | -732,374 | -827,653 |
Foreign exchange | -40,717 | 34,363 | -19,746 | -16,925 |
Net reserve for losses and loss expenses, end of period | 2,453,666 | 2,802,217 | 2,453,666 | 2,802,217 |
Losses and loss expenses recoverable, end of period | 298,502 | 421,518 | 298,502 | 421,518 |
Reserve for losses and loss expenses, end of period | 2,752,168 | 3,223,735 | 2,752,168 | 3,223,735 |
Components of incurred losses and loss expenses | ' | ' | ' | ' |
Gross losses and loss expenses | 222,356 | 226,130 | 587,111 | 684,080 |
Reinsurance recoverable | 1,769 | -48,165 | -41,570 | -96,300 |
Net incurred losses and loss expenses | $224,125 | $177,965 | $545,541 | $587,780 |
Reinsurance_Details
Reinsurance (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | $361,493 | $450,234 |
Percentage of reinsurance recoverables | 100.00% | 100.00% |
Reinsurance (Textuals) [Abstract] | ' | ' |
Incurred but not reported recoverable | 144,414 | 196,840 |
Provision for uncollectible reinsurance relating to losses recoverable | 5,380 | 5,794 |
A- or better | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Percentage of reinsurance recoverables | 97.30% | 96.70% |
Top 10 reinsurers | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 264,131 | 340,253 |
Percentage of reinsurance recoverables | 73.10% | 75.60% |
Top 10 reinsurers | Lloyd's Syndicates | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 60,218 | 73,398 |
Percentage of reinsurance recoverables | 16.70% | 16.30% |
Top 10 reinsurers | National Indemnity | AA plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | ' | 51,037 |
Percentage of reinsurance recoverables | ' | 11.30% |
Top 10 reinsurers | Everest Re | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 46,765 | 48,055 |
Percentage of reinsurance recoverables | 12.90% | 10.70% |
Top 10 reinsurers | Third Point Re | A- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 34,180 | 30,428 |
Percentage of reinsurance recoverables | 9.50% | 6.80% |
Top 10 reinsurers | Fully Collateralized | NR | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 33,770 | 36,683 |
Percentage of reinsurance recoverables | 9.30% | 8.10% |
Top 10 reinsurers | Hannover Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 33,124 | 41,483 |
Percentage of reinsurance recoverables | 9.20% | 9.20% |
Top 10 reinsurers | Swiss Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 13,849 | 20,022 |
Percentage of reinsurance recoverables | 3.80% | 4.50% |
Top 10 reinsurers | Transatlantic Re | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 11,649 | 14,114 |
Percentage of reinsurance recoverables | 3.20% | 3.10% |
Top 10 reinsurers | XL Re | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 10,334 | 12,673 |
Percentage of reinsurance recoverables | 2.90% | 2.80% |
Top 10 reinsurers | Munich Re | AA- | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 10,232 | 12,360 |
Percentage of reinsurance recoverables | 2.80% | 2.80% |
Top 10 reinsurers | Aioi Nissay Dowa Insurance | A plus | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 10,010 | ' |
Percentage of reinsurance recoverables | 2.80% | ' |
Other reinsurers' balances greater than $1 million | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | 89,584 | 100,784 |
Percentage of reinsurance recoverables | 24.80% | 22.40% |
Other reinsurers' balances less than $1 million | ' | ' |
Ceded Credit Risk [Line Items] | ' | ' |
Reinsurance recoverable | $7,778 | $9,197 |
Percentage of reinsurance recoverables | 2.10% | 2.00% |
Share_capital_Details
Share capital (Details) (USD $) | 0 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||||||||||
In Thousands, except Share data, unless otherwise specified | Feb. 05, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Mar. 31, 2013 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Mar. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 |
Common shares | Common shares | Common shares | Common shares | Common shares | Common shares | Common shares | Common share equivalents | Common share equivalents | Common share equivalents | Common share equivalents | Performance shares | Performance shares | Warrants | Warrants | Deferred share units | Restricted share awards | Restricted share awards | Restricted share units | Restricted share units | Employee director | |||||||
Special dividend declared | Special dividend declared | Deferred share units | |||||||||||||||||||||||||
Share Capital (Narrative) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, shares authorized | ' | 571,428,571 | ' | 571,428,571 | ' | 571,428,571 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, par value | ' | $0.18 | ' | $0.18 | ' | $0.18 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock voting rights | ' | ' | ' | 'one vote per share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restriction on percentage of voting power | ' | ' | ' | 9.09% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share repurchases | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Repurchase Program, Authorized Amount | $500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share repurchase program, cumulative shares repurchased | ' | ' | ' | 64,502,410 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares repurchased, cumulative | 1,774,436 | ' | ' | 2,006,875 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Remaining share repurchase authorization amount | ' | ' | ' | $267,561 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of warrants exercised during period | ' | ' | ' | ' | 1,114,416 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,174,114 | 5,296,056 | ' | ' | ' | ' | ' | ' |
Deferred share units, adjustment factor | ' | ' | ' | 100.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total outstanding deferred share units | ' | 0 | ' | 0 | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 32,746 | 39,094 | ' | ' | ' | 769,971 | 930,296 | 18,325 | 21,814 | 5,039 |
Cash dividends declared per share | ' | $0.30 | $0.30 | $0.90 | $2.90 | ' | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $2 | $0.30 | $0.30 | $0.30 | $2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Summary of common shares issued and outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares issued, beginning balance | ' | ' | ' | 154,488,497 | 152,698,191 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested, net of shares withheld | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25,767 | 31,897 | ' | ' | ' | 594,582 | 768,889 | 10,265 | 14,381 | ' |
Options exercised (in shares) | ' | ' | ' | 133,385 | 277,615 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrants exercised | ' | ' | ' | ' | 591,480 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Direct issuance of common stock | ' | ' | ' | 1,060 | 928 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred share units vested, net of shares withheld | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,935 | ' | ' | ' | ' | 2,935 |
Common shares issued, ending balance | ' | 155,253,556 | 154,386,316 | 155,253,556 | 154,386,316 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares repurchased, ending balance | ' | -66,141,285 | -54,488,320 | -66,141,285 | -54,488,320 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares outstanding, ending balance | ' | 89,112,271 | 99,897,996 | 89,112,271 | 99,897,996 | 96,044,312 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock_plans_Options_activity_D
Stock plans (Options activity) (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Options activities: | ' | ' |
Options outstanding, beginning balance (in shares) | 1,572,713 | 1,823,947 |
Options regranted (modified) (in shares) | ' | 1,833,414 |
Options exercised (in shares) | -133,385 | -277,615 |
Options cancelled (modified) (in shares) | ' | -1,733,139 |
Options outstanding, ending balance (in shares) | 1,439,328 | 1,646,607 |
Weighted Average Grant Date Fair Value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $6.66 | $6.52 |
Weighted average grant date fair value, options regranted (modified) (in dollars per share) | ' | $6.76 |
Weighted average grant date fair value, options exercised (in dollars per share) | $3.81 | $5.24 |
Weighted average grant date fair value, options cancelled (modified) (in dollars per share) | ' | $6.76 |
Weighted average grant date fair value, ending balance (in dollars per share) | $6.93 | $6.75 |
Weighted Average Grant Date Exercise Price | ' | ' |
Weighted average grant date exercise price, beginning balance (in dollars per share) | $18.88 | $20.69 |
Weighted average grant date exercise price, options regranted (modified) (in dollars per share) | ' | $19.02 |
Weighted average grant date exercise price, options exercised (in dollars per share) | $25.10 | $23.58 |
Weighted average grant date exercise price, options cancelled (modified) (in dollars per share) | ' | $20.12 |
Weighted average grant date exercise price, ending balance (in dollars per share) | $18.30 | $18.94 |
Stock_plans_Other_awards_activ
Stock plans (Other awards activity) (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2014 | Sep. 30, 2013 | |
Restricted share awards | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 2,684,745 | 2,170,547 |
Granted (in shares) | 925,610 | 1,580,117 |
Vested (in shares) | -769,971 | -930,296 |
Forfeited (in shares) | -69,117 | -110,912 |
Ending balance (in shares) | 2,771,267 | 2,709,456 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $33.74 | $29.24 |
Weighted average grant date fair value, granted (in dollars per share) | $37.33 | $36.06 |
Weighted average grant date fair value, vested (in dollars per share) | $31.47 | $28.08 |
Weighted average grant date fair value, forfeited (in dollars per share) | $36.28 | $28.34 |
Weighted average grant date fair value, ending balance (in dollars per share) | $35.50 | $33.65 |
Restricted share units | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 66,518 | 47,238 |
Granted (in shares) | 53,025 | 36,635 |
Vested (in shares) | -18,325 | -21,814 |
Issued in lieu of cash dividends (in shares) | 1,479 | 3,924 |
Ending balance (in shares) | 102,697 | 65,983 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $33.74 | $29.61 |
Weighted average grant date fair value, granted (in dollars per share) | $38.10 | $36.11 |
Weighted average grant date fair value, vested (in dollars per share) | $30.71 | $28.17 |
Weighted average grant date fair value, issued in lieu of cash dividends (in dollars per share) | $34.19 | $30.29 |
Weighted average grant date fair value, ending balance (in dollars per share) | $36.54 | $33.74 |
Performance shares | ' | ' |
Activities | ' | ' |
Beginning balance (in shares) | 101,820 | 220,845 |
Granted (in shares) | 52,639 | 38,386 |
Vested (in shares) | -32,746 | -39,094 |
Forfeited (in shares) | ' | -18,701 |
Conversion adjustment (in shares) | -15,344 | -99,616 |
Ending balance (in shares) | 106,369 | 101,820 |
Weighted average grant date fair value | ' | ' |
Weighted average grant date fair value, beginning balance (in dollars per share) | $33.56 | $31.81 |
Weighted average grant date fair value, granted (in dollars per share) | $37.33 | $36.11 |
Weighted average grant date fair value, vested (in dollars per share) | $32.62 | $28.70 |
Weighted average grant date fair value, forfeited (in dollars per share) | ' | $31.05 |
Weighted average grant date fair value, conversion adjustment (in dollars per share) | $31.38 | $33.05 |
Weighted average grant date fair value, ending balance (in dollars per share) | $36.03 | $33.56 |
Stock_plans_Components_of_shar
Stock plans (Components of share compensation expenses) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | $8,764 | $10,527 | $24,252 | $19,483 |
Restricted share awards | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | 8,180 | 10,041 | 23,101 | 20,035 |
Restricted share units | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | 269 | 168 | 602 | 419 |
Performance shares | ' | ' | ' | ' |
Total share compensation expenses | ' | ' | ' | ' |
Share compensation expenses | $315 | $318 | $549 | ($971) |
Stock_plans_Narrative_Details
Stock plans (Narrative) (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Stock plans (other details) | ' | ' | ' | ' | ' |
Number of shares reserved for issuance under the LTIP and STIP | 13,126,896 | ' | 13,126,896 | ' | ' |
Remaining number of shares reserved for issuance | 1,018,998 | ' | 1,018,998 | ' | ' |
Share compensation expenses | $8,764 | $10,527 | $24,252 | $19,483 | ' |
Options | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Life of options | ' | ' | '10 years | ' | ' |
Share compensation expenses | 0 | 0 | 0 | 0 | ' |
Unrecognized share compensation expenses | 0 | 0 | 0 | 0 | ' |
Restricted share awards | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 8,180 | 10,041 | 23,101 | 20,035 | ' |
Unrecognized share compensation expenses | 77,920 | ' | 77,920 | ' | 69,219 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '3 years 0 months 0 days | '3 years 2 months 12 days | ' |
Restricted share units | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 269 | 168 | 602 | 419 | ' |
Unrecognized share compensation expenses | 3,038 | ' | 3,038 | ' | 1,678 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '3 years 3 months 29 days | '3 years 4 months 24 days | ' |
Performance shares | ' | ' | ' | ' | ' |
Stock plans (other details) | ' | ' | ' | ' | ' |
Share compensation expenses | 315 | 318 | 549 | -971 | ' |
Unrecognized share compensation expenses | $2,527 | ' | $2,527 | ' | $1,642 |
Weighted average period of recognizing share based compensation expenses | ' | ' | '2 years 3 months 18 days | '2 years 0 months 4 days | ' |
Performance share awards performance period | ' | ' | '3 years | ' | ' |
Debt_and_financing_arrangement2
Debt and financing arrangements (Schedule of finance structure) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | $850,153 | $851,616 |
Debt instrument, outstanding | 789,953 | 791,416 |
Debt instrument, drawn | 787,232 | 788,614 |
Credit facility, commitment | 1,605,000 | 1,599,800 |
Credit facility, issued and outstanding | 682,091 | 751,250 |
Total debt and financing arrangements, commitment | 2,455,153 | 2,451,416 |
Total debt and financing arrangements, outstanding | 1,472,044 | 1,542,666 |
$400,000 syndicated unsecured letter of credit facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 400,000 | 400,000 |
Credit facility, issued and outstanding | 0 | 0 |
$525,000 syndicated secured letter of credit facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 525,000 | 525,000 |
Credit facility, issued and outstanding | 301,340 | 358,567 |
$200,000 secured bi-lateral letter of credit facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 200,000 | 200,000 |
Credit facility, issued and outstanding | 19,743 | 16,726 |
Talbot FAL facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 25,000 | 25,000 |
Credit facility, issued and outstanding | 25,000 | 25,000 |
PaCRe Senior secured letter of credit facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 10,000 | 10,000 |
Credit facility, issued and outstanding | 294 | 294 |
AlphaCat Re secured letter of credit facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 30,000 | 24,800 |
Credit facility, issued and outstanding | 30,000 | 24,800 |
IPC bi-lateral facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 40,000 | 40,000 |
Credit facility, issued and outstanding | 16,975 | 20,177 |
$375,000 Flagstone bi-lateral facility | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Credit facility, commitment | 375,000 | 375,000 |
Credit facility, issued and outstanding | 288,739 | 305,686 |
Total debentures payable | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 600,153 | 601,616 |
Debt instrument, outstanding | 539,953 | 541,416 |
Debt instrument, drawn | 539,953 | 541,416 |
2006 Junior Subordinated Deferrable Debentures | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 150,000 | 150,000 |
Debt instrument, outstanding | 150,000 | 150,000 |
Debt instrument, drawn | 150,000 | 150,000 |
2007 Junior Subordinated Deferrable Debentures | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 200,000 | 200,000 |
Debt instrument, outstanding | 139,800 | 139,800 |
Debt instrument, drawn | 139,800 | 139,800 |
Flagstone 2006 Junior Subordinated Deferrable Debentures | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 136,403 | 137,866 |
Debt instrument, outstanding | 136,403 | 137,866 |
Debt instrument, drawn | 136,403 | 137,866 |
Flagstone 2007 Junior Subordinated Deferrable Debentures | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 113,750 | 113,750 |
Debt instrument, outstanding | 113,750 | 113,750 |
Debt instrument, drawn | 113,750 | 113,750 |
2010 Senior Notes Due 2040 | ' | ' |
Debt Instruments [Line Items] | ' | ' |
Debt instrument, commitment | 250,000 | 250,000 |
Debt instrument, outstanding | 250,000 | 250,000 |
Debt instrument, drawn | $247,279 | $247,198 |
Debt_and_financing_arrangement3
Debt and financing arrangements (Summary of notes and debentures) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | ||||||||||||
In Thousands, unless otherwise specified | 2006 Junior Subordinated Deferrable Debentures | 2006 Junior Subordinated Deferrable Debentures | Flagstone 2006 Junior Subordinated Deferrable Interest Notes | Flagstone 2006 Junior Subordinated Deferrable Interest Notes | 2007 Junior Subordinated Deferrable Debentures | 2007 Junior Subordinated Deferrable Debentures | 2010 Senior Notes Due 2040 | 2010 Senior Notes Due 2040 | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Information At Issuance [Member] | Debt Outstanding [Member] | Debt Outstanding [Member] | Debt Outstanding [Member] | Debt Outstanding [Member] | Debt Outstanding [Member] | Debt Outstanding [Member] | ||||||||||||||
2006 Junior Subordinated Deferrable Debentures | Flagstone 2006 Junior Subordinated Deferrable Interest Notes | Flagstone 2006 Junior Subordinated Deferrable Interest Notes | 2007 Junior Subordinated Deferrable Debentures | Flagstone 2007 Due July 30 2037 | Flagstone 2007 Due July 30 2037 | Flagstone 2007 Debt Due September 15 2037 | Flagstone 2007 Debt Due September 15 2037 | 2010 Senior Notes Due 2040 | 2006 Junior Subordinated Deferrable Debentures | Flagstone 2006 Junior Subordinated Deferrable Interest Notes | 2007 Junior Subordinated Deferrable Debentures | Flagstone 2007 Due July 30 2037 | Flagstone 2007 Debt Due September 15 2037 | 2010 Senior Notes Due 2040 | |||||||||||||||||||||||
London Interbank Offered Rate (LIBOR) [Member] | London Interbank Offered Rate (LIBOR) [Member] | London Interbank Offered Rate (LIBOR) [Member] | |||||||||||||||||||||||||||||||||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Issuance Date | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 15-Jun-06 | 23-Aug-06 | ' | 21-Jun-07 | 8-Jun-07 | ' | 20-Sep-07 | ' | 26-Jan-10 | 15-Jun-06 | 23-Aug-06 | 21-Jun-07 | 8-Jun-07 | 20-Sep-07 | 26-Jan-10 | ||||||||||||
Debt instrument, commitment | $850,153 | $851,616 | $150,000 | $150,000 | $136,403 | $137,866 | $200,000 | $200,000 | $250,000 | $250,000 | $150,000 | $136,403 | ' | $200,000 | $88,750 | ' | $25,000 | ' | $250,000 | $150,000 | $136,403 | $200,000 | $88,750 | $25,000 | $250,000 | ||||||||||||
Debt Instrument, Maturity Date | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 15-Jun-36 | 15-Sep-36 | ' | 15-Jun-37 | 30-Jul-37 | ' | 15-Sep-37 | ' | 26-Jan-40 | 15-Jun-36 | 15-Sep-36 | 15-Jun-37 | 30-Jul-37 | 15-Sep-37 | 26-Jan-40 | ||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.07% | [1] | ' | ' | 8.48% | [1] | ' | ' | ' | ' | 8.88% | [1] | ' | ' | ' | ' | ' | 8.88% | [1] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3.54% | [2] | ' | ' | 3.00% | [2] | ' | 3.10% | [2] | ' | ' | ' | ' | ' | ' | ' | |||||||||
Debt Instrument, Interest Rate, Effective Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.83% | [3] | 6.46% | [3] | 5.18% | [3] | 5.90% | [3] | 5.98% | [3] | ' | |||||||
Debt Instrument, Frequency of Periodic Payment | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'Quarterly | 'Quarterly | ' | 'Quarterly | 'Quarterly | ' | 'Quarterly | ' | 'Semi-annually in arrears | 'Quarterly | 'Quarterly | 'Quarterly | 'Quarterly | 'Quarterly | 'Semi-annually in arrears | ||||||||||||
[1] | Fixed interest rate. | ||||||||||||||||||||||||||||||||||||
[2] | Variable interest rate is the three-month LIBOR, reset quarterly, plus spread as noted in the table. | ||||||||||||||||||||||||||||||||||||
[3] | Interest rate has been fixed as a result of interest rate swap contracts entered into by the Company. |
Debt_and_financing_arrangement4
Debt and financing arrangements (Components of finance expenses) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | $15,354 | $15,317 | $47,380 | $47,252 | ||||
Credit facilities | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 1,295 | 1,248 | 4,225 | 5,001 | ||||
Bank charges | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 88 | 187 | 303 | 420 | ||||
AlphaCat ILS fund fees | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 384 | [1] | 78 | [1] | 2,030 | [1] | 2,406 | [1] |
Talbot FAL facility | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | -169 | 32 | -165 | 95 | ||||
2006 Junior Subordinated Deferrable Debentures | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 2,235 | 2,235 | 6,633 | 6,633 | ||||
2007 Junior Subordinated Deferrable Debentures | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 1,848 | 1,848 | 5,492 | 5,492 | ||||
Flagstone 2006 Junior Subordinated Deferrable Debentures | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 2,269 | 2,285 | 6,736 | 5,988 | ||||
Flagstone 2007 Junior Subordinated Deferrable Debentures | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | 1,807 | 1,807 | 5,335 | 4,426 | ||||
2010 Senior Notes Due 2040 | ' | ' | ' | ' | ||||
Debt Instruments [Line Items] | ' | ' | ' | ' | ||||
Financing Interest Expense | $5,597 | $5,597 | $16,791 | $16,791 | ||||
[1] | Includes finance expenses incurred by AlphaCat Managers, Ltd. in relation to fund raising for the AlphaCat ILS funds, AlphaCat 2014 and AlphaCat 2013. |
Debt_and_financing_arrangement5
Debt and financing arrangements (Narrative) (Details) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 |
Senior Notes and Junior Debentures | ' | ' |
Long-term Debt | $539,953 | $541,416 |
Credit Facilities | ' | ' |
Credit facility, commitment | 1,605,000 | 1,599,800 |
Credit facility, issued and outstanding | 682,091 | 751,250 |
Credit Facilities | ' | ' |
Credit Facilities | ' | ' |
Minimum level of consolidated net worth | 2,600,000 | ' |
Percent of consolidated net income quarterly increase under covenant | 50.00% | ' |
Percent of any net proceeds from issuance of common shares | 50.00% | ' |
Ratio consolidated total debt to net worth under covenant | '0.35:1.00 | ' |
Four-year syndicated unsecured credit facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 400,000 | 400,000 |
Credit facility, issued and outstanding | 0 | 0 |
Letter of credit facility period | '4 years | ' |
Aggregate commitments, maximum | 500,000 | ' |
Line of credit facility initiation date | 9-Mar-12 | ' |
Four-year syndicated secured credit facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 525,000 | 525,000 |
Credit facility, issued and outstanding | 301,340 | 358,567 |
Letter of credit facility period | '4 years | ' |
Aggregate commitments, maximum | 700,000 | ' |
Line of credit facility initiation date | 9-Mar-12 | ' |
Talbot FAL Facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 25,000 | 25,000 |
Credit facility, issued and outstanding | 25,000 | 25,000 |
IPC bi-lateral facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 40,000 | 40,000 |
Credit facility, issued and outstanding | 16,975 | 20,177 |
$200,000 secured bi-lateral letter of credit facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 200,000 | 200,000 |
Credit facility, issued and outstanding | 19,743 | 16,726 |
PaCRe Senior secured letter of credit facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 10,000 | 10,000 |
Credit facility, issued and outstanding | 294 | 294 |
AlphaCat Re secured letter of credit facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 30,000 | 24,800 |
Credit facility, issued and outstanding | 30,000 | 24,800 |
$375,000 Flagstone bi-lateral facility | ' | ' |
Credit Facilities | ' | ' |
Credit facility, commitment | 375,000 | 375,000 |
Credit facility, issued and outstanding | 288,739 | 305,686 |
2010 Senior Notes Due 2040 | ' | ' |
Senior Notes and Junior Debentures | ' | ' |
Long-term Debt | 250,000 | ' |
2010 Senior Notes Due 2040 | Maximum | ' | ' |
Senior Notes and Junior Debentures | ' | ' |
Debt Instrument Redemption Required Notice Period | '60 days | ' |
2010 Senior Notes Due 2040 | Minimum | ' | ' |
Senior Notes and Junior Debentures | ' | ' |
Debt Instrument Redemption Required Notice Period | '30 days | ' |
Junior subordinated deeferrable debentures | ' | ' |
Senior Notes and Junior Debentures | ' | ' |
Long-term Debt | $539,953 | ' |
Debt Instrument Redemption Period Duration | '5 years | ' |
Accumulated_other_comprehensiv2
Accumulated other comprehensive (loss) income (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' | ' | ' |
Balance, beginning of period | ' | ' | ($617) | ' |
Other comprehensive (loss) income | -5,198 | 4,390 | -2,121 | -5,209 |
Balance, end of period | -2,738 | ' | -2,738 | ' |
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Translation Adjustment [Member] | ' | ' | ' | ' |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ' | ' | ' | ' |
Balance, beginning of period | 2,460 | -8,262 | -617 | -2,953 |
Amounts reclassified to retained earnings | 0 | 0 | 0 | 4,290 |
Other comprehensive (loss) income | -5,198 | 4,390 | -2,121 | -5,209 |
Balance, end of period | ($2,738) | ($3,872) | ($2,738) | ($3,872) |
Commitments_and_contingencies_1
Commitments and contingencies (Investment portfolio) (Details) | 9 Months Ended |
Sep. 30, 2014 | |
Shareholders' Equity | Concentrations of credit risk | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Maximum aggregate exposure to risk assets, allowed as a percentage of Shareholder's Equity | 35.00% |
Investment portfolio excluding government and agency securities | Concentrations of credit risk | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Maximum aggregate exposure to single issuer, allowed | 3.50% |
Aggregate exposure to single issuer, actual | 0.90% |
Bank loan portfolio | Concentrations of credit risk | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Total investment portfolio, fair value | 6.80% |
Investment portfolio excluding bank loans | Concentrations of credit risk | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Minimum credit rating of any security purchased | 'Baa3/BBB- |
Holding in aggregate market value permitted with written pre-authorization | 10.00% |
Percent of investment portfolio with a credit rating below the minimum required credit rating of Baa3/BBB- | 1.70% |
Weighted Average [Member] | Shareholders' Equity | ' |
Concentrations Of Credit Risk [Abstract] | ' |
Minimum credit rating of any security purchased | 'A+ |
Commitments_and_contingencies_2
Commitments and contingencies (Lloyd's syndicate) (Details) | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | USD ($) | USD ($) | Lloyd's Syndicate 1183 | Lloyd's Syndicate 1183 | 20114 Underwriting year | 2013 Underwriting year |
USD ($) | GBP (£) | Lloyd's Syndicate 1183 | Lloyd's Syndicate 1183 | |||
USD ($) | USD ($) | |||||
Components Of Required Capital [Abstract] | ' | ' | ' | ' | ' | ' |
Credit facility, commitment | $1,605,000 | $1,599,800 | ' | ' | $25,000 | $25,000 |
Required Capital Group Funds | ' | ' | ' | ' | 450,000 | 403,700 |
Cash, investments and letters of credit amount | ' | ' | ' | ' | 475,000 | 428,700 |
Funds at Lloyd's and Lloyd's Central Fund | ' | ' | ' | ' | ' | ' |
Maximum premium levies assessable, percent | ' | ' | 3.00% | 3.00% | ' | ' |
Estimated underwriting capacity | ' | ' | ' | 625,000 | ' | ' |
Exchange rate | ' | ' | '£1 equals $1.6195 | '£1 equals $1.6195 | ' | ' |
Maximum premium levies assessable, amount | ' | ' | $30,366 | ' | ' | ' |
Commitments_and_contingencies_3
Commitments and contingencies (Aquiline commitment) (Details) (Aquiline Capital Partners II GP Offshore Ltd, USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 |
Aquiline Capital Partners II GP Offshore Ltd | ' | ' |
Related Party Transaction [Line Items] | ' | ' |
Total capital commitment | $50,000 | ' |
Remaining capital commitment | $17,890 | $17,890 |
Commitments_and_contingencies_4
Commitments and contingencies (Other investment commitments) (Details) (Investment commitment [Member], USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | funds | |
Investment commitment [Member] | ' | ' |
Other Commitments [Line Items] | ' | ' |
Other Investments Number Of Funds | 5 | ' |
Contractual Obligation | $105,000 | $5,045 |
Remaining Commitment | $79,259 | ' |
Related_party_transactions_Det
Related party transactions (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Reinsurance Payable | $141,482 | ' | $141,482 | ' | $154,874 |
Aquiline Capital Partners LLC | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Shares owned by related party | 3,446,643 | ' | 3,446,643 | ' | ' |
Warrants to purchase shares | 2,756,088 | ' | 2,756,088 | ' | ' |
Related Parties Number Of Employees | ' | ' | 2 | ' | ' |
Group Ark Insurance Holdings Ltd | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Gross premiums written | 246 | 0 | 2,190 | 2,848 | ' |
Premiums receivable | 733 | ' | 733 | ' | 238 |
Reinsurance premiums ceded | 127 | 23 | 127 | 23 | ' |
Related Party Transaction Reinsurance Balances Payable | 4 | ' | 4 | ' | 4 |
Loss reserves recoverable | 2,005 | ' | 2,005 | ' | 3,698 |
Earned premium adjustments | 694 | 718 | 1,653 | 2,147 | ' |
Conning Inc | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Investment management fees | -7 | 165 | 219 | 396 | ' |
Accounts payable and accrued expenses | 239 | ' | 239 | ' | 283 |
Aquiline Capital Partners II GP Offshore Ltd | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Accounts payable and accrued expenses | 0 | ' | 0 | ' | 0 |
Percentage of Assignor's interest assumed | ' | ' | 100.00% | ' | ' |
Total capital commitment | ' | ' | 50,000 | ' | ' |
Partnership fees incurred | 0 | 505 | 0 | 625 | ' |
Capital contributions | $0 | $6,185 | $0 | $13,089 | ' |
Earnings_per_share_Details
Earnings per share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Basic earnings per share | ' | ' | ' | ' |
Net income | ($13,397) | $229,063 | $381,172 | $419,503 |
Loss (income) attributable to noncontrolling interest | 53,069 | -45,694 | -25,745 | 17,831 |
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 |
Less: Dividends and distributions declared on outstanding warrants | -1,552 | -1,552 | -4,656 | -17,662 |
Income available to common shareholders | 38,120 | 181,817 | 350,771 | 419,672 |
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 |
Basic earnings per share available to common shareholders | $0.42 | $1.82 | $3.83 | $4.06 |
Earnings per diluted share | ' | ' | ' | ' |
Net income | -13,397 | 229,063 | 381,172 | 419,503 |
Loss (income) attributable to noncontrolling interest | 53,069 | -45,694 | -25,745 | 17,831 |
Net income available to Validus | 39,672 | 183,369 | 355,427 | 437,334 |
less: Dividends and distributions declared on outstanding warrants | -1,552 | 0 | 0 | -17,662 |
Income available to common shareholders | $38,120 | $183,369 | $355,427 | $419,672 |
Weighted average number of common shares outstanding | 90,593,329 | 99,834,563 | 91,665,950 | 103,451,396 |
Weighted average number of diluted common shares outstanding | 91,939,610 | 103,613,766 | 95,937,641 | 105,264,913 |
Earnings per diluted share available to common shareholders | $0.41 | $1.77 | $3.70 | $3.99 |
Other details: | ' | ' | ' | ' |
Anti-dilutive securities excluded from the calculation of diluted earnings per share | 4,712 | 125,728 | 235,460 | 464,516 |
Warrants | ' | ' | ' | ' |
Earnings per diluted share | ' | ' | ' | ' |
Weighted average number of diluted common shares outstanding, aggregate | 0 | 2,606,669 | 2,747,399 | 0 |
Stock options | ' | ' | ' | ' |
Earnings per diluted share | ' | ' | ' | ' |
Weighted average number of diluted common shares outstanding, aggregate | 760,267 | 782,158 | 752,145 | 1,090,298 |
Unvested restricted shares | ' | ' | ' | ' |
Earnings per diluted share | ' | ' | ' | ' |
Weighted average number of diluted common shares outstanding, aggregate | 586,014 | 390,376 | 772,147 | 723,219 |
Segment_information_Details
Segment information (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | $358,974 | $356,760 | $2,026,639 | $2,163,833 | ' | ||||
Reinsurance premiums ceded | -30,137 | -39,415 | -275,610 | -348,027 | ' | ||||
Net premiums written | 328,837 | 317,345 | 1,751,029 | 1,815,806 | ' | ||||
Change in unearned premiums | 165,859 | 213,943 | -307,373 | -205,999 | ' | ||||
Net premiums earned | 494,696 | 531,288 | 1,443,656 | 1,609,807 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 224,125 | 177,965 | 545,541 | 587,780 | ' | ||||
Policy acquisition costs | 86,404 | 94,900 | 251,006 | 275,663 | ' | ||||
General and administrative expenses | 83,319 | 81,089 | 231,606 | 232,335 | ' | ||||
Share compensation expenses | 8,764 | 10,527 | 24,252 | 19,483 | ' | ||||
Total underwriting deductions | 402,612 | 364,481 | 1,052,405 | 1,115,261 | ' | ||||
Underwriting income (loss) | 92,084 | 166,807 | 391,251 | 494,546 | ' | ||||
Net investment income | 25,261 | 20,009 | 69,909 | 71,868 | ' | ||||
Other (loss) income | -4,080 | -2,806 | 14,985 | 4,297 | ' | ||||
Finance expenses | -15,354 | -15,317 | -47,380 | -47,252 | ' | ||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 97,911 | 168,693 | 428,765 | 523,459 | ' | ||||
Tax benefit (expense) | 953 | -5 | -398 | 220 | ' | ||||
Income from operating affilates | 3,761 | 1,463 | 13,580 | 8,779 | ' | ||||
(Income) attributable to operating affiliate investors | -25,807 | -11,815 | -82,833 | -42,156 | ' | ||||
Net operating income (loss) | 76,818 | 158,336 | 359,114 | 490,302 | ' | ||||
Net realized gains on investments | 4,595 | -6,320 | 16,193 | -1,190 | ' | ||||
Change in net unrealized gains on investments | -84,974 | [1] | 69,967 | [1] | 16,146 | [1] | -78,618 | [1] | ' |
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 | ' | ||||
Foreign exchange gains (losses) | -11,441 | 6,036 | -14,761 | 4,735 | ' | ||||
Transaction expenses | -149 | [2] | 0 | -3,401 | [2] | 0 | ' | ||
Net (loss) income | -13,397 | 229,063 | 381,172 | 419,503 | ' | ||||
Net loss (income) attributable to noncontrolling interest | 53,069 | -45,694 | -25,745 | 17,831 | ' | ||||
Net income (loss) available (attributable) to Validus | 39,672 | 183,369 | 355,427 | 437,334 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net Premium To Gross Premium Ratio | 91.60% | [3] | 89.00% | [3] | 86.40% | [3] | 83.90% | [3] | ' |
Losses and loss expenses | 45.30% | [3] | 33.50% | [3] | 37.80% | [3] | 36.50% | [3] | ' |
Policy acquisition costs | 17.50% | [3] | 17.90% | [3] | 17.40% | [3] | 17.20% | [3] | ' |
General and Administrative Expense Ratio | 18.60% | [3],[4] | 17.20% | [3],[4] | 17.70% | [3],[4] | 15.60% | [3],[4] | ' |
Underwriting Expense Ratio | 36.10% | [3] | 35.10% | [3] | 35.10% | [3] | 32.80% | [3] | ' |
Combined ratio | 81.40% | [3] | 68.60% | [3] | 72.90% | [3] | 69.30% | [3] | ' |
Total assets | 10,053,050 | 10,317,368 | 10,053,050 | 10,317,368 | 9,846,432 | ||||
Operating Segments [Member] | Validus Re Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 114,897 | 130,925 | 1,104,169 | 1,232,272 | ' | ||||
Reinsurance premiums ceded | -10,899 | -13,006 | -184,074 | -226,292 | ' | ||||
Net premiums written | 103,998 | 117,919 | 920,095 | 1,005,980 | ' | ||||
Change in unearned premiums | 122,712 | 157,873 | -233,271 | -122,303 | ' | ||||
Net premiums earned | 226,710 | 275,792 | 686,824 | 883,677 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 102,005 | 62,250 | 247,848 | 319,298 | ' | ||||
Policy acquisition costs | 36,177 | 47,662 | 106,547 | 142,195 | ' | ||||
General and administrative expenses | 18,522 | 19,785 | 53,757 | 69,649 | ' | ||||
Share compensation expenses | 2,582 | 2,479 | 7,126 | 5,421 | ' | ||||
Total underwriting deductions | 159,286 | 132,176 | 415,278 | 536,563 | ' | ||||
Underwriting income (loss) | 67,424 | 143,616 | 271,546 | 347,114 | ' | ||||
Net investment income | 20,762 | 15,628 | 56,285 | 61,770 | ' | ||||
Other (loss) income | -6,827 | -1,892 | 912 | 11,237 | ' | ||||
Finance expenses | -3,622 | -3,640 | -11,131 | -12,133 | ' | ||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 77,737 | 153,712 | 317,612 | 407,988 | ' | ||||
Tax benefit (expense) | 1,058 | 143 | 1,176 | 1,755 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
(Income) attributable to operating affiliate investors | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | 78,795 | 153,855 | 318,788 | 409,743 | ' | ||||
Net realized gains on investments | 1,641 | -10,137 | 5,411 | -5,790 | ' | ||||
Change in net unrealized gains on investments | -20,149 | 23,144 | 5,279 | -36,883 | ' | ||||
Income from investment affiliate | 1,754 | 1,044 | 7,881 | 4,274 | ' | ||||
Foreign exchange gains (losses) | -6,056 | 2,168 | -9,384 | 7,448 | ' | ||||
Net (loss) income | 55,985 | 170,074 | 327,975 | 378,792 | ' | ||||
Net loss (income) attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | 55,985 | 170,074 | 327,975 | 378,792 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net Premium To Gross Premium Ratio | 90.50% | [3] | 90.10% | [3] | 83.30% | [3] | 81.60% | [3] | ' |
Losses and loss expenses | 45.00% | [3] | 22.60% | [3] | 36.10% | [3] | 36.10% | [3] | ' |
Policy acquisition costs | 16.00% | [3] | 17.30% | [3] | 15.50% | [3] | 16.10% | [3] | ' |
General and Administrative Expense Ratio | 9.30% | [3],[4] | 8.10% | [3],[4] | 8.90% | [3],[4] | 8.50% | [3],[4] | ' |
Underwriting Expense Ratio | 25.30% | [3] | 25.40% | [3] | 24.40% | [3] | 24.60% | [3] | ' |
Combined ratio | 70.30% | [3] | 48.00% | [3] | 60.50% | [3] | 60.70% | [3] | ' |
Total assets | 4,716,426 | 5,854,354 | 4,716,426 | 5,854,354 | ' | ||||
Operating Segments [Member] | AlphaCat Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 6,936 | 3,481 | 135,073 | 146,757 | ' | ||||
Reinsurance premiums ceded | -648 | -525 | -4,348 | -525 | ' | ||||
Net premiums written | 6,288 | 2,956 | 130,725 | 146,232 | ' | ||||
Change in unearned premiums | 28,850 | 34,210 | -32,444 | -46,459 | ' | ||||
Net premiums earned | 35,138 | 37,166 | 98,281 | 99,773 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 3,738 | 15,615 | -7,155 | 16,928 | ' | ||||
Policy acquisition costs | 3,378 | 3,787 | 9,414 | 10,011 | ' | ||||
General and administrative expenses | 7,719 | 5,728 | 15,627 | 13,757 | ' | ||||
Share compensation expenses | 179 | 152 | 330 | 314 | ' | ||||
Total underwriting deductions | 15,014 | 25,282 | 18,216 | 41,010 | ' | ||||
Underwriting income (loss) | 20,124 | 11,884 | 80,065 | 58,763 | ' | ||||
Net investment income | 837 | 967 | 2,546 | 2,821 | ' | ||||
Other (loss) income | 5,980 | 3,791 | 21,482 | 17,439 | ' | ||||
Finance expenses | -385 | -80 | -2,039 | -4,273 | ' | ||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 26,556 | 16,562 | 102,054 | 74,750 | ' | ||||
Tax benefit (expense) | 0 | 0 | 0 | 0 | ' | ||||
Income from operating affilates | 3,761 | 1,463 | 13,580 | 8,779 | ' | ||||
(Income) attributable to operating affiliate investors | -25,807 | -11,815 | -82,833 | -42,156 | ' | ||||
Net operating income (loss) | 4,510 | 6,210 | 32,801 | 41,373 | ' | ||||
Net realized gains on investments | 2,563 | 4,084 | 10,230 | 4,084 | ' | ||||
Change in net unrealized gains on investments | -60,253 | 44,145 | 15,706 | -31,029 | ' | ||||
Income from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange gains (losses) | -51 | 388 | -204 | -663 | ' | ||||
Net (loss) income | -53,231 | 54,827 | 58,533 | 13,765 | ' | ||||
Net loss (income) attributable to noncontrolling interest | 53,069 | -45,694 | -25,745 | 17,831 | ' | ||||
Net income (loss) available (attributable) to Validus | -162 | 9,133 | 32,788 | 31,596 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net Premium To Gross Premium Ratio | 90.70% | [3] | 84.90% | [3] | 96.80% | [3] | 99.60% | [3] | ' |
Losses and loss expenses | 10.60% | [3] | 42.00% | [3] | -7.30% | [3] | 17.00% | [3] | ' |
Policy acquisition costs | 9.60% | [3] | 10.20% | [3] | 9.60% | [3] | 10.00% | [3] | ' |
General and Administrative Expense Ratio | 22.50% | [3],[4] | 15.80% | [3],[4] | 16.20% | [3],[4] | 14.10% | [3],[4] | ' |
Underwriting Expense Ratio | 32.10% | [3] | 26.00% | [3] | 25.80% | [3] | 24.10% | [3] | ' |
Combined ratio | 42.70% | [3] | 68.00% | [3] | 18.50% | [3] | 41.10% | [3] | ' |
Total assets | 1,688,191 | 1,446,941 | 1,688,191 | 1,446,941 | ' | ||||
Operating Segments [Member] | Talbot Segment | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | 245,685 | 246,468 | 854,324 | 855,516 | ' | ||||
Reinsurance premiums ceded | -27,134 | -49,998 | -154,115 | -191,922 | ' | ||||
Net premiums written | 218,551 | 196,470 | 700,209 | 663,594 | ' | ||||
Change in unearned premiums | 14,297 | 21,860 | -41,658 | -37,237 | ' | ||||
Net premiums earned | 232,848 | 218,330 | 658,551 | 626,357 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 118,382 | 100,100 | 304,848 | 251,554 | ' | ||||
Policy acquisition costs | 47,862 | 44,899 | 138,383 | 127,092 | ' | ||||
General and administrative expenses | 37,709 | 37,402 | 107,031 | 100,506 | ' | ||||
Share compensation expenses | 2,990 | 2,992 | 8,434 | 6,754 | ' | ||||
Total underwriting deductions | 206,943 | 185,393 | 558,696 | 485,906 | ' | ||||
Underwriting income (loss) | 25,905 | 32,937 | 99,855 | 140,451 | ' | ||||
Net investment income | 4,965 | 4,395 | 14,322 | 13,496 | ' | ||||
Other (loss) income | 109 | 73 | 384 | 564 | ' | ||||
Finance expenses | 162 | -107 | 68 | -256 | ' | ||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | 31,141 | 37,298 | 114,629 | 154,255 | ' | ||||
Tax benefit (expense) | 332 | -513 | -902 | -1,184 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
(Income) attributable to operating affiliate investors | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | 31,473 | 36,785 | 113,727 | 153,071 | ' | ||||
Net realized gains on investments | 391 | -267 | 552 | 516 | ' | ||||
Change in net unrealized gains on investments | -3,097 | 2,678 | 2,159 | -10,706 | ' | ||||
Income from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange gains (losses) | -7,114 | 4,238 | -5,897 | -1,877 | ' | ||||
Net (loss) income | 21,653 | 43,434 | 110,541 | 141,004 | ' | ||||
Net loss (income) attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | 21,653 | 43,434 | 110,541 | 141,004 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Net Premium To Gross Premium Ratio | 89.00% | [3] | 79.70% | [3] | 82.00% | [3] | 77.60% | [3] | ' |
Losses and loss expenses | 50.80% | [3] | 45.80% | [3] | 46.30% | [3] | 40.20% | [3] | ' |
Policy acquisition costs | 20.60% | [3] | 20.60% | [3] | 21.00% | [3] | 20.30% | [3] | ' |
General and Administrative Expense Ratio | 17.50% | [3],[4] | 18.50% | [3],[4] | 17.50% | [3],[4] | 17.10% | [3],[4] | ' |
Underwriting Expense Ratio | 38.10% | [3] | 39.10% | [3] | 38.50% | [3] | 37.40% | [3] | ' |
Combined ratio | 88.90% | [3] | 84.90% | [3] | 84.80% | [3] | 77.60% | [3] | ' |
Total assets | 2,898,755 | 2,892,477 | 2,898,755 | 2,892,477 | ' | ||||
Corporate And Eliminations [Member] | ' | ' | ' | ' | ' | ||||
Underwriting income | ' | ' | ' | ' | ' | ||||
Gross premiums written | -8,544 | -24,114 | -66,927 | -70,712 | ' | ||||
Reinsurance premiums ceded | 8,544 | 24,114 | 66,927 | 70,712 | ' | ||||
Net premiums written | 0 | 0 | 0 | 0 | ' | ||||
Change in unearned premiums | 0 | 0 | 0 | 0 | ' | ||||
Net premiums earned | 0 | 0 | 0 | 0 | ' | ||||
Underwriting deductions | ' | ' | ' | ' | ' | ||||
Losses and loss expenses | 0 | 0 | 0 | 0 | ' | ||||
Policy acquisition costs | -1,013 | -1,448 | -3,338 | -3,635 | ' | ||||
General and administrative expenses | 19,369 | 18,174 | 55,191 | 48,423 | ' | ||||
Share compensation expenses | 3,013 | 4,904 | 8,362 | 6,994 | ' | ||||
Total underwriting deductions | 21,369 | 21,630 | 60,215 | 51,782 | ' | ||||
Underwriting income (loss) | -21,369 | -21,630 | -60,215 | -51,782 | ' | ||||
Net investment income | -1,303 | -981 | -3,244 | -6,219 | ' | ||||
Other (loss) income | -3,342 | -4,778 | -7,793 | -24,943 | ' | ||||
Finance expenses | -11,509 | -11,490 | -34,278 | -30,590 | ' | ||||
Operating income (loss) before taxes, income from operating affiliates and (income) attributable to operating affiliate investors | -37,523 | -38,879 | -105,530 | -113,534 | ' | ||||
Tax benefit (expense) | -437 | 365 | -672 | -351 | ' | ||||
Income from operating affilates | 0 | 0 | 0 | 0 | ' | ||||
(Income) attributable to operating affiliate investors | 0 | 0 | 0 | 0 | ' | ||||
Net operating income (loss) | -37,960 | -38,514 | -106,202 | -113,885 | ' | ||||
Net realized gains on investments | 0 | 0 | 0 | 0 | ' | ||||
Change in net unrealized gains on investments | -1,475 | 0 | -6,998 | 0 | ' | ||||
Income from investment affiliate | 0 | 0 | 0 | 0 | ' | ||||
Foreign exchange gains (losses) | 1,780 | -758 | 724 | -173 | ' | ||||
Transaction expenses | -149 | [2] | ' | -3,401 | [2] | ' | ' | ||
Net (loss) income | -37,804 | -39,272 | -115,877 | -114,058 | ' | ||||
Net loss (income) attributable to noncontrolling interest | 0 | 0 | 0 | 0 | ' | ||||
Net income (loss) available (attributable) to Validus | -37,804 | -39,272 | -115,877 | -114,058 | ' | ||||
Selected ratios: | ' | ' | ' | ' | ' | ||||
Total assets | $749,678 | $123,596 | $749,678 | $123,596 | ' | ||||
[1] | Includes change in net unrealized gains (losses) and realized gains on investments held by PaCRe in which the Company has an equity interest of 10%. The remaining 90% interest is held by third party investors and is included in the Consolidated Statements of Comprehensive Income as net loss (income) attributable to noncontrolling interest. | ||||||||
[2] | The transaction expenses relate to costs incurred in connection with the acquisition of Western World, which was completed on October 2, 2014. Western World results have not been included in the Company's consolidated results for the three months ended September 30, 2014. Transaction expenses are primarily comprised of legal, financial advisory and audit related services. | ||||||||
[3] | Ratios are based on net premiums earned. | ||||||||
[4] | The general and administrative expense ratio includes share compensation expenses. |
Segment_information_Segment_ge
Segment information (Segment geographic) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | $358,974 | $356,760 | $2,026,639 | $2,163,833 | ||||
Percent of gross premiums written | 100.00% | 100.00% | 100.00% | 100.00% | ||||
United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 47,000 | 60,895 | 558,433 | 660,658 | ||||
Percent of gross premiums written | 13.10% | 17.00% | 27.50% | 30.60% | ||||
Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 39,366 | [1] | 47,586 | [1] | 186,658 | [1] | 184,780 | [1] |
Percent of gross premiums written | 10.90% | [1] | 13.30% | [1] | 9.20% | [1] | 8.40% | [1] |
Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 3,783 | -6,780 | 28,268 | 30,795 | ||||
Percent of gross premiums written | 1.10% | -1.90% | 1.40% | 1.40% | ||||
Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 18,382 | 13,421 | 92,842 | 105,131 | ||||
Percent of gross premiums written | 5.10% | 3.80% | 4.60% | 4.90% | ||||
Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 36,866 | 40,633 | 103,860 | 122,693 | ||||
Percent of gross premiums written | 10.30% | 11.40% | 5.10% | 5.70% | ||||
Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,887 | -1,688 | 44,365 | 46,887 | ||||
Percent of gross premiums written | 0.80% | -0.50% | 2.20% | 2.20% | ||||
Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,538 | 3,978 | 11,407 | 12,775 | ||||
Percent of gross premiums written | 0.70% | 1.10% | 0.60% | 0.60% | ||||
Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 27,599 | [2] | 25,978 | [2] | 90,945 | [2] | 88,314 | [2] |
Percent of gross premiums written | 7.70% | [2] | 7.30% | [2] | 4.50% | [2] | 4.10% | [2] |
Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 131,421 | 123,128 | 558,345 | 591,375 | ||||
Percent of gross premiums written | 36.60% | 34.50% | 27.60% | 27.30% | ||||
Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 51,275 | [1] | 46,217 | [1] | 319,854 | [1] | 309,225 | [1] |
Percent of gross premiums written | 14.30% | [1] | 13.00% | [1] | 15.80% | [1] | 14.30% | [1] |
Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 129,278 | [3] | 126,520 | [3] | 590,007 | [3] | 602,575 | [3] |
Percent of gross premiums written | 36.00% | [3] | 35.50% | [3] | 29.10% | [3] | 27.80% | [3] |
Operating Segments [Member] | Validus Re Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 114,897 | 130,925 | 1,104,169 | 1,232,272 | ||||
Operating Segments [Member] | Validus Re Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 28,665 | 38,881 | 452,470 | 542,692 | ||||
Operating Segments [Member] | Validus Re Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 10,639 | [1] | 16,973 | [1] | 80,671 | [1] | 69,482 | [1] |
Operating Segments [Member] | Validus Re Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 610 | -9,482 | 20,025 | 21,116 | ||||
Operating Segments [Member] | Validus Re Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 8,560 | 4,252 | 57,884 | 64,986 | ||||
Operating Segments [Member] | Validus Re Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 12,945 | 5,902 | 22,167 | 5,885 | ||||
Operating Segments [Member] | Validus Re Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 1,664 | -2,637 | 41,137 | 41,939 | ||||
Operating Segments [Member] | Validus Re Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 188 | 1,469 | 3,508 | 4,503 | ||||
Operating Segments [Member] | Validus Re Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 1,527 | [2] | 5,641 | [2] | 23,870 | [2] | 29,211 | [2] |
Operating Segments [Member] | Validus Re Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 36,133 | 22,118 | 249,262 | 237,122 | ||||
Operating Segments [Member] | Validus Re Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 28,747 | [1] | 29,611 | [1] | 168,337 | [1] | 180,621 | [1] |
Operating Segments [Member] | Validus Re Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 21,352 | [3] | 40,315 | [3] | 234,100 | [3] | 271,837 | [3] |
Operating Segments [Member] | AlphaCat Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 6,936 | 3,481 | 135,073 | 146,757 | ||||
Operating Segments [Member] | AlphaCat Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,206 | 2,546 | 31,160 | 50,935 | ||||
Operating Segments [Member] | AlphaCat Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -81 | [1] | 0 | [1] | 7,331 | [1] | 14,801 | [1] |
Operating Segments [Member] | AlphaCat Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 33 | 1,019 | 2,216 | ||||
Operating Segments [Member] | AlphaCat Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 312 | 377 | 3,005 | 2,514 | ||||
Operating Segments [Member] | AlphaCat Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 0 | 0 | 0 | ||||
Operating Segments [Member] | AlphaCat Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 22 | 0 | 608 | 653 | ||||
Operating Segments [Member] | AlphaCat Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | 500 | 215 | 818 | ||||
Operating Segments [Member] | AlphaCat Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] |
Operating Segments [Member] | AlphaCat Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 253 | 910 | 12,178 | 21,002 | ||||
Operating Segments [Member] | AlphaCat Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 4,477 | [1] | 25 | [1] | 91,735 | [1] | 74,820 | [1] |
Operating Segments [Member] | AlphaCat Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] |
Operating Segments [Member] | Talbot Segment | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 245,685 | 246,468 | 854,324 | 855,516 | ||||
Operating Segments [Member] | Talbot Segment | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 17,003 | 21,573 | 85,465 | 77,630 | ||||
Operating Segments [Member] | Talbot Segment | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 29,781 | [1] | 34,751 | [1] | 105,397 | [1] | 109,562 | [1] |
Operating Segments [Member] | Talbot Segment | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 3,312 | 2,905 | 7,615 | 7,930 | ||||
Operating Segments [Member] | Talbot Segment | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 9,821 | 9,778 | 36,110 | 41,523 | ||||
Operating Segments [Member] | Talbot Segment | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 24,740 | 38,084 | 86,111 | 124,120 | ||||
Operating Segments [Member] | Talbot Segment | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 1,274 | 1,066 | 3,404 | 5,258 | ||||
Operating Segments [Member] | Talbot Segment | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 2,430 | 2,749 | 8,325 | 8,790 | ||||
Operating Segments [Member] | Talbot Segment | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 27,145 | [2] | 22,167 | [2] | 70,702 | [2] | 62,803 | [2] |
Operating Segments [Member] | Talbot Segment | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 98,503 | 111,500 | 317,664 | 359,986 | ||||
Operating Segments [Member] | Talbot Segment | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 18,611 | [1] | 18,246 | [1] | 71,147 | [1] | 63,998 | [1] |
Operating Segments [Member] | Talbot Segment | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | 111,568 | [3] | 95,149 | [3] | 380,048 | [3] | 353,902 | [3] |
Corporate And Eliminations [Member] | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -8,544 | -24,114 | -66,927 | -70,712 | ||||
Corporate And Eliminations [Member] | United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -874 | -2,105 | -10,662 | -10,599 | ||||
Corporate And Eliminations [Member] | Worldwide excluding United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -973 | [1] | -4,138 | [1] | -6,741 | [1] | -9,065 | [1] |
Corporate And Eliminations [Member] | Australia and New Zealand | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -139 | -236 | -391 | -467 | ||||
Corporate And Eliminations [Member] | Europe | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -311 | -986 | -4,157 | -3,892 | ||||
Corporate And Eliminations [Member] | Latin America and Caribbean | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -819 | -3,353 | -4,418 | -7,312 | ||||
Corporate And Eliminations [Member] | Japan | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -73 | -117 | -784 | -963 | ||||
Corporate And Eliminations [Member] | Canada | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -80 | -740 | -641 | -1,336 | ||||
Corporate And Eliminations [Member] | Rest of the world | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -1,073 | [2] | -1,830 | [2] | -3,627 | [2] | -3,700 | [2] |
Corporate And Eliminations [Member] | Sub-total, non United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -3,468 | -11,400 | -20,759 | -26,735 | ||||
Corporate And Eliminations [Member] | Worldwide including United States | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | -560 | [1] | -1,665 | [1] | -11,365 | [1] | -10,214 | [1] |
Corporate And Eliminations [Member] | Other location non-specific | ' | ' | ' | ' | ||||
Gross premiums written allocated to the territory of coverage exposure | ' | ' | ' | ' | ||||
Gross premiums written | ($3,642) | [3] | ($8,944) | [3] | ($24,141) | [3] | ($23,164) | [3] |
[1] | Represents risks in two or more geographic zones. | |||||||
[2] | Represents risks in one geographic zone. | |||||||
[3] | The other locations non-specific category refers to business for which an analysis of exposure by geographic zone is not applicable, such as marine and aerospace risks, since these exposures can span multiple geographic areas and, in some instances, are not fixed locations. |
Segment_information_Narrative_
Segment information (Narrative) (Details) | 9 Months Ended |
Sep. 30, 2014 | |
segments | |
Segment Reporting [Abstract] | ' |
Number of operating segments | 3 |
Subsequent_events_Details
Subsequent events (Details) (USD $) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 0 Months Ended | |||||||||||||
In Thousands, except Per Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Nov. 05, 2014 | Nov. 05, 2014 | Jun. 23, 2014 | Oct. 02, 2014 |
Common shares | Common shares | Common shares | Common shares | Common shares | Common shares | Common share equivalents | Common share equivalents | Common share equivalents | Subsequent Event | Subsequent Event | Western World Insurance Group, Inc [Member] | Western World Insurance Group, Inc [Member] | |||||
Common shares | Common share equivalents | Subsequent Event | |||||||||||||||
Subsequent Event [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash dividends declared per share | $0.30 | $0.30 | $0.90 | $2.90 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | ' | ' |
Business Acquisition, Date of Acquisition Agreement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 23-Jun-14 | ' |
Business Acquisition, Effective Date of Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2-Oct-14 |
Business Combination Purchase Agreement Aggregate Purchase Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $690,000 |